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ABSTRACT 
The multiple functions of the pineal gland have been collectively 
interpreted as constituting a general anti-stressogenic role. The 
adrenal glands playa central role in maintaining homeostasis. The 
major neuroendocrine consequence of long-term stress is elevated 
circulating glucocorticoid levels. 
In this study, the effect of chronic, oral hydrocortisone treatment 
on pineal biochemistry was investigated in male Wi star rats of the 
albino strain. The results show that seven days .of oral 
hydrocortisone treatment endows the pineal gland with the ability 
to increase melatonin synthesis in organ culture. The increase is 
accompanied by a rise in NAT activity, cyclic AMP levels and 
enhanced specific binding to the pineal B-adrenergic receptors. 
It appears that hydrocortisone sensitizes the pineal gland to 
stimulation by B-adrenergic agonists. thus rendering the pineal 
more responsive to B-adrenergic agonists. 
Further studies were directed at demonstrating an anti-stressogenic 
function for the pineal gland by investigating whether the 
principal pineal indole, melatonin. could protect against the 
deleterious effects of elevated. circulating hydrocortisone levels. 
The results show that chronic, oral hydrocortisone treatment 
significantly increases liver tryptophan pyrrolase activity. The 
catabolism of tryptophan by tryptophan pyrrolase is an important 
determinant of tryptophan availability to the brain, and therefore, 
brain serotonin levels. The findings show that melatonin inhibits 
basal and hydrocortisone-stimulated liver tryptophan pyrrolase 
apoenzyme activity in a dose-dependent manner. This inhibition 
suggests that melatonin may protect against excessive loss of 
tryptophan from circulation and against deficiencies in t.he 
cerebral serotinergic system which are associated with mood and 
behavioural disorders. 
It was shown that another deleterious effect of chronic 
hydrocortisone treatment is a significant increase in the number 
of glutamate receptors in the forebrain of male Wistar rats. The 
increase in receptor number observed in this study is probably due 
- xiv -
to an increase in the synthesis of glutamate receptors and is 
associated wi th a marked reduction in the affinity of the glutamate 
receptors for glutamate. 
possible to demonstrate an 
receptor number or the 
For practical reasons, it was not 
effect of melatonin on either glutamate 
affinity of glutamate receptors for 
glutamate in rat forebrain membranes. 
In view of the neurotoxic effect of glutamate in the eNS, the 
functional significance of recently described glutamate receptors 
in the pineal gland was investigated. The results show that 10-4 M 
glutamate significantly inhibits the isoprenaline-stimulated 
synthesis of N-acetylserotonin and melatonin in organ culture when 
the pineal glands were pre-incubated with glutamate for 4 hours 
prior to stimulation with isoprenaline. and when glutamate and 
isoprenaline were administered together in vitro. GABA, a 
glutamate metaboli te. could not mimic the decrease in isoprenaline-
stimulated melatonin, and it is likely that the observed effects 
were directly attributed to glutamate. Incubation of the pineal 
gland with 10-4 M glutamate in organ culture did not affect HIOMT 
activity in pineal homogenates, but significantly elevated both 
basal and isoprenaline-stimulated NAT activity. It was concluded 
that glutamate only inhibits melatonin synthesis in intact pineal 
glands and not in pineal homogenates. 
The present study has provided further support for an interaction 
between the pineal and the adrenal glands. There is an ever 
increasing likelihood that melatonin is an anti-stressogenic 
hormone and that the pineal gland may have a protective role to 
play in the pathology of stress-related diseases. 
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CHAPTER 1 
LITERATURE REVIEW 
1.1 INTRODUCTION 
After centuries of disregard, the pineal gland has, over the last 
few decades, finally become appreciated as an important, functional 
neuroendocrine gland. It has overcome a history clouded by 
unfounded philosophical ideologies, and survived the demand for its 
profound cytological and physiological evolutions to be dismissed 
as phylogenetic regression. Far from being a vestigial remnant 
with enigmatical function, the pineal gland is presently recognized 
as being an active, functioning and integral component of the 
neuroendocrine system. 
While the full extent of pineal function has not been clearly 
defined, its many actions have been collectively interpreted as 
constituting a general function to regulate and stabilize 
homeostatic equilibrium in close association with changing 
environmental conditions. The evolutionary changes wi thin the 
pineal gland should be considered to reflect adaptations to the 
increasingly sophisticated integrating systems which have evolved 
in higher animals, rather than functional regression. 
In the following review, an attempt has been made to describe 
anatomical, cytological and phylogenetic aspects of the pineal 
gland' as well as to describe the unique mechanism by which it is 
regulated. In view of the central role previously ascribed to the 
adrenal glands in maintaining homeostatic conditions in vivo. the 
interaction between the pineal and adrenal glands is explored with 
the aim of substantiating the anti-stressogenic role proposed for 
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the pineal gland. 
1.2 HISTORICAL ASPECTS OF PINEAL RESEARCH 
The history of pineal research has traditionally been divided into 
3 eras, each reflecting the prevailing philosophies and available 
technology. 
1.2.1 The First Period (circa 300 Be - mid 19th century) 
The discovery of the human pineal gland is credited to the famous 
anatomist, Herophilos, (325 - 280 Be). At a time when the problem 
of localizing the soul was the principle challenge to philosophers 
and scientists. many were attracted to the cone-shaped. unpaired 
organ on account of its location on top of the brain. The brain 
had already been proposed as the seat of the soul and during the 
course of the following nearly 20 centuries, a myriad of theories 
were proposed implicating the pineal as a regulator of the flow of 
the spirit. The dualistic philosophy concerning mind and matter 
supported by Rene Descartes (1596 1650) lead him to devise 
theories of pineal function that have been hailed as insightful and 
ingenious given the predominant philosophies of the time. He 
conceived brain function to be purely physico-mechanical and the 
body to be merely a machine. According to Descartes, the pineal 
gland - the seat of the soul - was responsible for directing the 
"fine, fierce wind of the spirit" along"different pores of the 
ventricular system to stimulate target muscles. The Renaissance 
(14th - 16th centuries) revived numerous scientific ideologies. but 
biological research was slow to respond and even after this period 
of intellectual revival, ancient views about the spiritual 
significance of the brain were incorporated into physiological 
studies. With few technological tools at their disposal, 
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anatomical and physiological data were limited and primitive. 
1.2.2 The Second Period (Mid 19th to mid 20th centuries) 
By the 18th and 19th centuries, scientists in general were 
approaching their subjects more systematically with greater 
emphasis on personal observation and experimentation. The 
development of increasingly sophisticated tools and techniques 
enabled a more methodical and thorough investigation o~ pineal 
macro- and micro-anatomical structure in non-vertebrate and 
vertebrate animals. Comparative cytological studies revealed that 
the pineal gland of lower vertebrates obviously functions as a 
photosensory organ and was referred to as "the third eye". The 
gradual loss of the photosensory apparatus in higher vertebrates 
was interpreted as phylogenetic regression, and the complex, solid 
organ in mammals was considered to be a rudimentary remnant of the 
non-mammalian pineal gland having enigmatical function. However, 
many cytological characteristics including subcellular granules and 
clear vesicles consistent with a secretory function were observed 
in the mammalian pineal which indicated a glandular function. In 
1898, Heubner described a boy with pinealoma showing signs of 
premature puberty. This was the first indication of an 
antigonadotrophic hormone produced by the pineal and following the 
discovery of the endocrine organs by Claude Bernard (1813 - 1878) 
and Brown - Sequard (1817 - 1894), the pineal was considered a 
serious candidate for an endocrine role. Marburg (1930) was the 
first to suggest a hormonal connection between the pineal gland and 
the hypothalamus. He believed specific pineal parenchyma produced 
an antigonadotrophic hormone which normally acted on the 
hypothalamus to retard sexual development in infants. 
Hypopinealism or destruction of the specific parenchyma would hence 
cause premature puberty while hyperpinealism would be responsible 
for delayed puberty. Bargmann, better known for his valuable and 
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well-respected review on the microscopic anatomy. histology and 
cytology of the pineal gland from fish to man published in 1943. 
also critically surveyed all available endocrinological research 
on the gland. Based on the findings of Berblinger (1932) and 
Roussy and Mosinger (1938) which indicated a neural connection 
between the pineal gland and the hypothalamus, Bargmann proposed 
that the regulation of hypothalamic function was possibly of a 
neural nature and not necessarily hormonal. The pineal, the 
hypothalamus and the pituitary gland together repres~nted a 
functional system regulating gonadal growth and function. 
According to Berblinger, the pineal and the pi tui tary exerted 
antagonistic effects on the vegetative centres in the hypothalamus, 
the former exercising an inhibitory influence while the latter 
would stimulate the same centres. 
1.2.3 The Third Period (Mid 19th century onwards) 
There is no clear division between the second and third periods of 
pineal research. The tremendous multi-disciplinary approach 
facilitated by the technological advancement following World War 
II has lead to a burgeoning of information on every aspect of 
pineal anatomy, histology, cytology, biochemistry, physiology and 
pharmacology. International communication and co-operation has 
been stimulated through numerous international congresses and 
publications devoted to pineal research. Although many scientists 
outside the immediate field are reluctant to accept the diminutive 
organ as a bona fide endocrine gland on account of its historical 
vestigal associations, the pineal gland has secured its place in 
the neuroendocrine system and its principle metabolite currently 
recognized as the pineal hormone, melatonin, has been used 
commercially. The full extent of the function of the pineal gland 
is yet to be established. but many have proposed that there are no 
organs within the body that escape its influence and it has been 
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dubbed "the regulator of all regulators." 
In spite of the tremendous advances in our understanding of the 
pineal gland over the past four decades, there still remain many 
grey areas which are the target of ongoing research. Current aims 
of research are focused on gaining a more complete understanding 
of the pineal system in order to establish whether it may 
contribute to the cause or relief of many problematic diseases of 
our time including cancer, heart and other stress-related d~seases, 
depressive disorders. Parkinson's and Alzheimer's diseases. 
1.3 PINEAL ANATOMY 
1.3.1 Embryology and Location 
Embryologically, the pineal gland or epiphysis cerebri develops 
from an evagination of the region of the neural tube which becomes 
the diencephalon [Ariens Kappers, 1971]. The size, shape and 
location of the gland varies in different species. In the rat, it 
is superficially located between the cerebral hemispheres, in front 
of the cerebellum where it is covered by the confluence of the 
superior sagittal and transverse sinuses (Figures 1.1 and 1.2). 
The cone-shaped organ remains attached to the brain via the pineal 
stalk, which is formed by the fusion and forward projection of the 
walls of the original epiphyseal evagination, but it loses direct 
neural contact with the brain. The stalk, which consists of 
pinealocytes. pinealoblasts and fibrocytes. is generally divided 
into ~hree distinct sections: a proximal part, a midpart and a 
distal part. The proximal part is connected to the brain between 
the posterior and habenular commissures. The midpart is often 
extremely thin and connects the proximal and distal parts. The 
latter is the longest of the three sections, its terminal being 
- 5 -
~\-------olbctQry lobe 
.....)..--- cerebral hemisphere 
~-----~,-I- pineal body 
vermis --""r-""~=--+-
panfiOCCUIUS} 
flocculus ere bellum 
=-+---7'----vermis 
medulla oblcn&aa -----_\_ 
---.,..::::::::=--I-=-_____ lroove continuous with 
posterior choroid plexus 
spinal cord ------"_t_ 
FIGURE 1.1 Dorsal view of the Rat Brain [Daya, 1982] 
posterior commissure 
h 3rd ventricle· pineal sulk C orold plexus pineal body 
- .. --..... ~.., corpora quadrlgemlna 
spinal cord 
olfactory lobe 
4th ventrlde 
anterior commissure 
opuc chiasma 
massa Intermedia 
lUI' medulla oblongata 
crura cerebrl 
pons varolll 
hypophysJS Litultary body 
Infundibulum (l" 
FIGURE 1.2 Medial Sagittal View of the Rat Brain 
(Daya, 1982] 
6 
connected to the pineal gland. 
1.3.2 Blood Supply 
Like other circumventricular organs, the pineal gland is located 
outside the blood brain barrier. It has been shown in the rat to 
have one of the richest blood systems in the body, exceeding that 
of the other endocrine organs, being surpassed only by that of the 
kidney [Goldman and Wurtman, 1964]. 
The blood supply to the pineal gland is provided by up to four 
branches of the posterior cerebral artery which penetrates the 
pineal capsule and forms a dense capillary network in the pineal 
parenchyma [Hodde, 1979]. Venous blood is collected by twelve to 
sixteen superficial veins which drain into the great cerebral vein 
and thereafter via the superior sagittal sinus into the systemic 
venous circulation. 
The high rate of blood flow through the pineal indicates that 
hormones in the blood could quickly be detected by the gland and 
secretions from the pineal could equally rapidly be transported to 
the systemic circulation. 
1.3.3 Innervation 
The innervation of the pineal gland has attracted much attention 
and has been proven to be of utmost importance for its function. 
Two types of pineal innervation have been distinguished: an 
afferent or pinealofugal system which has shown evolutionary 
regression and gradually been surpassed by a complex efferent or 
pinealopetal nerve system. The latter is predominantly derived 
from the sympathetic nervous system, although parasympathetic 
innervation has also been described in some animals. 
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1.3.3.1 Pinealofugal Innervation 
In vertebrates in which the pineal gland functions as a 
photosensory organ. photic stimuli perceived by the gland are 
transported to the brain via sensory neurons in the pineal tract 
[ArH~ns Kappers, 1971]. The nerve fibres have been found to 
terminate in the pretectal area, the area of the subcommissural 
organ and in the deep mesencephalic periventricular grey nuclei 
[Ueck. 1979] . There is evidence to suggest that the 
neurotransmitter involved is acetylcholine [Wake et a1, 1974]. The 
exact function of this nervous communication is unknown. 
This type of innervation which is predominant in fish and 
amphibians, is also present to a limited extent in reptiles and 
birds, but is totally absent in mammals [Ariens Kappers, 1971]. 
1.3.3.2 Sympathetic Innervation 
Phylogenetically, the sympathetic innervation starts developing in 
fish and develops progressively in amphibians, reptiles and birds 
as the pinealofugal innervation disappears IAriens Kappers, 1971]. 
It is of vital importance in mammals where it is responsible for 
the profound effects of light on the pineal gland (Figure 1.3). 
There are two major components of this system: the retino-
hypothalamic projection and the suprachiasmatic nucleus. 
The retinal-hypothalamic pathway is an unmyelinated tract in the 
optic nerve which originates in the ganglion layer of the retina 
[Hendrickson et a1, 1972]. The axons of ganglion cells pass 
through the optic nerve and project directly from the optic chiasma 
to make synaptic contact with neuronal parikarya in the ipsilateral 
and contralateral suprachiasmatic nuclei of the anterior 
hypothalamus. The retino-hypothalamic projection is distinct from 
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the primary optic tract and the inferior accessory optic tract. 
FIGURE 1.3 
Retinohypothalamic _J-'" ...... -~ 
Tract 
Suptachiasmatic 
Nuclei of 
Hypothalamus 
Pmtganglionic 
Sympathetic 
Neurons 
Olfactory Bulb 
Medial ""'--~J,.....:I-_ f<)Tebr~in 
Bundle 
PineJI 
Spinal Cord 
tinteromediolaterJI 
cell column) 
Sympathetic Neural Pathway to the Pineal Gland 
[Daya, 1982] 
Axonal projections from the suprachiasmatic nucleus follow a mul ti-
synaptic pathway through the brainstem, eventually terminating on 
neurons in the intermediolateral cell columns of the upper thoracic 
cord. The axons of the preganglionic sympathetic neurons leave 
the spinal cord in the ventral roots passing in the direction of 
the head in the sympathetic trunk to synapse with postganglionic 
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fibres in the superior cervical ganglia. The postganglionic fibre~ 
enter the cranial cavity via the internal carotid plexus and form 
discrete nerves called the nervi conarii which penetrate the pineal 
capsule at the apex of the gland. The nerves ramify among the 
pinealocytes and eventually terminate in the perivascular spaces 
of the pineal parenchyma [Young and Silman, 1982; Reiter, 1988; 
Klein. 1978 J • The dense network of nerve fibres known as a 
plexus. 
synapses, 
in the 
is characterized not by the formation of classical 
but rather by the frequent appearance of swollen areas 
neural processes described as varicosities. These 
varicosities contain dense-cored vesicles within which 
neurotransmi tters such as norepinephrine. dopamine. serotonin, 
GABA, histamine and octopamine are present [Klein, 1978]. 
Norepinephrine is the principal neurotransmitter involved in pineal 
function [Wolfe, 1965J. 
1.3.3.3 Parasympathetic Innervation 
In some mammals. parasympathetic innervation has been observed in 
the pineal gland. Preganglionic fibres arising in the superior 
salivatory nucleus in the medulla oblongata, leave the brainstem 
with the facial nerve. The fibres run with the greater petrosal 
nerve and reach the pineal gland together with the sympathetic 
fibres in the nervi conarii synapsing with ganglionic neurons along 
the nerves or within the pineal [cf. Young and Silman, 1982]. The 
function of the parasympathetic innervation is unknown. 
Electrophysiological investigations have provided evidence of 
nervous stimuli reaching the pineal gland from parts of the limbic 
system via the medullary striae, the habenular nuclei and the 
pineal stalk [Dafny, 1977; Ariens Kappers, 1971]. This is 
significant in that it indicates that stimuli of limbic origin may 
exert an influence on pineal function. The limbic system is 
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associated with olfaction, autonomic functions and certain aspect~ 
of emotion and behavior. It has been proven that olfaction does 
exert an influence on pineal function. 
Extrahypothalamic neurosecretory fibres have also been observed in 
the pineal of some mammals. While the function of these fibres is 
unknown. they are considered to be associated with peptidergic 
compounds demonstrated in the pineal [Ariens Kappers, 1971]. 
1.4 PINEAL CYTOLOGY 
Cytologically, the pineal gland of vertebrates has undergone 
profound evolutionary changes which should be considered when 
attempting to define the functional significance of the gland. The 
primary anlage of all vertebrate pineal glands is derived from the 
embryonic ectoderm, but the cellular differentiation in each 
vertebrate class is distinct. 
1.4.1 The cellular structure of the submammalian pineal gland 
Three cell types have been distinguished in the pineal gland of the 
lower vertebrates (fish and amphibians): photoreceptor cells, 
ependymal supportive or interstitial cells and sensory nerve cells 
[Ariens Kappers, 1971; Oksche er al, 1987]. 
1.4.1.1 Photoreceptor cells 
The photoreceptor or primary sensory cells are not neurons, but 
have a similar structure to the cone cells of the lateral eye. 
They display distinct structural and functional 
compartmentalization in four basic cellular regions: the outer 
segment, the inner segment, the cell soma and the basal process or 
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synaptic pedicle [Ariens Kappers, 1971; Collin and Oksche, 1981].-
The complex outer segment is characterized by a single ciliary 
structure and numerous successive membraneous evaginations which 
undergo constant degeneration and renewal. It is known as the 
photic pole because of its sensitivity to light. 
The distal section of the inner segment contains aggregates of 
mitochondria to provide energy for the transduction proces~ in the 
outer segment. It is connected to the proximal section through a 
neck region which is transversed by parallel arrays of 
microtubules. The proximal section contains a second concentration 
of mitochondria, rough endoplasmic reticulum. polysomes. lysosomes, 
glycogen particles and Golgi bodies which elaborate clear vesicles 
and dense cored vesicles. 
The cell soma is the largest of the four segments and contains the 
nucleus. 
The basal process or pedicle is a projection from the cell body 
toward the basal membrane which separates the perivascular spaces 
from the parenchyma, were it establishes synaptic contact with 
sensory neurons. Microfilaments and tubules run longitudinally 
through the central part of the cellular extensions. The cytoplasm 
contains rough and smooth endoplasmic reticulum. few free 
ribosomes, single mitochondria, synaptic ribbons and vesicles. 
In higher vertebrates. the outer segment becomes transformed into 
a rudimentary, frequently club-shaped structure. The 
photoreceptive capacity of the cells is lost and they are referred 
to as rudimentary photoreceptor cells {Collin, 1971]. This cell 
type gradually replaces the photoreceptor cells in reptiles and 
birds lcf. Ariens Kappers, 1971]. The basal processes may ramify 
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into smaller branches which terminate in close association with the 
basal membrane or, in some cases, penetrate through the membrane 
and project into the perivascular spaces. Synaptic contact with 
sensory nerve cells is diminished and the latter are quantitatively 
reduced. Synaptic ribbons disappear and are replaced by 
vesicle-crowned ribbons which occur in all regions of the cytoplasm 
[cf. Collin and Oksche. 1981]. They are electron-dense rodlets 
surrounded by a single layer of small clear vesicles and are often 
found close to the cell membrane. 
1.4.1.2 Ependymal Supportive or Interstitial Cells 
These are highly variable cells located between the photoreceptor 
cells. They exhibit extensive microvilli which form tight and 
intermediate junctions and occasionally desmosomes with each other 
and the photosensory cells. Their cytoplasm contains abundant 
smooth endoplasmic reticulum, free ribosomes, mitochondria, 
lysosome-like organelles, dense core granules and Golgi complexes 
which produce coated vesicles. Glycogen particles may be scattered 
in various amounts throughout the cytoplasm. Microtubules are few 
or missing, but microfilaments course through the cytoplasm. 
Pinocytotic vesicles have been observed in the microvilli and near 
the apical cell membrane. Myeloid bodies are found closely 
associated with the nuclear envelope and endoplasmic reticulum 
[cf. Collin and Oksche, 1981]. 
1.4.1.3 Sensory Nerve Cells 
Mul tipolar. bipolar and unipolar sensory neurons have been observed 
in the pineal gland [cf. Ariens Kappers, 1971 J • They form 
somato-somatic. axo-somatic. somato-dendri tic and axo-dendri tic 
ribbon synapses with the basal pedicle of the photoreceptor cells. 
An increase in the density of the post-synaptic membrane has been 
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linked with active neurotransmission. The axons of these sensory 
nerve cells constitute the pineal tract which conveys the photic 
stimuli to the brain [cf. Ariens Kappers, 1971; cf. Collin and 
Oksche, 1981]. 
1.4.2 The cellular structure of the mammalian pineal gland 
The mammalian pineal gland generally contains two categories of 
cells principally derived from the photoreceptor and su,Pporti ve 
cell lines described in submammalian pineal glands. They are 
pinealocytes and interstitial or glial cells [Peveto 1981]. 
1.4.2.1 Pinealocytes 
Pinealocytes are the predominant cells in the mammalian pineal 
gland and are variously referred to as pinealocytes of population 
I, chief cells, parenchymal cells and pinealocytes sensu stricto 
or true pinealocytes. They are differentiated from the second 
category of cells by the presence of granular vesicles [Pevet, 
1981]. Pinealocytes are derived from the photoreceptor cells by 
further progress of the rudimentation process characterized by the 
complete disappearance of the photoreceptor pole and secondary 
neurosensory cells [Collin, 1971]. They belong to the APUD cell 
series. 
The pinealocytes are devoid of the distinct cellular 
compartmentalization observed in their phylogenetic predecessors 
and exhibit a functional rearrangement of cell organelles. They 
are spaped like unipolar or multipolar neurons having large cell 
bodies with a varying number of processes emerging from the cell 
soma, similar to the basal processes described previously_ The 
spherical or oval nucleus is located in the cell body and contains 
the chromatin material irregularly arranged in a combination of 
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helices, granular masses and mesh structures in the peripheral 
area. The cytoplasm contains smooth and granular endoplasmic 
reticulum, free ribosomes. mitochondria. glycogen granules. lipid 
droplets and various membraneous structures of unknown function. 
The processes are rich in microfilaments coursing longitudinally 
through the cytoplasm and like the rudimentary photoreceptor cells. 
contain clear vesicles. vesicle-crowned ribbons and granular 
vesicles. 
The granular vesicles which characterize the true pinealocytes 
arise from juxtanuclear Golgi saccules and migrate to the endings 
of the processes to release their content into the perivascular 
space. They are considered to be of importance to the functioning 
of the pineal gland and their numbers appear to depend on different 
physiological conditions. Their numbers undergo a dramatic 
increase following administration of gonadotrophic hormone [Karasek 
and Marek. 1978] and following cold stress [Matsushima and 
Morisawa. 1978]. 
Vesicle-crowned rodlets, once considered to be phylogenetic relics 
of the ribbon synapses [Collin, 1971], are now regarded as 
functionally significant because of the numerical changes they 
exhibit under various physiological conditions [Karasek and 
Vollrath, 1989]. These organelles have been shown to increase in 
number after cold [Krstic. 1973] and immobilization [Milne et a1. 
1968] stress. 
Depending on the degree of evolution and the systematic position. 
a given pineal gland may contain representatives of all the cells 
in the photoreceptor cell line or only a limited set dominated by 
one particular cell type [Collin and Oksche, 1981]. Only one 
single population of true pinealocytes have been described in the 
pineal gland of the rat. 
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1.4.2.2 Interstitial Cells 
The second category of cells is derived from the ependymal 
supportive cells and comprise interstitial or glial cells. This 
group of cells, also referred to as pinealocytes of population II. 
are categorized by the absence of granular vesicles and their 
location close to the perivascular spaces [Pevet, 1981]. 
1.5 PINEAL MELATONIN BIOCHEMISTRY 
A major interest in pineal biochemistry was stimulated by McCord 
and Allen in 1917 when they reported that pineal extracts contained 
a substance which lightened the skin of amphibians. The active 
blanching agent was isolated by Lerner et al [1958] and identified 
as N-acetyl-5-methoxytryptamine. It was termed melatonin because 
of its ability to cause aggregation of melanin granules in 
melanophores. This initial discovery led to the identification of 
other indoles in the pineal gland and the unravelling of their 
biosynthetic pathway (Figure 1.4). 
1.5.1 Indole Metabolism in the Pineal Gland 
Indole metabolism in pinealocytes commences with the uptake of the 
essential amino acid precursor, tryptophan, from the bloodstream. 
A small amount of the tryptophan is utilized in the synthesis of 
pineal proteins. but the major portion is converted to 
5-hydroxytryptophan. This initial hydroxylation is catalysed by 
trypt~phan hydroxylase [Lovenberg et al. 1967, 1968; Jequier et al, 
1969] in the presence of oxygen, ferrous iron and a reduced 
pteridine cofactor [Snyder and Axelrod. 1964a; Lovenberg et al, 
1962]. Tryptophan hydroxylase has a low affinity for its 
substrate, tryptophan, and it has been suggested that the 
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availabili ty of tryptophan is a rate determining factor in the 
pathway. 
5-Hydroxytryptophan is decarboxylated by a pyridoxal dependent 
aromatic-L-amino acid decarboxylase [Snyder and Axelrod, 1964a] to 
form 5-hydroxytryptamine or serotonin [Lovenberg et" a1, 1962; 
Snyder and Axelrod, 1964a]. This enzyme is more concentrated in 
the pineal gland than in any other organ in the body [Snyder and 
Axelrod, 1964b] , and pineal serotonin concentrations are 
significantly higher than those found in any other tissues examined 
[Giarman and Day. 1959]. Serotonin can undergo a three way 
transformation: 
(1) A portion is methoxylated by hydroxyindo1e-O-methy1 transferase 
(HIOMT) to form 5-methoxytryptamine, a biologically active 
pineal hormone. 
donor. 
S-adenosy1methionine serves as the methyl 
(2) Serotonin is also oxidized by monoamine oxidase to 5-
hydroxyindo1e acetaldehyde {Axelrod et a1, 1969]. This 
unstable intermediate follows one of two metabolic fates. It 
may be converted by aldehyde dehydrogenase to 5-hydroxyindo1e 
acetic acid [Wurtman and Larin, 1968; Lerner and Case, 1960] 
which is then O-methy1ated by HIOMT to form 5-methoxyindo1e 
acetic acid !Wurtman and Axelrod, 1967]. Alternatively, 
5-hydroxyindole acetaldehyde may be converted to 
5-hydroxytryptophol by alcohol dehydrogenase [McIsaac and 
Page. 1959] which is then methylated by HIOMT to form 
5-methoxytryptophol rWurtman and Axelrod. 1967]. 
(3) The major pathway of serotonin metabolism is its conversion 
to N-acety1serotonin by the enzyme N-acety1transferase. This 
enzyme constitutes an important rate-determining step in the 
synthesis of melatonin [Klein and Weller, 1970]. The acetyl 
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group is donated by Acetyl CoA [Weissbach e~ a1, 19601. Finally, 
N-acetylserotonin is O-methylated to melatonin by HIOMT [Axelrod 
and Weissbach, 1960; Cardinali and Wurtman, 1972]. 
Melatonin is the pineal indoleamine of highest repute and the focus 
of most pineal research. It is considered by many to be the pineal 
hormone responsible for the principle endocrine effects associated 
with the pineal gland. 
1.5.2 Pineal Melatonin Secretion and Catabolism 
Melatonin has not been found to be stored in large pools in the 
pineal gland and events which alter melatonin synthesis are rapidly 
reflected in the blood [Arendt, 1988]. It is now generally 
accepted that the hormone is secreted into the bloodstream rather 
than into the cerebrospinal fluid. Although little is known about 
the mode of secretion. it appears to be secreted by simple 
diffusion as no active mechanism has been described. Melatonin 
is transported in the blood non-covalently bound to high-capacity, 
low-affini ty binding sites on plasma albumin [Cardinali e~ a1, 
1972; Reiter, 1981]. It has a half life of about 20 minutes in the 
blood of rats [Gibbs and Vriend, 1981]. 
The liver is the primary site of melatonin catabolism, but the 
metabolic routes vary from species to species [Arendt, 1988]. In 
humans and rodents, melatonin is hydroxylated in the 6 position and 
then conjugated to sulphate and sometimes to glucuronide 
derivatives rendering 6-sulphatoxymelatonin as the major urinary 
metaboli te. There is a very close correlation between plasma 
melatonin levels and both plasma and urinary 6-suphatoxymelatonin 
levels. This fact is sometimes used as a non-invasive technique 
of assessing melatonin levels in clinical situations. 
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1.5.3 Non-Pineal Sites of Melatonin Synthesis 
Initially melatonin synthesis was thought to be confined to the 
pineal gland and when it was discovered to be synthesized in other 
organs. a hormonal role for pineal melatonin was discounted. 
However. organ specificity is not a requirement of a hormone and 
many hormones are synthesized in a variety of sites. 
At present. melatonin is known to be synthesized in the retinas of 
the eyes. the Harderian gland, the intra-orbital lacrimal glands 
[Reiter, 1989] and the enterochromaffin cells of the 
gastro-intestinal tract [Raikhlin and Kvetnoy, 1976]. Many more 
tissues may also possess the enzymes required for melatonin 
synthesis. It is tentatively believed that pineal melatonin is 
solely, or at least predominantly responsible for the circulating 
melatonin levels in the blood. However, it is possible that the 
non-pineal sites may exhibit a compensatory increase in melatonin 
synthesis in pinealectomized animals. 
1 . 6 CIRCADIAN RHYTHMS IN PINEAL MELATONIN SYNTHESIS 
1.6.1 Description of the Circadian Rhythms in Melatonin 
Intermediates 
Except where there is a genetically based enzyme deficiency, pineal 
indoleamines exhibit a distinctive and well described circadian 
rhythmicity. 
1.6.1.1 Tryptophan: Primary Precursor in Melatonin 
Synthesis 
A circadian rhythm in pineal tryptophan levels has not been well 
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defined. The levels of pineal tryptophan appear to be modulated by 
the concentration of tryptophan in circulation. Injections of 
tryptophan which increase serum tryptophan concentrations, can 
elevate pineal levels of the indole [Deguchi and Barchas. 19721. 
As tryptophan is an essential amino acid, circulating 
concentrations depend largely on dietary intake. Being the least 
abundant amino acid in dietary protein, the mammalian body's supply 
is usually quite small [Fernstrom and Wurtman, 1974]. However. 
it is unique among amino acids in that 90% is transported bound to 
serum albumin, leaving only 10% freely diffusible [Bender, 1975]. 
The circulating serum levels of tryptophan therefore remain fairly 
constant. Furthermore, as the pineal gland is outside the blood 
brain barrier, tryptophan does not have to compete with the other 
large, neutral amino acids for an uptake system as it must to gain 
entry to the brain [Fernstrom and Wurtman, 1974]. 
1.6.1.2 Tryptophan Hydroxylase: Role in Melatonin Synthesis 
Tryptophan hydroxylase has been located in the mitochondria of the 
pinealocytes [Lovenburg et a1, 1967. 1968], and does not appear to 
be present in the nerve terminals. The enzyme has a low affinity 
for its substrate, tryptophan, and it has been proposed that it may 
act as a rate-limiting factor in the synthesis of serotonin 
[Reiter, 19891. However, tryptophan hydroxylase activity in the 
pineal gland is relatively high compared with other tissues and its 
pteridine cofactor, tetrahydrobiopterin (BH4 ) , is present in higher 
concentrations than in any other tissues' examined [Klein et a1, 
1981}. 
A circadian rhythm in pineal tryptophan hydroxylase activity has 
not been irrefutably established. Measurements of the biological 
half life of the enzyme suggest that it is synthesized continually 
[Sitaram and Lees, 1978}. Shibuya and co-workers [1978] reported 
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a S-adrenergic receptor-dependent 1~-fold rise in enzyme activi~y 
in the middle of the dark period. Deguchi [1977J was unable to 
demonstrate a circadian rhythm in tryptophan hydroxylase activity 
and its existence remains controversial. 
1.6.1.3 Aromatic L-Amino Acid Decarboxylase: Role in 
Melatonin Synthesis 
This non-specific enzyme is confined mainly to the cytosol of 
pinealocytes where it is present in relatively high concentrations 
[Snyder and Axelrod. 1964aJ. The activity of aromatic L-amino acid 
decarboxylase is only influenced by several days of constant 
exposure to environmental lighting [Snyder eL a1. 1965] and hence 
it does not appear to contribute to the circadian rhythms in the 
pineal gland. 
1.6.1.4 Serotonin: Circadian Variations 
Serotonin levels in the pineal gland are higher than in any other 
tissue in the body IGiarman and Day, 1959]. being approximately 
100-fold higher than those in the forebrain. This high 
concentration of serotonin serves to protect the pineal from any 
changes in circulating tryptophan and hence pineal serotonin levels 
are highly conserved IDaya eL a1, 1989]. However, in both 
nocturnal and diurnal animals, the levels of serotonin in the 
pineal exhibit a circadian variation (Figure 1.5). They are 
highest at midday and fall pre~ipitously "at night to a low level 
at about 11 pm [Quay, 1963]. Fiske [1964] reported day or 
light-time serotonin levels 13 times higher than those observed 
during the night or dark-time. 
Pineal serotonin levels are conceivably regulated by three 
metabolic factors: (1) its rate of synthesis; (2) the conversion 
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of serotonin to oxidation products, and (3) the rate at which 
serotonin is converted to N-acetylserotonin by N-acetyl transferase. 
The latter has been proven to be the most important regulatory 
component [Klein and Weller, 1970]. Enhanced N-acetylation of 
serotonin to N-acetylserotonin is responsible for the 
decrease in pineal serotonin levels at night. 
1.6.1.5 N-Acetyltransferase: Circadian Variations 
dramatic 
Normally, after the onset of darkness, there is a 30 - 70 fold rise 
in the activity of N-acetyltransferase (NAT) [Axelrod, 1974; 
Arendt, 1988]. The rise in activity in the first hour of darkness 
is quite small. Thereafter, NAT acti vi ty increases rapidly to 
reach a maximum four hours into the dark period. This rise 
persists until the animal is exposed to light, usually the onset 
of the next light period. The regulation of NAT activity is fairly 
complex and will be discussed in greater detail in later sections. 
1.6.1.6 N-Acetylserotonin: Circadian Variations 
The circadian rhythm in pineal N-acetylserotonin is 180· out of 
phase with that of serotonin: levels are low during the day and 
elevated at night (Figure 1.5). This is due to the activity of 
N-acetyltransferase [Klein and Weller, 1970]. 
1.6.1.7 Hydroxyindole-O-methyltransferase: Role in 
Melatonin Synthesis 
Pineal hydroxyindole-O-methyltransferase (HIOMT) is located almost 
entirely in the cytosol of the pinealocytes. The distribution of 
this methyl transferase is limited in mammals, but it is one of the 
most abundant single proteins in pinealocytes comprising 2 - 4~ of 
the soluble protein fraction [Klein er ai, 1981J. HIOMT has been 
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found to exhibit a small rise in activity at night or in the dark 
phase [Klein, 1979], (see Figure 1.5). During exposure to constant 
darkness there is a gradual increase in HIOMT acti vi ty and in 
constant light there is a gradual decrease in enzyme activity. The 
intracellular mechanisms involved in regulating HIOMT have not 
been clearly eludicated, and at this time it is not considered to 
be an important contributor to the melatonin circadian rhythm in 
the pineal gland. It may playa more important role in seasonally 
al tering the amplitude of the melatonin cycles 
Mosher, 1989]. 
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FIGURE 1.5 Diurnal Variation in the Components in the 
Pathway of Melatonin Synthesis from Serotonin 
[Arendt, 1988] 
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1.6.1.8 Melatonin: Circadian Variations 
The pineal melatonin circadian rhythm is in phase with that of 
N-acetyltransferase and N-acetylserotonin (Figure 1.5). The 
magnitude of the nocturnal rise in pineal melatonin varies among 
species, with the trough to peak ratio usually ranging from 1:2 to 
1: 10 [Reiter. 1988]. 
When the circadian rhythms of melatonin in various mammalian 
species were compared, it was apparent that the nature of the 
rhythm varied in a species-specific manner [Reiter, 1988]. These 
24 hour rhythms have thus been classified into 3 types: A, Band 
C, based on the nature of the nocturnal rise in melatonin [Reiter, 
1983], (see Figure 1.6). The type A pattern of melatonin 
production is associated with a delayed rise in pineal melatonin 
following the onset of the dark period. Levels of the indole 
remain low for several hours into the dark period and then rise 
rapidly to reach a short-term peak in the latter half of the dark 
cycle. The peak is followed by a rapid reduction in melatonin to 
near basal levels by the onset of the light period. The type B 
pattern is associated with a gradual rise in melatonin 
concentrations at the beginning of, or in some cases just before, 
the onset of the dark period. The peak is established near the 
middle of the dark period after which there is a gradual decline 
in values to basal levels just prior to the onset of the next light 
phase. In the type C pattern, pineal melatonin levels increase 
rapidly after the onset of darkness, reaching a plateau which'is 
maintained for the majori ty of the dark phase. Levels drop steeply 
to b~sal values just before the onset of the next light phase. 
Within certain limits, a change in the light : dark ratio alters 
the duration of the nocturnal rise in melatonin accordingly. 
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1.6.1.9 Norepinephrine: Daily Variations 
A 24 hour rhythm has also been established for the turnover of 
norepinephrine in the sympathetic nerves innervating the mammalian 
pineal gland rWurtman e~ a1, 1967; Brownstein and Axelrod, 19741. 
The highest turnover of norepinephrine apparently occurs at night. 
Norepinephrine is synthesized from the amino acid tyrosine. The 
first and rate determining step in the pathway is the conversion 
of tyrosine to L-dopa catalysed by tyrosine hydroxylase. The 
latter is subsequently converted to dopamine by dopa decarboxylase 
and finally hydroxylated to norepinephrine by dopamine hydroxylase 
[Stryer, 1981]. The acti vi ty of tyrosine hydroxylase in the 
intrapineal nerve endings has heen found to rise at night [Craft 
- 26 -
at: 81, 1984]. The resul~ is enhanced synthesis and release of 
norepinephrine at night. 
1.6.2 Regulation of the Circadian Rhythm in Melatonin 
Synthesis 
1.6.2.1 Light: The Primary Regulator 
Fiske e"t 81 [1960] reported that continuous exposure to light 
resulted in a decrease in the mass of the pineal gland in rats. 
This was the first indication of an influence of light on the 
pineal gland. The normal daily variations in the components of the 
melatonin biosynthetic pathway mentioned above indicate that light 
is an important regulator of melatonin synthesis. The daily 
variations in sero~onin. N-acetylserotonin, melatonin and 
norepinephrine persis~ unchanged in constant darkness and in 
blinded animals. but are completely abolished in animals exposed 
~o continuous light [Snyder e"t 81. 1965; Brownstein and Axelrod. 
1974; Axelrod, 1974]. Reversal of the lighting scheme (lights kept 
on at night and off during the day-time hours) causes a complete 
inversion of the rhythms within six days [Snyder a"t 81. 1967]. 
The rhythms have also been shown to adapt to changes in the lengths 
of the dark and light schedule. 
The abili~y of light to modify the circadian rhythms in ~he pineal 
is thus evident. Animals born and raised in continuous darkness 
have been found to exhibit a circadian rhy~hm, but this may not be 
in phase with the external day: night rhythm. This suggests that 
the rhythms are endogenous and probably generated by the central 
nervous system. Light is not required to entrain the cyclic 
production of melatonin by the pineal gland, but modifies the 
rhythm to be in phase with the external environment. 
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Early investigations indicated that the principal target of the 
light-induced responses in the pineal gland was NAT. When 
stimulated. the enzyme depletes its substrate. serotonin. resulting 
in concomitant elevation of its main product. N-acetylserotonin. 
and subsequently melatonin. When rats were exposed to as little as 
one minute of light during the dark period. th~re was a precipitous 
fall in pineal NAT activity [Deguchi and Axelrod, 1972a; Klein and 
Weller, 1972J. However. exposing the animals to darkness during 
the normal light period when NAT activity was low did not 
necessarily induce an increase in the acti vi ty of the enzyme 
[Binkley et a1. 1973J. There appeared to be a refractory period 
approximately coincident with the normal light period during which 
time darkness could not initiate a rise in NAT or melatonin levels. 
From this it was deduced that light could "switch off" NAT at any 
time once it has been stimulated and returning the animals to the 
dark would only initiate enzyme activity again during a sensitive 
period. 
The brightness or irradiance of the light which effects the above 
responses in pineal indole metabolism. varies greatly among mammals 
[Rei ter, 1986; 1988]. The pineal gland of the albino rat will 
respond to as little as 0.0005 ~Watts/cm2 of white light. while the 
pineal of the Richardson's ground squirrel requires an irradiance 
of at least 1850 IlWatts/c~. All other species have light 
sensitivities which lie in between these two extremes. The human 
pineal responds to about 150 IlWatts/cm2. Environmental lighting 
which naturally controls pineal function ranges between full 
moonlight (0.03 - O. 05 ~Watts/c~) to full sunlight which on a 
clear day can be as bright as 25000 to 50000 IlWatts/cm2. Normal 
room light is on average 50 - 100 IlWatts/cm2. 
Besides brightness. the wavelength of the irradiance also 
determines its ability to effect pineal indole metabolism IReiter, 
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1988]. Wavelengths of light in the blue range (SOD - 510 A) are 
most effective, while wavelengths of light in the red range are 
least effective. 
1.6.2.2 Innervation: Facilitates Light Regulation 
The principal pineal circadian rhythms are abolished by denervating 
the sympathetic nerves to the pineal or by interrupting the nerve 
impulses from the brain [Snyder et a1, 1965; Klein et a1, 1971J, 
(see Figure 1.7]. 
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FIGURE 1.7 Schematic Representation of Melatonin Output 
under conditions of alter Nervous Input 
[Young and Silman. 1982] 
The sympathetic innervation of the pineal gland has been previously 
described (section 1.3.3.2). Interruption of the sympathetic 
fibres at any point between the suprachiasmatic nucleus (SeN) and 
the pineal gland renders the gland non-functional [Reiter, 1988]. 
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Lesions which completely destroy the SeN, abolish pineal rhythms 
while incomplete lesions which leave part of the SeN and its 
proj ections intact, do not affect the rhythms [Klein, 1978]. 
Severance of the optic nerves or optic tracts without affecting the 
retinohypothalamic projection will result in blindness, but will 
not disrupt any essential component of the retinal - pineal pathway 
[Klein 1978; Young and Silman, 1982]. If the SeN and the retina 
become uncoupled, the pineal rhythms follow the free-running rhythm 
of the SeN independent of environmental lighting stimuli [Klein and 
Weller, 1970]. 
The effects of light on pineal function are attributed to the 
inhibitory effects of light on the sympathetic nerves to the pineal 
gland [Klein, 1973]. 
1.6.2.3 Norepinephrine: Primary Messenger of Light Regulation 
The importance of the sympathetic innervation for melatonin 
synthesis and the corresponding daily rhythm observed in pineal 
norepinephrine turnover implicated the neurotransmitter as a 
regulatory component of pineal indoleamine synthesis. 
The two main neurotransmitters identified in the intrapineal nerve 
terminals are norepinephrine and serotonin. In vi~ro experiments 
showed that the addition of norepinephrine to pineal glands in 
culture initiated a significant increase in the synthesis of 
melatonin from a radioactive tryptophan precursor [Shein at a1. 
1967; Axelrod at 81, 1969; Klein and Weller. 1970]. The same 
effect was achieved in vitro with other sympathomimetics: 
epinephrine. dopamine, octopamine and tyramine. The addition of 
serotonin to the culture media was completely ineffective. In vivo 
administration of reserpine, a drug that depletes catecholamines 
and serotonin from nerve terminals, has been found to prevent the 
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nocturnal rise in NAT activity. However. the administration of 
p-chlorophenylalanine. a compound which depletes nerve terminals 
of serotonin, has no effect on the nocturnal rise in NAT. This 
evidence has established norepinephrine as the neurotransmitter 
responsible for the sympathetic neural control of pineal 
indoleamine synthesis acting by a mechanism involving NAT. Light 
reduces the amount of norepinephrine released from sympathetic 
nerve endings in the gland [Brownstein and Axelrod, 1974] and this 
accounts for the reduction in NAT activity when the animals are 
exposed to light. 
1.6.2.4 S-Adrenergic Receptors: Transducers of Light Regulation 
Having established that norepinephrine is responsible for the 
elevation in NAT activity in the pineal gland, it was necessary to 
determine the receptor population involved in the transduction of 
the neural signal. Norepinephrine is a multi-receptor agonist 
active at al-' a2-' B1- and B2-adrenergic receptors. 
In vitro studies revealed that the B-adrenergic antagonist, 
propranolol, is able to prevent the norepinephrine-induced 
stimulation of NAT acti vi ty. but the a-adrenergic antagonist. 
phenoxybenzamine, has no effect [Wurtman et al, 1971]. In vivo 
administration of propranolol before the onset of the dark period 
inhibits the night-time rise in NAT activity. Similar treatment 
with a-blocking agents had no effect [Deguchi and Axelrod. 1972a]. 
Administration of isoprenaline. a B-adrenergic agonist, during the 
day-time when NAT is at basal levels, results in a large increase 
in the activity of the enzyme IDeguchi and Axelrod, 1972b]. This 
effect is inhibited by B-blocking agents. Furthermore. injection 
of isoprenaline at the end of the dark period prior to light 
exposure prevents the light induced decrease in NAT acti vi ty 
[Deguchi and Axelrod, 1972a]. Studies using selective B1- and 
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B2-adrenergic agonists 
demonstrate that the 
and antagonists in pineal organ cultures 
rat pineal responds to acti vi ty at the 
B1-adrenergic receptor subpopulation. 
These findings clearly indicate that the effects of norepinephrine 
on NAT acti vi ty and therefore pineal metabolism are mediated 
primarily by B-adrenergic receptors. 
1.6.2.4.1 Supersensitivity and Subsensitivity of the S-Adrenergic 
receptor 
Deguchi and Axelrod [1973] found that the response of pineal 
B-adrenergic receptors to nervous stimulation is dependent in 
previous exposure to norepinephrine. When the noradrenergic 
stimulation is abolished by denervation or severely diminished by 
reserpine administration, decentralization or continuous lighting, 
subsequent stimulation of the B-adrenergic receptor results in 
greatly enhanced NAT activity. The maximum response is unchanged, 
but greatly reduced concentrations of norepinephrine are required 
to produce the same response in sensitized pineals relative to 
desensitized glands. Conversely. increased simulation of the 
B-adrenergic receptor reduces the sensitivity of the receptor to 
subsequent stimulation. The phenomena of super- and 
sub-sensi ti vi ty are primarily attributed to an increase or decrease 
in the number of B-receptors respectively [Kebabian e~ a1, 1975; 
Romero e~ a1; 1975b]. 
The diurnal. light-induced variation in norepinephrine release in 
the pineal gland induces a daily variation in the sensitivity of 
the B-receptors [Romero and Axelrod, 1974]. The reduced release 
of norepinephrine during the day induces B-receptor 
supersensitivity while increased stimulation of the B-receptors at 
night leads to the phenomenon of subsensi ti vi ty. The rapid 
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increase in the number of B-receptors towards the end of the dark 
period [Romero er al, 1975b] suggests that the B-receptor density 
is regulated by an activation process possibly involving the 
internalization or uncoupling of the receptors, rather than the 
slower process of de novo receptor synthesis. 
1.6.2.5 a-Adrenergic Receptors: Role in Regulation of Melatonin 
Synthesis 
More recent data have shown that functional ai-adrenergic receptors 
are also present in the pineal gland [Sugden and Klein, 1984]. 
These receptors do not exhibit a circadian variation or the 
phenomena of super- or sub-sensitivity. They are located 
postsynaptically and are involved in potentiating the B-adrenergic 
response. 
ai-Adrenergic receptors have been implicated in enhanced turnover 
of phosphoinositol and elevation of cytosolic calcium by mediating 
the release of intracellular calcium and the entry of extracellular 
calcium into the pinealocytes. 
a2-Adrenergic receptors have also been demonstrated in the pineal 
gland. Pre-synaptic a2-receptors regulate the release of 
norepinephrine via a classical negative feedback mechanism. These 
receptors have also been shown to mediate the inhibition of 
adenylate cyclase [Sabol and Niremberg, 1979]. 
1.6.2.6 Cyclic AMP: Second Messenger of Neural Regulation 
Cyclic adenosine-3' ,5'-monophosphate (cyclic AMP) is a well 
recognized second messenger which initiates numerous intracellular 
events in response to hormonal or neural stimuli via receptor 
coupled adenylate cyclase. Adenylate cyclase is the enzyme which 
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catalyzes the conversion of adenosine triphosphate (ATP) to cyclic 
AMP. In other tissues, B-adrenergic receptors had often been found 
to elicit numerous intracellular events coupled to adenylate 
cyclase and resulting from a classical rise in intracellular cyclic 
AMP concentrations. Early studies indicated that the same system 
was functional in the pineal gland. 
Norepinephrine was found to stimulate adenylate cyclase 1n pineal 
homogenates [Weiss and Costa 1967] . Furthermore, dibutyryl 
cyclic AMP, a cyclic AMP analogue, which unlike cyclic AMP is not 
catabolized by phosphodiesterase, was found to significantly 
stimulate melatonin 
precursor in vitro 
only stimulated 
formation from a radioactive tryptophan 
[Shein and Wurtman, 1969]. Cyclic AMP itself 
melatonin synthesis when theophylline, a 
phosphodiesterase inhibitor, was included in the culture medium 
[Strada et al, 1972]. Other studies showed that these effects were 
due to the ability to the cyclic nucleotide to enhance NAT 
activity. 
Deguchi [1973J reported that injection of isoprenaline, a 
E-adrenergic agonist, during the day-time resulted in a 15-fold 
increase in pineal cyclic AMP wi thin 2 minutes. The elevated 
levels were maintained for 10 minutes before returning to basal 
levels 30 minutes after injection. A further 30 minutes after 
basal cyclic AMP had been attained, NAT activity started to rise 
and reached a maximum 3 hours after injection. Enzyme activity 
returned to normal day-time values after 5 hours. Injection of the 
B-adrenergic antagonist, propranolol, before the isoprenaline, 
prevented the rise in both cyclic AMP and NAT activity. 
Propranolol even prevented the rise in NAT activity when it was 
injected 60 minutes after the isoprenaline and following the 
intracellular rise in cyclic AMP. Furthermore, propranolol 
administration during periods of maximal NAT activity resulted in 
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a rapid decline in the NAT activity. This indicates that elevation 
and maintenance of NAT activity is dependent not only on B-receptor 
stimulated elevation of intracellular cyclic AMP levels. but also 
on continuous stimulation of the B-receptor. This work provides 
evidence for a sensitive mechanism regulating NAT activity in which 
any event which interrupts the association of norepinephrine with 
the B-receptor will decrease NAT activity. 
The B-adrenergic receptor stimulated rise in NAT activity at night 
or after the injection of isoprenaline is prevented by 
cyclohexamide, a protein synthesis inhibitor, and by actinomycin 
D, an antibiotic which prevents the transcription of RNA from a 
double helical DNA template. This suggests that the cyclic AMP in 
the pineal is involved in both transcriptional and translational 
processes leading to the activation of NAT. However, when NAT is 
re-induced by isoprenaline at night after its activity has been 
reduced by a brief exposure to light. the effect is blocked by 
cyclohexamide, but not by actinomycin D {Romero e"t al, 1975a]. 
Thus protein synthesis is always required for NAT activity, but RNA 
synthesis is only required for the initial induction of the enzyme. 
The lag period between the rise in cyclic AMP levels and the 
increase in NAT activity appears to reflect a period of RNA 
synthesis (probably mRNA) as actinomycin D is ineffective in 
preventing the rise of NAT when administered after this lag period. 
This lag period varies from species to species and depends on the 
length of the previous light exposure. The rapid return of cyclic 
AMP to basal levels within half an hour ,of stimulation suggests 
that RNA synthesis is the primary cyclic AMP-dependent event 
responsible for increasing NAT. It is unclear whether the RNA 
synthesis induces de novo synthesis of NAT itself or the synthesis 
of an NAT activator protein. The former is considered more likely 
[Reiter, 1991], although the two possibilities are not mutually 
exclusive. 
- 35 -
A cyclic AMP - dependent protein kinase is present in the pineal 
gland [Fontana and Lovenberg. 1971; 1973]. The activity of this 
enzyme parallels the circadian variation in NAT. This 
phosphorylating enzyme is also involved in the induction of NAT. 
More recently, the potentiation of BI-adrenergic cyclic AMP 
response by aI-adrenergic receptors has been demonstrated [Reiter, 
1991]. Stimulation of BI-adrenergic receptors results in a 10-fold 
increase in intracellular cyclic AMP levels while aI-adrenergic 
receptor stimulation alone produces no changes in intracellular 
cyclic AMP levels. However, combined stimulation of al- and 
BI-adrenergic receptors results in a 30 - 100 fold increase in 
intracellular cyclic AMP. 
1.6.2.7 N-Acetyltransferase: Principal Target of Melatonin 
Regulation 
N-acetyltransferase has been shown to play a key role in 
controlling pineal melatonin synthesis: it is the focus of all of 
the factors normally regulating the circadian variation in 
melatonin synthesis (see Figure 1.8). Neural pathways from the SeN 
relay episodic sympathetic nerve impulses to the pineal gland. The 
release of norepinephrine from the nerve varicosities in the pineal 
gland stimulates postsynaptic B1-adrenergic receptors which are 
coupled to adenylate cyclase. The subsequent rise in intracellular 
cyclic AMP levels results in elevated NAT activity via a process 
involving protein transcription and translation. 
N-acetyltransferase then draws on its large supply of substrate to 
synthesize N-acetylserotonin, the direct precursor of melatonin. 
The availability of its substrate, serotonin, is not considered to 
be a rate-limiting factor as the latter is present in such high 
concentrations in the pineal gland. The activity of HIOMT which 
converts N-acetylserotonin to melatonin is also not considered to 
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be a rate-limiting step and hence control of melatonin synthesis 
is principally related to NAT activity. 
The precise and reproducible nature of the daily melatonin rhythm 
is the result of the episodic release of norepinephrine in the 
pineal gland under the control of the SeN synchronized by 
environmental lighting and the changing responsiveness of the 
pinealocyte a-receptors. 
FIGURE 1.8 : Diagrammatic Representation of Regulation of Pineal 
Melatonin Synthesis 
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1.6.3 Extra-Retinal Routes of Pineal Indoleamine Regulation 
There is a scarcity of information on the melatonin rhythms in 
lower vertebrates. Quantitatively indole metabolism appears to be 
important in these animals and it generates higher circulating 
melatonin levels than those found in more advanced animals. 
Non-pineal sites of melatonin synthesis are more prevalent with the 
retina of the eyes making an important contribution. This may 
also explain the failure of researchers to establish daily rhythms 
and obtain consistent effects of pinealectomy in all ·species. 
Pineal melatonin synthesis is probably influenced by light invading 
the skull and stimulating the pineal directly. 
In chickens, lesion of the sympathetic nerves innervating the 
pineal gland does not affect the synchronization of NAT to the 
light : dark cycle, or the response of NAT to continuous light or 
brief exposure to light during the dark period. Furthermore. when 
chicken pineal glands were cultured in constant darkness, they 
exhibited a circadian NAT variation which was remarkably similar 
to that in the intact animal before sacrifice. It was hence 
proposed that the pineal glands of at least some birds have an 
.... : 
innate timing ability independent of light and innervation 
[Binkley et al, 1977; 1978]. 
There is also evidence for a non-retinal pathway of light to the 
pineal gland in neonatal rats. As hooding abolished the effect of 
light in these animals, it appears that the pineal is directly 
photosensitive. This pathway probably controls physiological 
processes in the pineal gland before the eyes are fully developed 
[Binkley. 1981]. 
From the above discussion, it is evident that the evolutionary 
development in pineal photoreception in vertebrates reflects the 
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phylogenetic evolution of the anatomical structures in the pineal 
gland. 
1.6.4 Significance of the Melatonin Rhythm 
The ability of the pineal gland to convert incoming neural stimuli 
into outgoing hormonal messages led to the gland being classified 
as a neuroendocrine transducer, rather than being viewed as a true 
gland in the traditional sense. The latter classification would 
imply that it simply responds to substances in the bloodstream by 
secreting its own hormones into the blood. 
transducer, the pineal gland transduces 
As a neuroendocrine 
important photic 
information initially derived from the external environment into 
a hormonal message which can regulate numerous endogenous processes 
which cannot themselves perceive external, environmental 
conditions. The immediately obvious significance of this pineal 
function was related to the changing day-lengths associated with 
the annual progression of the seasons. By detecting the changing 
photoperiod, the pineal gland could control seasonal behavior by 
ini tiating physiological processes most appropriate to the external 
environment, e.g. reproduction and'hibernation, and thereby ensure 
the survival of the individual and propagation of the species. 
The mechanism 
oscillations in 
whereby target organs interpret the 
circulating melatonin levels is unclear. 
daily 
The 
oscillating nature of the melatonin signal may be essential for the 
endocrine activity of the hormone, as it-has been shown in some 
mammals that continued availability of melatonin seems to down 
regul~te the receptors on which it acts thereby rendering the 
indole physiologically impotent. A period of reduced melatonin 
availability is required for the receptors to become up-regulated 
and responsive to melatonin again [Reiter, 1989]. Three hypotheses 
have been proposed in an attempt to rationalize which component of 
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the melatonin signal is mos"t impor"tan"t for "the animal"s 
physiological adjus"tments: "the dura"tion hypo"thesis, the coincidence 
hypothesis and the ampli"tude hypo"thesis [Rei"ter, 1987; 1988; 1989]. 
1.6.4.1 The Duration Hypothesis 
The duration hypo"thesis proposes tha"t it is "the duration of the 
elevated melatonin levels that is responsible for end organ 
responses, particularly in relation to seasonal responses. The 
length of the night is directly proportional to the season of the 
year (short nights in summer and long nights in winter), therefore 
the length of the night-time rise in melatonin provides an 
important indication of the season (Figure 1.9). This hypothesis 
has been extended to include the direction of the change in 
elevated mela"tonin, i.e. whether the period is becoming longer 
(autumn) or shorter (spring). There is some evidence to suggest 
the duration of raised melatonin levels is important in controlling 
reproduction [Reiter, 1989]. 
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FIGURE 1.9 Graphical Representation of the Duration 
Hypothesis {Reiter, 1989] 
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The duration hypothesis fails to explain why in many reported 
cases, target organs are only responsive to melatonin at certain 
times of the day {Redman eL a1. 1983]. 
1.6.4.2 The Coincidence Hypothesis 
The coincidence hypothesis proposes that target organs exhibit a 
period or "window" of sensitivity to melatonin. According to this 
hypothesis, it is only when elevated melatonin levels coincide with 
the "window" of end-organ sensitivity, that the target urgan is 
responsive to stimulation by the indole hormone (Figure 1.10). 
This theory allows target tissues to each have their own unique 
period of responsiveness to melatonin and explains why some 
FIGURE 1.10 
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Graphical Representation of the Coincidence 
Hypothesis [Reiter, 1989] 
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melatonin messages selectively modify the functioning of certain 
end organs but not others. This hypothesis requires that melatonin 
receptors be widespread throughout the body and only intermittently 
sensitive to melatonin. The receptors may be rendered insensitive 
by processes such as down regulation, internalization, degradation 
or uncoupling from effector components. 
1.6.4.3 The Amplitude Hypothesis 
The amplitude hypothesis suggests that it is the amplitude of the 
nocturnal rise in melatonin which cues different physiological 
processes. However, except in some human diseases, the amplitude 
of the rise in blood melatonin concentrations has not been shown 
to be highly variable. 
1 .7 ENDOCRINE EFFECTS OF THE PINEAL GLAND 
The reported effects of the pineal indoles are numerous. However, 
the complex biological interactions in vivo have made the task of 
investigating the biochemical basis of the effects. a very 
difficult one. Moreover, pineal effects in different species are 
varied and generalizations are hence made with caution. 
1.7.1 Tissue Distribution 
An understanding of the tissue distribution of a compound is an 
important indication of its sites of action. In addition to its 
non-pineal sites of synthesis mentioned previously (section 1.5.3) , 
melatonin has also been located in various sites in the brain, 
peripheral nerves and the ovaries. It is a highly lipophilic 
substance and hence its access to the central nervous system is not 
affected by the blood brain barrier. 
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Intravenous injections of 
., 
., 
[3H]melatonin have revealed the ability of numerous organs to 
extract the indole from the blood. These include parts of the eye, 
peripheral nerves, the ovaries, the adrenal glands, and to a minor 
extent, other endocrine organs [cf. Burton. 1989; Reiter, 1989]. 
1.7.2 Binding Si~es 
The advent of radioligand binding assays have been an invaluable 
tool in identifying and quantifying melatonin receptors. Specific, 
saturable melatonin binding sites have been identified in 
synaptosomal preparations of the hypothalamus, SeN, striatum, 
medulla pons, hippocampus, cerebral cortex, choroid plexus, retina 
and the anterior pituitary [Zisapel e~ a1, 1988; Vanecek, 1988]. 
High affinity binding sites have also been demonstrated in 
cytosolic fractions of the hypothalamus, hippocampus and striatum. 
The presence of melatonin receptors in the hypothalamus is 
significant as a number of studies have implicated this region of 
the brain as the primary locus through which melatonin mediates 
many of its endocrine activities. Furthermore, a distinct diurnal 
rhythm in the density of melatonin binding sites has been reported 
in the hypothalamus [Zisapel e~ a1, 1988]. This may be of 
physiological significance especially in respect of the coincidence 
theory of melatonin's influence on target tissues (section 
1.6.4.2). 
1.7.3 Effec~s of Pineal Compounds on Endocrine Axes 
The effects of the pineal gland on three endocrine axes has 
attracted much research interest. They are the hypothalamic-
pituitary-gonadal axis. the hypothalamic-pituitary-thyroid axis 
and the hypothalamic-pituitary-adrenal (HPA) axis. The central 
role of the hypothalamus in each of these axes as well as in 
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control of the retinal-hypothalamic-pineal axis, may provide 
evidence of a co-operative link between these endocrine systems. 
1.1.3.1 Pineal Effects on Reproduction 
The effect of the pineal gland on the reproductive system was 
historically the first to be recognized. In view of this, it is 
not surprising that the interaction between the pineal gland and 
the reproductive organs has enjoyed most of the research interest. 
This has resulted in a large accumulation of data which 
acknowledges the role of the pineal gland and pineal derivatives 
in modulation of the hypothalamic-pituitary-gonadal axis. 
It has been conclusively demonstrated in both sexes that 
pinealectomy or any treatment which inhibits pineal function leads 
to premature physical maturation in juveniles. and to enlargement 
of the gonads and accessory organs in adults. The reproductive 
organs exhibit severe reduction in size and function following 
increased pineal acti vi ty. This antigonadotrophic effect has 
previously been attributed to melatonin, but recently, the 
involvement of other pineal indoles and peptides has been 
considered. 
The pineal gland has been shown to depress various aspects of the 
hypothalamic-pituitary-gonadal axis (Blask, 1981]. The primary 
si te of pineal-mediated antigonadal acti vi ty may be the 
hypothalamus. It has tentatively been proposed that melatonin acts 
through specific brain receptors to suppress the responsiveness 
of the pi tui tary to gonadotrophic releasing hormones and reduce the 
release of the gonadotrophic hormones from the pituitary. 
Reiter and co-workers demonstrated that the pineal gland regulates 
the seasonal reproductive cycles in hamsters by utilizing the day-
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length as a primary environmental cue. The shorter day-lengths 
which occur during the winter months enhances antigonadotrophic 
activity of the pineal gland. This is mirrored by the observation 
that arctic animals such as the seal, the walrus and the penguin 
have inordinately large pineal glands. 
1.7.3.2 Pineal Effects on the Thyroid Gland 
The thyroid gland is the end organ in the hypothalamic-
pi tui tary-thyroid axis. The hypothalamus releases thyrotropin 
releasing hormone which stimulates the pi tui tary gland. The latter 
responds by releasing thyroid stimulating hormone which induces the 
synthesis and release of triiodothyronin and thyroxine from the 
thyroid gland. The thyroid hormones stimulate general metabolism 
in most body tissues and are essential for normal growth and 
development. Thyroxine stimulates enzymes in the Krebs Cycle and 
the Embden-Meyerhoff glycolytic pathway as well as increases lipid 
metabolism in rat pineal cultures [Milcu et a1, 1968]. 
The general consensus is that the pineal gland exhibits an 
lnhibi tory action on the thyroid gland {Johnson, 1982] . 
Pinealectomy has been shown to result in enlargement of the thyroid 
gland in numerous mammalian species and significantly elevates 
plasma thyroxine levels relative to sham-operated controls [Narang 
et a1, 1967; Vriend, 1983]. Intrinsic to thyroid function is the 
uptake of iodide from the blood and its incorporation into 
synthesized thyroid hormones. This factor has frequently been 
moni tored to measure hormone production in the thyroid gland. 
Pinealectomy has been shown to increase iodide uptake by the 
thyroid gland. 
The site of action of the pineal on the thyroid axis is uncertain. 
There is some evidence to suggest that the hypothalamus may be a 
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locus of pineal func~ion [Johnson, 1982]. However, mos~ evidence 
supports the hypothesis ~ha~ the pineal in~erferes wi~h thyroid 
func~ion at ~he levels of ~he gland itself by modula~ing the 
syn~hesis and release of ~hyroid hormones. 
Thyroxine and ~riiodo~hyronine added ~o ~he cuI ~ure medium of 
incubated pineal glands have been found ~o increase ~he conversion 
of 14C-~ryp~ophan ~o 14C-mela~onin [Nir and Hirschmann, 1978 J. The 
minimum effec~ive doses of ~he ~hyroid hormones required ~o media~e 
~he latter effects were considerably higher than ~he levels of 
these hormones normally presen~ in serum. I~ has been sugges~ed 
that ~he stimulation of mela~onin synthesis by ~hyroid hormones may 
be a posi~ive feedback regulatory sys~em which would be operative 
under conditions of increased thyroid activity. 
The HPA axis is in~ima~ely associated wi ~h the body's stress 
responses and will be discussed in detail in ~he subsequent 
sec~ions. 
1.8 NEUROENDOCRINOLOGlCAL ASPECTS OF STRESS 
The response of an animal to stress is multifaceted involving both 
adrenal cor~ical and medullary activities and generalized 
sympa~hetic discharge. Adrenocorticotropic hormone (ACTH) has been 
assigned a pivotal role in media~ing physiological s~ress 
responses. In terms of this, a »stressor~ is often defined as any 
noxious stimulus which resul~s in an increase in the secretion of 
ACTH ~rom the pituitary gland. The principle sites of ACTH ac~ion 
are the adrenal glands. In particular the adrenal cortex is known 
to playa vital role in maintaining physiological homeostasis and 
endows organisms wi~h ~he capacity to resist many types of noxious 
stimuli and environmental changes which are essential to survival. 
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1. 8.1 Stress and the Pineal Gland 
In an attempt to define a role for the pineal gland which would 
explain its apparent multi-functionality, Romijn [1978] reviewed 
all the known and proposed endocrine acti vi ties of the pineal 
gland. He concluded that the pineal acts as a general 
tranquillizing gland to synchronize, stabilize and regulate 
homeostatic equilibrium in close association with changing 
environmental conditions. Many other researchers have proposed 
that the principle function of the pineal gland is to 'control, 
coordinate and regulate the physiological adaptation to stress 
[Milne, 1980; Armstrong et a1, 1982], where stress is generally 
defined as the sum of the biological reactions to any adverse 
stimulus - physical, mental or emotional. internal or external -
that tends to disturb an organism's homeostasis. 
Theories implicating the pineal gland in the physiological response 
to stress are abundant, and while many are conceptually appealing, 
decisive evidence in their favour is still lacking. For example. 
a number of the lower vertebrates exhibit skin colour changes in 
response to some stressful stimuli to facilitate protective 
coloration or temperature regulation. It may be proposed that the 
possible involvement of melatonin in these responses reflects an 
antistressogenic role for the pineal gland in these animals 
IJohnson, 1982J. In higher vertebrates which have more 
sophisticated defense and adaptational systems, the target site of 
pineal function would no longer be the skin, but possibly a higher 
integrating centre such as the brain. The evolutionary changes in 
pineal gland structure and regulation described and discussed 
earlier would tend to support this theory. 
Milne [1980] reported numerous physiological and cytological 
changes in the hypothalamus, pineal, adrenal and pituitary glands 
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of rats exposed to chronic auditory stress. They also examined 
these neuroendocrine organs from men who suffered from ulcer 
disease: gastric ulcer formation is considered an obvious 
peripheral consequence of exposure to prolonged stress. The 
findings were consistent with the idea that the pineal gland is 
antagonistic in function to the hypophysis exerting its 
anti-stressogenic effect by opposing the stress-induced 
hyperactivity of the hypothalamo-pituitary complex. Khan et; a1 
[1990] showed that pinealectomy exacerbates stress-induced gastric 
ulceration. an effect which could be counteracted by me'latonin. 
It was further shown that rats exhibit a circadian variation in 
response to stress manifest by the significant reduction in gastric 
ulceration in rats stressed during the night relative to those 
stressed during the day. Lynch et; a1 [1973] reported that factors 
which influence sympathetic activity, such as insulin-induced 
hypoglycaemia and immobilization stress, can rapidly increase 
pineal melatonin synthesis. As the rise in melatonin levels were 
inhibited by propranolol, it was concluded that the effects were 
mediated by catecholamines, either directly released onto the 
pineal gland or derived from sympathetic nerves terminating 
elsewhere in the body, or from the adrenal medulla. In view of the 
pivotal role of the adrenal glands in the stress response, if the 
pineal gland is a major regulator of physiological homeostasis and 
rr 
stress, an interaction between itself and the adrenal glands would 
be almost inevitable. 
1.8.2 The Adrenal Glands 
1.8.2.1 Structure of the Adrenal Glands 
The adrenal glands are composed of two structurally and 
functionally distinct regions: a cortex responsible for the 
secretion of steroid hormones and a highly innervated medulla which 
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secretes catecholamines [Haynes and Larner, 1975; Ganong, 1979]~ 
The cortex is further divided into three functional zones: the zona 
glomerulosa adjacent to the adrenal capsule and which is the site 
of mineralocorticoid production; the zona fasciculata which is the 
principal site for the synthesis and secretion of gluc6corticoids; 
and finally, the innermost region, the zona reticularis, from which 
glucocorticoids and sex steroids are secreted. 
1.8.2.2 Metabolism of Adrenocorticosteroids 
The adrenocorticosteroids and adrenal androgens are synthesized 
from cholesterol via the pathway presented in Figure 1.11. 
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[Ganong. 1979] 
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The major adrenocorticosteroids secreted by all species o~ 
vertebrates are the mineralocorticoid, aldosterone. and the 
glucocorticoids, hydrocortisone or cortisol and corticosterone. 
The ratio of hydrocortisone to corticosterone varies from species 
to species. Birds, mice and rats mainly secrete corticosterone, 
while cats, sheep, monkeys and humans secrete predominantly 
hydrocortisone. Neither of the glucocorticoids are stored in the 
adrenal glands and for this reason the rate of their biosynthesis 
is tantamount to their rate of secretion and levels of 
physiological acti vi ty. Hydrocortisone. and to a lesser extent 
corticosterone, circulate in the blood system reversibly bound to 
an a-globulin called corticosteroid binding globulin {CGB} or 
transcortin. This glycoprotein has a high affinity but low total 
binding capacity. The corticosteroids also bind with low affinity 
to high capacity binding sites on serum albumin. The bound 
fraction appears to be inactive. It probably functions as a 
circulating reservoir of the hormones to lengthen their half life 
in the blood and maintain a readily available supply for the 
tissues. The half life of hydrocortisone in the blood is 60 - 90 
minutes. 
Glucocorticoids are principally catabolised in the liver. The ring 
structures are reduced to deri vati ves which are enzymatically 
conjugated to sulphate or glucuronic acid to form water-soluble 
sulphate esters or glucuronides which are predominantly secreted 
in the urine. 
1.8.2.3 Actions of Adrenocorticosteroids 
Glucocorticoids. like other steroid hormones, are thought to act 
by controlling the rate of synthesis of proteins. The 
glucocorticoids react with receptor proteins in the cytoplasm of 
sensitive cells to form a steroid-receptor complex. This complex 
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undergoes a conformational change and moves into the nucleus of the 
cells, where it binds to the chromatin material. In this way, 
glucocorticoids appear to stimulate the transcription and 
ultimately the synthesis of specific proteins. [Haynes and Larner, 
1975; Ganong, 1979]. 
Glucocorticoids subserve widespread functions including the 
regulation of the mobilization of amino acids from tissue proteins, 
the metabolic degradation of amino acids in the liver, liver 
glycogen synthesis, the degradation of fats and the release of 
fatty acids into the bloodstream. These steroids perform a vital 
role in the stress response by causing tremendous shifts in 
carbohydrate metabolism throughout the body. which increase 
circulating energy substrates at the cost of stored energy. 
Glucocorticoids also increase cardiovascular tone, alter cognition 
and inhibit growth, the immune and inflammatory responses and 
reproduction. These changes are central to successful adaptation 
to acute and physical stress, as they increase readily available 
energy and supportive metabolism and defer energetically costly 
anabolism until less stressful times. The notorious fragility of 
organisms with adrenocortical insufficiency in adapting to stress 
testifies to the importance of glucocorticoids. 
Mineralocorticoids playa major role in the regulation of body's 
sodium, potassium and water levels. The most important 
mineralocorticoid is aldosterone. This hormone acts directly on 
the kidney to increase both tubular reabsorption of sodium and 
urinary excretion of potassium. Sodium levels are in turn, a major 
determinant of water balance. Thus factors which affect 
mineralocorticoid levels have vi tal implications for the health and 
survival of the animal. 
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1.8.3 The Hypothalamic-Pituitary-Adrenal Axis 
The adrenal glands are the end organs of the hypothalamic 
-pituitary-adrenal (HPA) axis [Haynes and Larner, 1975; Ganong, 
1979]. The adrenal cortex secretes glucocorticoids as the final 
step in a neuroendocrine cascade initiated· on perception of a 
stressor by the brain (see Figure 1.12). In response to a variety 
of stressors, the hypothalamus releases corticotropin-regulatory 
hormone (CRH) from nerve endings in the median eminence into the 
hypophyseal-portal blood vessels which transport it directly to the 
adenohypophysis or anterior glandular lobe of the pituitary gland. 
Here, CRH stimulates the release of ACTH which subsequently 
stimulates steroidogenesis and the secretion of corticosteroids 
from the cortices of the adrenal glands. ACTH acts via adenylate 
cyclase and a protein kinase to increase the amount of cholesterol 
that enters mitochondria and is converted to pregnenolone. This 
step is the rate determining step in the biosynthetic pathway of 
the adrenal steroid hormones. 
Glucocorticoid levels in the blood as well as hypothalamic stores 
of CRH generally vary with a circadian rhythm [cf. Johnson, 1982]. 
In nocturnal species, levels are highest before the onset of 
darkness and reach their lowest levels in the early morning. In 
diurnal species. the glucocorticoid levels peak in the early 
morning and decline during the dark period [Touitou e~ al. 1982; 
1983] . The daily fluctuations in the rates of secretion of 
hydrocortisone and corticosterone are determined by the 
fluctuations in the release of ACTH from the adenohypophysis. The 
latter is under the control of the hypothalamus and a diverse 
negative corticosteroid feedback mechanism involving both rapid 
rate-sensi ti ve and delayed level-sensi ti ve forms of regulation 
[Haynes and Larner. 1975; Sapolsky e~ al, 1986]. 
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[Haynes and Larner, 1975] 
Glucocorticoids released from the adrenal cortex regulate the HPA 
axis by interacting with glucocorticoid receptors in the brain, 
pituitary and suprahypothalamic structures causing suppression of 
further eRH and ACTH rel~ase [Haynes and Larner. 1975. Keller-Wood 
and Dallman. 1984J. Of all the suprahypothalamic loci. the 
hippocampus has been most consistently implicated as an inhibitory 
influence upon the adrenocortical axis. It appears to regulate 
basal ACTH and glucocorticoid secretions as well as inhibiting the 
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stress-induced activation of the adrenal axis. Continua"l 
activation of the HPA axis eventually leads to a decrease in the 
sensi ti vi ty of this negative feedback system [Sapolsky et: a1, 
1986]. This effect is due to the loss of glucocorticoid receptors 
in the hippocampus which subsequently results in an inability to 
terminate the adrenocorticoid response to stress-induced HPA 
activation. A major neuroendocrine consequence of long term stress 
is therefore the sustained elevation of circulating glucocorticoid 
levels (see Figure 1.13). 
1.8.4 Neurotoxicity and Neuronal Degeneration 
The loss of glucocorticoid receptors in the hippocampus following 
acute stress or elevated glucocorticoid levels, appears to be 
transient, presumably involving changes in receptor processing 
rates. However, the receptor losses following prolonged stress and 
in aging result from the permanent degeneration of neurons 
[Sapolsky et: a1, 1986]. 
1.8.4.1 Glucocorticoid Neurotoxicity 
Sustained, elevated concentrations of circulating glucocorticoids 
have been shown to produce neuronal degeneration, particularly in 
the hippocampus. In an attempt to understand the cellular 
mechanisms underlying the vulnerability of neurons to 
glucocorticoids, Sapolsky et: a1 [1986] found evidence to suggest 
that these steroids directly compromise neuronal viability by 
impairing the ability of neurons to survive damaging insults. The 
seemipgly anomalous preference for the hippocampus may be explained 
by the fact that the structure has the highest concentration of 
corticosterone receptors in the brain [McEwen et: a1, 1968J. The 
actions of the glucocorticoids are at least partly mediated by 
glucocorticoid receptors. This is evidenced by the ability of 
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glucocorticoid receptor antagonists to attenuate the· enhanced 
insult-induced effects of glucocorticoids in vitro. 
Some of the damaging actions of glucocorticoids arise from their 
disruption of hippocampal neuronal energy_ Neurons consume energy 
at a high rate and are notoriously vulnerable to depletion of 
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energy supplies. They have limited abilities to store glycogen 
and are heavily reliant on blood glucose as an energy source. 
Glucocorticoids have been shown to significantly inhibit glucose 
uptake and utilization in the hippocampus, although measures of 
whole brain glucose content do not indicate a similar steroid 
action throughout the entire organ. In clinical studies, exogenous 
glucose has been shown to protect against hippocampal damage [cf. 
Sapolsky et 81, 1986]. 
Glucocorticoids also contribute to neuronal degeneration by 
exacerbating the effects of neurotoxins [Sapolsky et 81, 1986J. 
Two neurotoxins, kainic acid and 3-acetylpyridine, are more 
neurotoxic in rats with physiologically elevated corticosteroid 
levels [Sapolsky, 1985; Sapolsky and Pulsinelli, 1985]. Kainic 
acid is a glutamate receptor agonist. Glutamate, along with other 
acidic amino acids, is an excitatory neurotransmitter in the eNS 
[Johnson, 1972; Bradford, 1986] and glutamatergic neurons have been 
identified in the frontal cortex, septum, striatum and hippocampus 
[cf. Gilad et a1. 1990]. 
1.8.4.2 Glutamate Neurotoxicity 
Excitatory amino acid receptors have been divided into five 
subpopulations based on their affinity for a number of selective 
ligands [Watkins et 81, 1990]. N-Methyl-D-aspartate (NMDA) , 
D-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) , 
kainate, L-2-amino-4-phosphonobutyrate (APB) receptors as well as 
a quisqualate metabotropic receptor subgroup have been defined. 
Pathological studies of neurodegenerative diseases have focused on 
the ion-channel-linked NMDA, AMPA and kainate receptors IMeldrum 
and Garthwaite, 1990]. The metabotropic receptor whose activation 
results in the generation of inositol triphosphates. may also be 
invol ved in neurodegeneration, but this has yet to be directly 
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demonstrated. 
Glutamate, the most abundant excitatory amino acid in the brain, 
is an agonist at each of the receptor subgroups. Excitotoxicity 
mediated by glutamate has predominantly been ascribed to excessive 
Three types of neurotoxic activation of the NMDA receptor. 
processes have been distinguished [Schramm e1; a1, 1990]. The 
first requires the action of high concentrations of glutamate which 
leads to an influx of sodium and chloride ions and water causing 
swelling of the neurons and lysis within 1 - 2 hours. The second 
is a delayed type of glutamate-induced neurotoxicity which extends 
over approximately 20 hours and results in extensive calcium 
mobilization and prolonged elevation of free cytosolic calcium 
levels. It only requires glutamate to initiate the process and 
then becomes inevitable, being unaffected by glutamate antagonists. 
In the third process, neuronal death occurs a few minutes after 
exposure to low concentrations of glutamate. The mechanism is 
unclear although swelling appears to be an important factor. 
Glutamate released from pre-synaptic neurons is primarily 
inactivated by re-uptake into glial cells or astrocytes and 
presynaptic nerve terminals {Bradford, 1986; Gilad e1; 81, 1990]. 
Autoradiographic and biochemical studies indicate that glutamate 
is preferentially taken up by glial cells. r3H1GIutamate is 
selectively accumulated by glial cells while {3H] glutamine is 
preferentially sequestered by neurons. [Bradford and Ward, 1976; 
Bradford 1986 J • Both high affinity and low affinity transport 
systems have been identified. Glutamate is taken up into glia via 
the ~igh affinity, sodium-dependent transport system and either 
oxidized through the Krebs cycle or converted to glutamine by 
glutamine synthetase. Once formed, glutamine is readily released 
into the extracellular space by simple diffusion from where it 
enters nerve terminals via a low affinity uptake system or by 
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diffusion. In the neurons it is converted back to glutamate by 
glutaminase and can be re-employed in neurotransmission. The 
cellular distribution of glutamine synthetase and glutaminase also 
favours the existence of the above mechanism of glutamate uptake 
and re-cycling, (see Figure 1.14). 
Postsynaptic cell Nerve ending 
Glutaminase 
Glutamine 
e;lial cell 
Glutamine synthetase 
Glutamate + ATP + NH4+ • Glutamine 
FIGURE 1.14 The Recycling of Glutamate between Neurons and 
Glial Cell in the Central Nervous System 
[Bradford, 1986] 
Gilad e~ a1 [19901 examined changes in the glutamate release and 
high-affinity uptake systems in .synaptosomes as an index of 
gluta~atergic activity in various regions of the rat forebrain. 
The authors reported an increase in the release and high-affinity 
uptake of glutamate by synaptosomal preparations from several brain 
regions in rats which had been subj ected to 1 and 2 hours of 
restraint stress. It was shown that restraint stress can lead to 
- 58 -
increased glutamate uptake by neurons in the frontal cortex, septum 
and hippocampus, but not in the striatum. The authors concluded 
that forebrain glutamatergic neurons are activated by stressful 
stimuli in a regionally selective manner, and suggest that 
high-a£finity uptake is important in clearing increased levels of 
released glutamate. However, it is known that glucocorticoids 
inhibit the uptake of excitatory amino acids by glial cells. Thus, 
in cases of chronic stress both cerebral glutamatergic activity and 
adrenocorticoid activity will increase. The high levels of 
circulating glucocorticoids may inhibit 
leading to increased concentrations of 
glutamate inactivation, 
the neurotoxin in the 
synapse and profound neuronal degeneration. 
In a recent study, Marinova and co-workers [1991] investigated the 
effect of exogenous melatonin on glucocorticoid receptors in the 
hippocampus and hypothalamus of rats on long-term glucocorticoid 
treatment. They showed that melatonin significantly decreased the 
affinity of corticosterone receptors for their natural ligands. 
They proposed that by decreasing the sensitivity of glucocorticoid 
receptors, melatonin could possibly protect the neurons from the 
deleterious influence of elevated corticosterone concentrations as 
well as possibly prevent hippocampal receptor loss following 
chronic stress or long-term exposure to elevated circulating 
glucocorticoid levels. This finding strengthens the proposal that 
the pineal gland may play a role in regulating the effects of the 
adrenal glands. 
1.9 PINEAL - ADRENAL GLAND INTERACTIONS 
1.9.1 Effects of the Pineal Gland on Adrenal Function 
The pineal gland is generally considered to exert an inhibitory or 
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regulatory influence on the adrenal glands. Unfortunately, much 
of the literature on the subject is contradictory and difficult to 
compare due to inadequacies in the experimental design. 
Conflicting evidence is likely to be due to the small magnitude of 
some of the reported significant differences, sex and species 
differences as well as variation in the length of the experiments. 
Most research on pineal - adrenal gland interactions has involved 
modifying pineal output and measuring the adrenal response. 
1.9.1.1 Pineal Effects on Adrenal Hypertrophy 
The first suggestion that the pineal gland might have an effect on 
the adrenal axis came when pinealectomized rats were reported to 
have enlarged adrenal glands [Wurtman et; a1, 1959]. Adrenal 
hypertrophy was demonstrated in mice following pinealectomy and 
found to be reversed by exogenous melatonin [Vaughan et; a1, 1972]. 
Similar effects have also been demonstrated in submammalian 
vertebrates. Light deprivation has been shown to decrease adrenal 
mass, an effect reversed by pinealectomy [Reiter and Hester, 1966]. 
However, these significant differences have not been universally 
found probably for the reasons mentioned above. 
The effect of the pineal gland on compensatory adrenal hypertrophy 
has also been monitored. After a unilateral adrenalectomy, plasma 
glucocorticoid levels decrease. These lowered levels feed back on 
the hypothalamus and anterior pituitary gland to increase plasma 
ACTH levels. Hence the remaining adrenal gland becomes the target 
of increased ACTH levels and exhibits a compensatory increase in 
mass. Compensatory adrenal hypertrophy, and the thickness of the 
zona fasciculata in particular. are significantly reduced by 
treatments known to stimulate pineal function, such as blinding, 
and treatment with crude pineal extracts or exogenous melatonin. 
These effects are reversed by pinealectomy or ACTH treatment 
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[Dickson and Hasty, 1972; Vaughan e1: 81, 1972; Johnson, 1982}-. 
These data suggest that the site of pineal inhibitory action is at 
the level of the anterior pituitary or higher, since ACTH treatment 
reverses pineal inhibition. Furthermore, pineal extracts fail to 
inhibi t adrenal hypertrophy resulting from exogenous administration 
of ACTH. It has therefore been hypothesized that pineal 
derivatives may regulate the adrenal axis by inhibiting the 
synthesis or release of this pituitary hormone. 
1.9.1.2 Pineal Effects on Steroidogenesis and Plasma 
Corticosteroid Levels 
Other researchers have proposed that the pineal functions directly 
by regulating steroidogenesis. Melatonin has been directly 
implicated in the metabolism and release of corticosteroids. Mehdi 
and Sandor [1977] demonstrated that melatonin could inhibit the 
transformation of carbon-labelled progesterone to hydrocortisone 
and aldosterone in vi1:ro. Studies on the influence of the pineal 
on plasma glucocorticoid levels are difficult to interpret because 
of the limited number of time points assayed and the varying length 
of the photoperiods employed. Furthermore, it remains 
controversial whether manipulations of the photoperiod such as 
blinding, light deprivation or exposure to constant light, used to 
presumably alter pineal activity in many of the experiments, are 
able to directly induce phase shifts in the daily corticosteroid 
rhythm. This would lead to apparent differences in plasma 
corticosteroid levels which were independent of pineal activity. 
Although the results of these experiments must therefore be 
interpreted with caution, there is some evidence that the pineal 
gland can influence patterns of glucocorticoid secretion. 
Lateral ventricular administration of melatonin and other pineal 
indoles was shown to reduce rat plasma corticosterone 
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concentrations [Motta e"t 81, 1971]. Melatonin failed to affect the 
corticosterone response when brain catecholamines had been depleted 
by reserpine treatment. This finding suggested that ACTH is under 
the inhibitory control of a central adrenergic mechanism and that 
melatonin may act by stimulating this mechanism. The theory is 
supported by the finding that melatonin added to pituitary 
incubates in vi"tro does not alter ACTH secretion. 
Kinson and co-workers {1967] indicated that the pineal gland may 
exert an inhibitory effect on the adrenal glands by demonstrating 
that the secretion rates of corticosterone and aldosterone were 
significantly elevated one month after pinealectomy. Niles and 
co-workers lcf. Armstrong e"t a1, 1982] reported that blinding or 
exposure to short daily photoperiods flattened the normal diurnal 
plasma corticosteroid rhythm. This effect was partially reversed 
by pinealectomy. and completely reversed by immunization with 
melatonin and N-acetylserotonin antibodies. Immunization alone 
resul ted in reduced corticosterone levels throughout the whole 
diurnal cycle. These findings show that the pineal gland does not 
simply restrict adrenal steroidogenesis, but that melatonin and 
N-acetylserotonin could somehow be involved in the regulation of 
the resting diurnal adrenocortical rhythm. 
In the case of mineralocorticoids, the pineal gland has been 
reported to both stimulate and inhibit aldosterone secretion, while 
a number of researchers have failed to demonstrate any effect of 
the pineal gland on adrenal mineralocorticoid function. The 
predominant theme of research in this area has been the 
investigation of the pineal gland and hypertension [Johnson, 1982]. 
Pinealectomy results in small elevations in blood pressure from one 
to seven weeks after the operation, with normal levels possibly 
re-established after 3 months. Melatonin administered in the 
drinking water of pinealectomized rats from the time of surgery 
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prevented hypertension, and when administered after hypertension 
had been established, lowered the blood pressure IZanoboni and 
Zanoboni-Muciaccia, 1967; Johnson, 1982 J • Other studies have 
produced inconsistent and controversial findings which require 
further research. 
1.9.1.3 Influence of Pineal Antigonadal effects on Adrenal 
Function 
Another line of research proposes that the pineal gland may exert 
its inhibitory influences on the pituitary-adrenal axis, at least 
in part, by virtue of its antigonadal effects. 
Ogle and Kitay [1976] investigated the influence of pinealectomy 
on adrenal function in intact and previously ovariectomized rats. 
Pinealectomy of previously ovariectomized rats appeared to increase 
the proportion of corticosterone secreted by altering intra-adrenal 
metabolism without altering the total steroid output. hypophyseal 
ACTH secretion or the corticosteroid feedback mechanism. However. 
in intact animals. pinealectomy enhanced both the resting plasma 
levels of corticosterone and the total steroid production, 
suggesting an increase in ACTH secretion. The enhancement of 
circulating estrogen levels which occur subsequent to pinealectomy, 
due to release of pineal inhibition on the ovaries, may be partly 
responsible for the increase in corticosterone levels. Estradiol 
is not only known to stimulate ACTH secret~on, but is also a potent 
inhibi tor of adrenal reductase acti vi ty. . Thus the pineal gland 
could have affected ACTH secretion and adrenal steroid metabolism 
either directly or indirectly via estradiol. 
1.9.1.4 Pineal influences on the stress-activated adrenal glands 
There is a large body of evidence which implies that the pineal 
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gland functions to moderate stress-induced changes in adrenal 
cortical activity. 
Motta et 81 [1971] showed that melatonin counteracts the increased 
secretion of ACTH effected by the injection of histamine, a potent 
stressful stimulus. They further showed that melatonin loses its 
ability to interfere with the stimulating effect of histamine on 
ACTE secretion in rats deprived of catecholamines. This. coupled 
wi th other findings, raised the suggestion that the effect of 
melatonin on the HPA axis might be mediated by the activation of 
a central adrenergic pathway normally inhibiting ACTH secretion. 
In an attempt to assess the effect of the pineal on cold 
stress-induced changes in plasma corticosteroid levels, Rivest et 
81 [1979] subjected male albino rabbits to pineal stalk lesion or 
sham-operation. Six days later, the rabbits were exposed to 7°C 
environmental temperatures. Although both groups displayed 
increased corticosteroid levels in response to the cold stress, the 
lesioned rabbits exhibited an earlier and a higher elevation. 
Previously Vaughan et a1 r 1972] had reported that the adrenal 
glands of male. but not female, mice were significantly 
hypertrophied after exposure to 4 hour periods at SoC for three 
successive days. This effect of cold stress could not be prevented 
by melatonin administration. 
These data could suggest a role for the pineal gland in promoting 
homeostasis and stress adaptation, rather-than a simple inhibitory 
effect of the pineal on the HPA axis. 
1.9.1.5 Pineal Products Mediating Pineal-Adrenal Effects 
Early attempts to elucidate the potential of pineal derivatives to 
influence the adrenal glands involved monitoring the effect of 
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crude pineal extracts on adrenal function. Both organic and 
aqueous extracts were shown to alter adrenocorticoid function. 
An aqueous extract was found to potently inhibit corticosterone 
release from incubated rat adrenal glands [Porter and Heiman. 
19771. The researchers concluded that the active substance could 
not be a lipophillic indole and substantiated their conclusion by 
showing that neither melatonin nor 5-methoxytryptophol could 
simulate the effects of the crude extract. The existence of a 
non-indole pineal factor responsible for influencing adrenocortical 
function has gained favour recently with the increased interest in 
pineal peptide hormones. The identity of many pineal peptide 
hormones remains to be elucidated. Arginine vasotocin is a 
physiologically active peptide which has been reported to inhibit 
compensatory adrenal hypertrophy in mice and block the action of 
CRR in cats, as well as inhibit ACTH release in vivo [cf. Johnson, 
1982]. However, although arginine vasotocin is known to be present 
in submammalian vertebrates, its presence and hence functional 
significance in the mammalian pineal remains to be clarified. 
There is extensive evidence implicating the principal pineal 
indole, melatonin, in modifying adrenal function. Melatonin has 
been demonstrated to reverse many of the effects of pinealectomy 
on adrenal hypertrophy and compensatory adrenal hypertrophy. 
although it could not significantly counteract adrenal enlargement 
following castration or cold stress. Melatonin treatment was 
reported to increase adrenal 5a-reductase activity in 
hypophysectomized and pinealectomized rats indicating that this 
indole acts at the level of the adrenal cortex to reduce 
glucocorticoid secretion from the gland {Ogle and Ki tay. 1976; 
Johnson, 1982]. 
The inj ection and implantation of melatonin into various organs and 
sites in the central nervous system have led to reports of 
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inhibitory, indifferent and stimulatory effects of melatonin on 
adrenal function. Armstrong e"t a1 {1982] has cautioned that it may 
be necessary to distinguish between the effects of endogenous and 
exogenous pineal substances. and hence the effects of pineal 
deactivation by pinealectomy and administration of substances like 
melatonin. Furthermore it may also be necessary to distinguish 
between melatonin in the cerebral spinal fluid (CSF) and that 
circulating in the plasma. as it is possible that melatonin 
released into systemic circulation may have a different role and 
mode of action to that released in the eSF. When melatonin is 
introduced intraventricularly, evidence favours a mode of action 
dependent on central monoamine levels. while when melatonin is 
introduced peripherally. it appears to act independent of central 
structures. 
1.9.2 Effects of the Adrenal Gland on Pineal Physiology 
Relatively few studies have investigated any possible influence of 
adrenal derivatives on pineal function. It is conceivable that if 
the pineal gland were a regulator of the adrenal glands, the former 
should respond physiologically to altered adrenal output. Such 
"feedback" mechanisms are characteristic of most endocrine systems. 
Unfortunately, most of the scanty literature available on this 
aspect of pineal-adrenal interactions is contradictory, and many 
researchers have been unable to confirm reports of glucocorticoid 
effects on pineal physiology. 
In 1982. Reiter and co-workers Icf. Johnson, 1982; Touitou. 1989] 
showed that bilateral adrenalectomy resulted in decreases in the 
night-time rise in pineal melatonin and N-acetyltransferase 
acti vi ty 8 hours into the dark phase. The inability of other 
researchers to confirm this finding may be the result of shorter 
experiments. As stress results in natural increases in the 
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· secretions of ACTH and glucocorticoids, researchers have 
investigated the effect of various stresses on pineal physiology. 
A variety of studies have shown that exposure of rats to stressful 
stimuli increase 
production [Lynch 
Contrastingly, in 
N-acetyltransferase activity and melatonin 
et 81, 1973; Vaughan et 81. 1978] . 
human studies various stresses including 
insulin-induced hypoglycaemia, pneumonencephalography, 
electro-shock therapy, sleep deprivation, sprinting and 
psychosocial stress did not cause increases in melatonin secretion 
despi te activation of the hypothalamic-pi tui tary adrenal axis 
[Toui tou, 1989]. Studies of this nature are confounded by the 
number of variables involved in specific stress responses including 
the severity or duration of the stress, predictability of onset, 
control of onset or termination of the stress, preparedness in 
dealing with the stress, previous experience with similar or 
dissimilar stressors, species-specific defense mechanisms and 
species/strain differences. Results from these studies of 
pineal-adrenal interactions are thus very unlikely to produce 
conclusive evidence and a more direct approach is required. 
Observations in disease states are equally inconclusive. An 
interaction between glucocorticoids and pineal derivatives has been 
suggested in depressive disorders. Wetterberg et a1, [1982] 
reported an inverse correlation between high levels of serum 
hydrocortisone and low levels of serum melatonin in depressive 
patients. However, these correlations are not evident when 
patients are treated with antidepressant drugs [Touitou, 1989]. 
Adrenal insufficiency and pituitary dysfunction have been described 
in some patients with pineal tumour. However, in these cases, 
parameters such as age and sex are often variable, interfering 
factors. ITouitou, 1989]. 
From the preceding discussion, it is obvious that the detailed 
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nature and characteristics of pineal-adrenal interaction remain 
unclear at this time. Although much effort has been expended in 
." d :1ts stu y, the complexity of the individual endocrine axes 
involved, the host of contradictory findings and the lack of a 
clear, unambiguous paradigm to dramatically and reproducibly 
demonstrate interactions between these two systems. have delayed 
the eludication of the relationship between the pineal and adrenal 
glands. 
1.10 TRYPTOPHAN PYRROLASE AND THE PINEAL GLAND 
Tryptophan pyrrolase is a major determinant of tryptophan levels 
in vivo. Recent evidence has indicated that it may be a peripheral 
mediator of pineal gland function. 
1.10.1 Tryptophan Pyrrolase 
Tryptophan pyrrolase (L-tryptophan oxygen 2,3-oxidoreductase. Ee 
(1.13.11.11) is a haem-dependent liver cytosolic enzyme which 
catalyzes the oxidative cleavage of the pyrrole ring of 
L-tryptophan to form N'-formylkynurenine in the first and 
rate-determining step in the kynurenine-nicotinic acid pathway of 
tryptophan degradation £Badawy and Evans. 1975]. More than 90% of 
the body I s total tryptophan is degraded in the liver via this 
pathway (see Figure 1.15). In the livers of certain, but not all 
animal species. tryptophan pyrrolase exists in at least two forms: 
the active reduced holoenzyme and the predominant, inactive 
apoen~yme which requires the addition of exogenous haematin for the 
demonstration of its activity [Badawy and Evans. 1974]. Both forms 
are present in the livers of rats. mice. chickens and possibly man, 
while the apoenzyme is absent from the livers of guinea pigs. 
hamsters, rabbits. sheep. frogs, cats and the gerbil. Activation 
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of ~he apoenzyme in vi~ro involves i~s conjuga~ion wi~h haem ~o 
form the oxidized (ferrihaem) holoenzyme which is then reduced to 
~he ac~ive form in the presence of tryptophan. 
Tryptophan 
1 Try{)tO{)hsn Pyrrolase [Haem] 
N'-Formylkynurenine 
1 Formamidase 
L -Kynurenine 
1 KynurneJne -3-hydroxylase 
3 - Hydroxy- L - kynurenine 
1 Kynureninase 
3 - Hydroxyanthranilate 
1 Hydroxyanthranilate oxygenase 
2-Amino-3-carboxy muconate semialdehyde 
1 
Quinolate 
1 QUino/ate {)nos{)horlbosyJ transferase 
Ribose-P nicotinate nucleotide 
FIGURE 1.15 
1 
Nicotinate 
The Kynurenine-Nicotinic Acid Pathway 
{Bender, 19751 
1.10.2 Regulation of Tryptophan Pyrrolase 
Rat liver tryptophan pyrrolase is regula~ed by four known 
mechanisms: hormonal induction by glucocor~icoids. subs~rate 
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activation by tryptophan, cofactor activation by haem and feedback 
inhibition by NADPH [Badawy, 1979]. 
The glucocorticoids, hydrocortisone and corticosterone, cause a 
hormonal induction of tryptophan pyrrolase involving the synthesis 
of new apoenzyme [Knox and Auerbach, 1955; Young. 1981]. This 
hormonal induction mechanism is not found in species lacking the 
apoenzyme [Badawy and Evans. 1974J. Tryptophan pyrrolase exhibits 
a diurnal rhythm which correlates closely with plasma 
corticosteroid concentrations [Wurtman. 1974; Salter and Pogson, 
1985]. However, it is clear that the basal capacity of the liver 
to metabolize tryptophan is unaffected by the absence of 
glucocorticoids although larger tryptophan loads are handled much 
less effectively by adrenalectomized rats. This is presumably due 
to the fact that they lack the ability to induce the 
steroid-mediated increases in tryptophan pyrrolase activity. 
Glucocorticoids produce an RNA-dependent increase in total 
pyrrolase activity by stimulating the synthesis of new apoenzyme. 
Only about 50% of the new apoenzyme is saturated with haem so that 
the ratio of holoenzyme/apoenzyme is maintained at basal levels. 
Glucocorticoids do not increase haem synthesis or the saturation 
of apoenzyme with its cofactor. 
The substrate activation of tryptophan pyrrolase involves decreased 
degradation of pre-existing apoenzyme in conjunction with its 
normal rate of synthesis. This is accompanied by an initial 
increase in haem saturation and stabilization of the enzyme {Badawy 
and Evans, 1975]. The tryptophan-mediated effects are inhibited 
by protein synthesis inhibitors although tryptophan pyrrolase 
synthesis itself appears to be unaffected. Some evidence suggests 
that tryptophan may increase the availability of haem for 
tryptophan pyrrolase by stimulating the synthesis of haem 
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biosynthetic enzymes which subsequently result in enhanced 
synthesis of the cofactor [Badawy er 81, 1981]. 
Conjugation of tryptophan pyrrolase with its cofactor, haem. is the 
first step in the activation of the apoenzyme. The saturation of 
apo-tryptophan pyrrolase with haem is modified by treatments 
causing destruction. inhibition of synthesis, increased utilization 
and enhanced synthesis of liver haem. The administration of 
haematin or its precursor, 5-aminolaevulinate (5-ALA), enhances the 
activity of tryptophan pyrrolase £Badawy and Evans. 1975]. 
Utilization of endogenous haem, releases the negative feedback 
inhibition by this porphyrin on 5-aminolaevulinate synthase, the 
rate-limiting enzyme in its synthetic pathway. This leads to 
further synthesiS of haem and enhanced acti vi ty of tryptophan 
pyrrolase. Drugs (e.g. barbiturates) which are detoxified in the 
liver by the action of microsomal haem-dependent cytochrome P450 
increase hepatic turnover of haem and similarly enhance tryptophan 
pyrrolase activity_ 
1.10.3 Tryptophan Pyrrolase and Depression 
Liver tryptophan pyrrolase activity is the major peripheral factor 
that influences circulating tryptophan levels. It has been 
established that the availability of tryptophan to the brain is in 
turn a maj or determinant of cerebral tryptophan and serotonin 
levels. This followed from the finding that tryptophan uptake by 
the brain is mediated by a saturable carrier system which is 
responsible for transporting all the large neutral amino acids 
across the blood brain barrier. Since one species of carrier 
molecule facilitates the transport of six amino acids, tryptophan 
must compete with tyrosine, phenylalanine, leucine, isoleucine and 
valine for attachment and uptake into the brain _ Furthermore J 
tryptophan hydroxylase, the rate-limiting enzyme in the pathway of 
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serotonin synthesis, is not fully saturated with tryptophan unde"r 
normal physiological conditions. Activation of liver tryptophan 
pyrrolase has been shown to decrease forebrain serotonin levels" 
[Curzon, 1969; Young. 1981; Badawy e~ a1, 1987; Daya e~ a1, 1989; 
Van Wyk e~ a1, 1991] 
The cerebral serotoninergic system is intricately involved in 
various behavioural conditions of which its involvement in mental 
disorders has generated the most interest [Curzon. 1969; Goodwin 
and Post, 1974; Van Praag, 1982]. The highly substantiated 
indoleamine hypothesis of depressive disorders states that 
depression is associated with a deficiency of brain serotonin 
[Skene, 1979}. Numerous factors which stimulate liver tryptophan 
pyrrolase activity and subsequently reduce tryptophan availability 
to the brain, have been associated with depressive disorders. High 
plasma corticosteroid levels which stimulate tryptophan pyrrolase 
activity have been found to occur in depression IHullin e~ a1, 
1967], and depressive episodes are frequently found in patients 
wi th primary disturbances of the hypothalamic-pi tui tary-adrenal 
axis. Immobilization stress which leads to an increase in 
circulating corticosteroid concentrations. has also been shown to 
cause tryptophan pyrrolase activity to rise and brain serotonin 
levels to fall [Curzon and Green, 1969J. Badawy and Evans. [1981] 
established that a large number of antidepressant drugs increase 
brain tryptophan concentrations by inhibiting liver tryptophan 
pyrrolase acti vi ty. This inhibition appears to be due to the 
prevention of the conjugation of the apoenzyme with haem. 
1.10.4 Tryptophan Pyrrolase and the Pineal Gland 
The diurnal rhythm of tryptophan pyrrolase activity is consistent 
with an inhibitory effect of the pineal gland on the enzyme. The 
highest activity is observable during the late hours of the light 
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period when melatonin levels are lowest. Enzyme activity is lowest 
towards the end of the dark period when melatonin levels are high 
[Curzon, 1979]. 
It has been shown that activation of liver tryptophan pyrrolase by 
the barbiturate. pentobarbitone [Van Wyk et: a1, 1991]. and by 5-ALA 
[Daya et: a1, 1989], decreases forebrain serotonin levels without 
affecting pineal serotonin levels . Al though derived from the same 
precursor, pineal serotonin and melatonin levels are highly 
conserved. Furthermore, Daya et: a1 {1989] reported that forebrains 
from 5-ALA treated animals removed during the night-time, had 
significantly higher cerebral tryptophan and serotonin levels than 
those removed during the day-time. As the night-time rise in brain 
indoles coincided with the natural rise in pineal melatonin levels, 
it was proposed that melatonin could be responsible. However, the 
increases in brain indoles were not prevented by continuous 
exposure of the animals to light on the day of the experiment, and 
were reversed by inj ection of melatonin [Daya et: a1, 1990]. 
Although the results indicated that melatonin was not responsible 
for the nocturnal rise in brain indoles in the 5-ALA treated 
animals. the possibility of melatonin regulating tryptophan uptake 
by the brain could not be disregarded. Recently, Walsh and Daya 
[1991] demonstrated that melatonin displaces tryptophan from bovine 
serum albumin in vitro suggesting the possible potential of 
melatonin to effect the same displacement in vivo. This provides 
preliminary evidence for a mechanism whereby melatonin may increase 
tryptophan availability to the brain and elicit antidepressant 
effects. 
Wurtman and Wurtman 11989] implicated melatonin in cyclic mood and 
appetite disorders like seasonal affective· disorder (SAD) and 
carbohydrate craving obesity (CCO). They reported that the 
depression and carbohydrate craving associated with seasonal 
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affecti ve disorder. a syndrome predominantly found during the 
winter months, could be effectively eliminated by extending the 
photoperiod and treating patients with supplemental light therapy. 
These reports are not necessarily in conflict with the 
antidepressant effects of melatonin suggested by -che previous 
researchers. It is possible that prolonged elevation of melatonin 
resul-cs in large increases in plasma tryptophan levels and 
subsequent elevation of liver tryptophan pyrrolase activity. 
A further possibility of melatonin acting directly on the central 
nervous system in depression, cannot be excluded. 
1.11 EXPERIMENTAL OBJECTIVES 
The objective of this s-cudy was to investigate the interaction 
between the pineal and adrenal glands. While much research has 
focused on the effect of -che pineal gland on adrenal physiology, 
little work has been done on the effects of the adrenal steroids 
on pineal physiology and biochemistry. The firs-c part of this 
study is based on the assumption that if the pineal gland were to 
regulate adrenal steroid output, it would probably be capable of 
detecting and responding to changes in plasma corticosteroid 
levels. The first aim was therefore to establish whether adrenal 
glucocorticoids can alter pineal physiology. The effect of chronic 
hydrocortisone treatment on rat pineal melatonin synthesis was 
studied. 
The second objective was to determine whether the principal pineal 
indol~amine, melatonin, can protect against some of the deleterious 
effects of sustained, elevated plasma glucocorticoid levels. It 
has been proposed that such levels of corticosteroids may 
contribute to mental disorders by stimulating liver tryptophan 
pyrrolase -Co increase the catabolism of tryptophan, thereby 
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reducing the availability of this vital serotonin precursor to the 
brain. The effect of chronic hydrocortisone treatment and 
melatonin on rat liver tryptophan pyrrolase activity was 
investigated. 
Another effect of chronically elevated piasma glucocorticoid 
levels, is to elicit neuronal degeneration by inhibiting the uptake 
of excitatory amino acid neurotransmitters from the synaptic clefts 
in the eNS. The resultant continuous stimulation of particularly 
postsynaptic glutamate receptors, causes an influx of ions and 
water into the neurons and ultimately, lysis of the cells. It was 
intended to ascertain the effect of chronic hydrocortisone 
treatment and melatonin on cerebral glutamate receptors in the male 
albino rat. 
Finally, with the recent discovery of glutamate receptors in the 
pineal gland, an attempt was made to investigate the physiological 
significance of these receptors. 
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CHAPTER 2 
EXPERIMENTAL PROCEDURES 
2.1 ANIMALS 
The animals employed throughout this study were male Wistar rats 
of the albino strain. Female rats were not used, in order to 
eliminate the variable influences of the female hormonal cycle. 
The animals were housed in opaque plastic cages with metal grid 
floors and covers. They had free access to Epol rat pellets and 
tap water. The animal room was well ventilated and artificially 
illuminated by cool white tubes which were automatically regulated 
to maintain a 12 hour light/ 12 hour dark cycle (lights on at 
06hOO). The intensity of the illumination during the light phase 
was approximately 300 ~Watts/cm2. The temperature of the animal 
room was maintained between 20 and 24°C. The rats were killed 
swiftly by cervical dislocation and rapidly decapitated. The top 
of the skull was removed by making an incision through the bone on 
either side of the head from the foramen magnum to near the orbit. 
The skull was lifted with a pair of forceps exposing the pineal 
gland and brain for removal with tweezers. Care was taken to 
remove all adhering tissue and visible traces of blood from the 
organs. To remove the livers. a mid-ventral incision was made 
through the abdominal musculature from the pelvic region to the 
posterior edge of the sternum. A transverse cut was made 
anter:l.orly to expose the liver which was carefully removed and 
dissected free of blood vessels and connective tissue. 
When assays were not conducted immediately. all organs were frozen 
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in liquid nitrogen and stored at -70·C. Freezing did not alter the 
activity of the enzyme. 
2.1.1 Administration of Hydrocortisone to rats 
Hormonal treatment was provided for 7 days according to the scheme 
of Marinova e't 81 [1991]. Hydrocortisone was suspended in 
absolute ethanol : glycerine (1 : 9) to give a homogeneous stock 
suspension containing 6 mg hydrocortisone/mI. Before use it was 
diluted in 0.5% saline to a final concentration of 60 ~g/ml and 
provided to the animals as drinking fluid. Control animals 
received an equivalent volume of vehicle in 0.5% saline. 
This technique is advantageous in that it avoids the stress effects 
of handling and injection. Hydrocortisone is effectively absorbed 
when given by mouth and may be administered orally in clinical 
treatments [Haynes and Larner, 1975J. The daily oral dose of on 
average 2.5 mg per rat exceeds that which has previously been shown 
to produce supraphysiological circulating levels of the 
glucocorticoid IMarinova et 81, 1991]. 
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2.2 THE MEASUREMENT OF RAT PINEAL GLAND SEROTONIN METABOLISM IN 
ORGAN CULTURE USING THIN LAYER CHROMATOGRAPHY 
2.2.1 Introduction 
Tissue and organ culture techniques are invaluable tools in 
biochemistry. They allow the researcher to finely control the 
experimental conditions in vi~ro and avoid the complications of 
complex in vivo interactions. The pineal gland is particularly 
suitable for organ culture studies by virtue of its small'size and 
accessibility. Pineal organ culture systems have therefore been 
optimized and utilized by numerous researchers for various purposes 
[Klein and Rowe, 1970; Daya and Potgieter, 1982; Daya e~ 81, 
1989a]. The pineal gland in organ culture maintains its metabolic 
function and under the correct conditions may remain viable for 
more than six days. It is able to utilize an exogenous radioactive 
precursor such as [14C]tryptophan or [14 C]serotonin, and synthesize 
various indol,e metabolites. Approximately 95% of the synthesized 
radioactive indoles are secreted into the culture medium during 
incubation. The radioactive indoles can then be isolated from the 
culture medium and quantified. 
Previously, separation of pineal indoles was achieved using 
preparative organic extractions followed by chromatographic 
separations using combinations of thin layer adsorbants, paper and 
different solvents. Currently, the preferred method employs a 
bi-dimensional thin layer chromatography system [Klein and Notides. 
1969] . It employs two organic solvents J the first of which 
separates MEL from NAS and the 5-hydroxyindoles from the 
5-methoxyindoles. The inclusion of one part glacial acetic acid 
facilitates the complete separation of 5-MlAA from 5-HIAA. The 
second solvent improves the separation of MlAA and MTOH from MEL 
and the separation of HTOH and HIAA from NAS. The small amount of 
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acid which remains on the gel from the first solvent enhances th~ 
separation by the second solvent. Tryptophan. 5-HTP, 5-HT and 5-MT 
are unaffected by either solvent and remain at the origin. This· 
chromatographic technique is quick and simple to use and 
effectively separates trace quantities of the indoles (I pmole/I0 
!ll) . 
In this study. pineal glands were cultured by the method previously 
described by Klein and Notides [1969J and modified by Daya and 
Potgieter [1982]. The radioactive indole metabolites were isolated 
using the bi-dimensional thin layer chromatography method developed 
by Klein and Notides {1969] and quantified using liquid 
scintillometry. 
2.2.2 Materials 
2.2.2.1 Animals 
Male Wistar rats of the albino strain weighing 250 - 300 g were 
randomly assembled into test groups of five and maintained as 
described previously (Section 2.1). The animals were sacrificed 
between lOhOO and I1hOO for use in organ culture experiments. 
2.2.2.2 Chemicals and Reagents 
5-Hydroxy (side-chain-2-14C) tryptamine creatine sulphate was 
purchased from Amersham International (England). The specific 
activity was 53 mei/romol and the radioactive concentration was 50 
!lCi/ml. BGJb culture medium (Fitton-Jackson modification) was 
purchased from Gibco (Europe) and aseptically fortified with the 
antibiotics streptomycin, penicillin and amphotericin B. The 
composition of this medium is presented in Table 2.1. 
- 79 -
TABLE 2.1 Composition of BGJb Culture Medium (Fitton-Jackson 
modification) 
CONTENTS 
Amino Acids 
L-Alanine 
L-Arginine 
L-Aspartic Acid 
L-Cysteine HCl 
L-Glutamine 
Glycine 
L-Histidine 
L-Isoleucine 
L-Leucine 
L-Lysine HCl 
L-Methionine 
L-Phenylalanine 
L-Proline 
L-Serine 
L-Threonine 
L-Tryptophan 
DL-Valine 
Vitamins 
a-Tocopherol phosphate 
Ascorbic Acid 
Biotin 
Calcium pantothenate 
Choline chloride 
Folic acid 
Inositol 
Folic acid 
Para-aminobenzoic acid 
Pyridoxal phosphate 
Riboflavin 
Thiamine Hel 
Vitamin B12 
Inorganic Salts 
Dihydrogen sodium ortho-phosphate 
Magnesium sulphate (7HZO) Potassium Chloride 
Potassium dihydrogen phosphate 
Sodium bicarbonate 
Sodium chloride 
Other Compounds 
Calcium lactate 
Glucose 
Phenol red 
Sodium acetate 
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CONCENTRATION 
(mg/ml) 
250.00 
175.00 
150.00 
90.00 
200.00 
800.00 
150.00 
30.00 
50.00 
240.00 
50.00 
50.00 
400.00 
200.00 
75.00 
40.00 
65.00 
1. 00 
50.00 
0.20 
0.20 
50.00 
0.20 
0.20 
20.00 
2.00 
0.20 
0.20 
4.00 
0.04 
90.00 
200.00 
400.00 
160.00 
3 500.00 
5 300.00 
555.00 
10 000.00 
20.00 
50.00 
Aluminium 0.25 mm Kieselgel 60 0254 thin"layer chromatography plate"s 
were purchased from Merck (Germany) and PackardR Scintillator 299TY 
liquid scintillation cocktail 
Instrument Co Inc. (Netherlands). 
was purchased from Packard 
The Indole standard solution was prepared by dissolving 
approximately 1 mg of each of the serotonin metabolites: 5-HT. 
NAS, MEL, 5-HIAA, 5-HTOH, 5-MIAA and 5-MTOH in 2.5 ml absolute 
ethanol. This was mixed with 2.5 ml of 1% ascorbic acid in 0.1 N 
HCl as an antioxidant and stored at _20 0 C. The indoles were 
purchased from Sigma Chemical Co (St. Louis, USA). 
Van Urk's Reagent was prepared by dissolving 2 g para-
dimethylbenzaldehyde in 100 ml 25% HCl followed by the addition of 
100 ml 95% ethanol. 
Unless specified, all chemicals and reagents were purchased from 
local commercial sources. 
2.2.3 Organ Culture of Rat Pineal Glands 
A schematic representation of the organ culture procedure is 
presented in Table 2.2. After sacrifice. the pineal glands of the 
rats were swiftly removed as described previously (section 2.1). 
Each pineal gland was individually placed in a 10 mm x 12 mm Kimble 
tube containing 52 Jll of BGJb culture medium and 0.4 ttCi of 
r14C]serotonin. In experiments involving" the addition of a test 
compound, 10 Jll of the test compound was added to the incubation 
medium to give the desired final concentration in the total volume 
of 70 JlI. In control vials, the test compound was substituted with 
10 ttl of vehicle. A blank containing no tissue was also included 
in each series of incubations to determine background 
radioactivity. The incubation vials were then gassed with carbogen 
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(5% carbon dioxide: 95% oxygen), immediately sealed and incubated 
at 37·C in the dark for 24 hours. The incubation was terminated 
by removal of the pineal glands from the culture medium which was 
then analyzed using thin layer chromatography. 
TABLE 2.2 Scheme of Organ Culture Procedure 
REAGENTS 
BGJb Medium 
Test compound(s) 
Vehicle{s) 
r 3HJ Serotonin 
BLANK 
52 l1l 
CONTROL 
GROUP 
52 l1l 
TEST 
GROUP 
52 l1l 
Introduce pineal gland into medium 
10 111 
10 111 
8 111 8 !11 
Gas tubes with 5% CO2 : 95 02 
Incubate at 37°C for 24 hours 
Remove pineal from medium 
Store in freezer until assay 
2.2.4 Thin Layer Chromatography of Radioactive Indoles 
A 10 111 aliquot of the culture medium was applied to a 10 x 10 
cm chromatography plate to form a 4 - 5 rom spot. A 10 ttl aliquot 
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of the solution containing the indole standards was subsequently 
spotted on top of the culture medium. The spotting process took 
place under a continual gentle stream of nitrogen to aid with 
drying the spots and prevent atmospheric oxidation of the indoles. 
The TLC plate was then placed in a saturated TLCtank containing 
chloroform methanol glacial acetic acid (93 7 1) and 
allowed to develop until the solvent front had moved approximately 
9 cm. The plate was dried under nitrogen and re-developed in the 
same solvent a second time. Following this, the plate was again 
dried under nitrogen and developed once in ethyl acetate at right 
angles to the first direction. The total front movement in the 
second direction was approximately 5 cm. 
After drying under nitrogen, the plate was sprayed lightly with Van 
Urk I s reagent and dried in an oven at 60'C until the 6 spots 
coinciding with the 6 indole stands were clearly visible. The 
spots were cut out and placed into plastic scintillation vials. 
Thereafter, 3 ml of scintillation cocktail were added to each vial, 
which was then shaken for 30 minutes to elute the radioactive 
metabolites from the cuttings. The entire procedure was performed 
under subdued light. The radioacti vi ty was quantified in a Beckman 
LS 2800 scintillation counter. 
2.2.5 Results 
A typical bi-dimensional thin layer chromatogram of the pineal 
indole metabolites is presented in Figure- 2.1. The indoles are 
clearly separated from each other into characteristic green and 
blue ,spots. Approximately 90 95% of the radioactivity was 
recovered and blank values were negligible, representing less than 
0.02% of the total radioactive counts. 
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FIGURE 2.1 A typical bi-dimensional thin layer chromatogram of 
the pineal indole metabolites 
Abbr:eviations: 
MEL melatonin 
5-HT serotonin 
HlAA 5-hydroxyindole acetic acid 
MIAA 5-methoxyindole acetic acid 
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NAS N-acetylserotonin 
5-MT 5-methoxytryptamine 
UTOH 5-hydroxytryptophol 
MTOH 5-methoxytryptophol 
Results from these studies are expressed as dpm/lO III medium for 
each indole. The data were statistically analyzed by one-way 
analysis of variance and statistical differences between groups 
were determined using the Student's t-test. Results are expressed 
as the mean of the five separate incubations ± SEM. 
2.2.6 Discussion 
The pineal organ culture technique is a simple and effective method 
of monitoring pineal metabolism. Care should be taken to maintain 
aseptic conditions at all times and the culture medium should be 
analyzed as soon as possible after termination of the incubation 
to prevent sizable losses of radioacti vi ty. These losses are 
probably predominantly due to oxidative degradation of the indole 
metabolites. 
The bi-dimensional thin layer chromatography technique yields very 
good separations of the individual pineal indole metabolites when 
the original spots are kept as small as possible and the solvents 
are fresh and uncontaminated. 
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2.3 THE DETERMINATION OF PINEAL SEROTONIN N-ACETYLTRANSFERASE 
ACTIVITY 
2.3.1 Introduction 
Serotonin N-acetyltransierase (NAT) is an important, regulatory 
enzyme in the biosynthetic pathway of melatonin in the pineal 
gland. It is responsible for catalysing the conversion of 
serotonin to N-acetylserotonin with acetyl coenzyme A acti~g as the 
acetyl donor. 
This enzyme has been assayed by a number of methods. The method 
used in this study is based on that developed by Deguchi and 
Axelrod [1972c]. NAT is quantified by the rate at which it 
catalyzes the N-acetylation of tryptamine Hel with [3HJ acetyl 
coenzyme A acting as the acetyl donor, to form radioactive 
N-acetyltryptamine. Tryptamine is used in place of the natural 
substrate, serotonin, because it is more re~dily utilized by the 
enzyme. The labelled N-acetyl-r 3HJtryptamine can then be extracted 
into an organic solvent and the radioactivity measured by liquid 
scintillometry. 
2.3.2 Materials 
2.3.2.1 Animals 
Male Wistar rats of the albino strain weighing 250 - 300 g were 
randomly assembled into test groups of five and maintained as 
described previously (Section 2.1). The animals were sacrificed 
between lOhOO and 12hOO. 
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2.3.2.2 Chemicals and Reagents 
[3H]Acetyl-coenzyme A was purchased from Amersham International 
(England) . The specific activity was 3.9 Ci/mmol and the 
radioactive concentration was 50 ~Ci/200 ~l. Tryptamine HCl was 
purchased from Sigma Chemical Co. (St. Louis, USA) and PackardR 
Scintillator 299™ liquid scintillation cocktail from Packard 
Instrument Co Inc. {Netherlands). All other chemicals were obtained 
from local commercial sources. 
2.3.3 N-Acetyltransferase Assay Procedure 
The pineal glands were swiftly removed from the rats after 
sacrifice as previously described (section 2.1). Each pineal gland 
was individually placed in a small glass homogenizer containing 100 
~1 of ice cold 50 mM sodium phosphate buffer, pH 6.8. The pineals 
were then homogenized on ice for approximately 30 seconds until a 
homogeneous solution was obtained. A 20 ~l aliquot was transferred 
to an Eppendorf tube. 10 ~l of sodium phosphate buffer containing 
2.8 roM tryptamine HCI and 40 nCi [3H]acetyl coenzyme A was placed 
on the side of the Eppendorf tube. The surface tension was 
sufficient to keep the drops of homogenate and working solution 
separate until the tubes were tapped and quickly vortexed to 
thoroughly mix the two liqui-ds. This ensured a constant incubation 
time. Each assay was performed in triplicate and blanks were 
included in which the pineal homogenate was substituted with 20 ~l 
of 50 mM sodium phosphate buffer, pH 6.8. The tubes were incubated 
at 37·C for 45 minutes in a shaking water bath. Th~ reaction was 
termi~ated by the addition of 100 ~l chilled 0.2 M borate buffer, 
pH 10. 1 ml of toluene : isoamyl alcohol (97 : 3) was then added 
to each tube which was subsequently sealed and shaken for 5 
minutes. The resulting emulsion was centrifuged at 2000 x g for 
30 seconds in a Hettich Universal II centrifuge. The supernatant 
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was washed by the addition of a further 100 ~l of borate buffer, 
pH 10, re-shaken for 5 minutes and re-centrifuged at 2000 x g for 
30 seconds. A 0.5 ml aliquot of the supernatant was transferred 
to a plastic scintillation vial containing 3 ml of scintillation 
cocktail. The vials were 
radioactivity quantified in 
shaken for 
a Beckman 
10 minutes and the 
LS 2800 scintillation 
counter. The procedure is summarized in Table 2.3. 
In experiments involving the evaluation of a test compound on 
N-acetyltransferase activity in viLro, pineal glands removed from 
the rats following sacrifice were incubated with the test compound 
for 6 hours in organ culture as described in section 2.2.3. 
2.3.4 Results 
The cpm obtained from the enzyme assay were converted to dpm by 
correcting for the counting efficiency of the scintillation counter 
and blank values were subtracted from the sample values. The dpm 
were converted to Curies (1 Curie = 2.2 x 1022 dpm) and subsequently 
to moles of N-acetyltryptamine using the specific activity of the 
[3H] acetyl coenzyme A (1 mole = 3.9 x 102 Ci). Corrections were 
also made for using one fifth of the pineal homogenate and for 
incubating the enzyme for 45 minutes. The final results were 
expressed as pmoles N-acetyltryptamine formed per pineal gland per 
hour. Triplicate determinations were found to agree closely and 
were averaged before the data were statistically analyzed by 
one-way analysis of variance. Statistical differences between 
groups were determined using the Student's t-test. Results are 
expressed as the mean of the five incubations ± SEM. Preliminary 
time course studies indicated a linear increase in the amount of 
N-acetyl- r3H] tryptamine formed wi th time. Blank values obtained in 
the absence of enzyme were low indicating that a negligible amount 
of [3H]acetyl coenzyme A was extracted into the solvent. 
- 88 -
TABLE 2.3 Schematic Representation of N-Acetyl transferase 
Assay 
REAGENTS BLANK SAMPLE 
Homogenate 20 J.11 
Sodium phosphate buffer 10 J.11 
Working solution' 10 J.11 10 J.1l 
Vortex for 10 seconds 
Incubate at 37°C for 45 minutes 
Borate buffer 100 J.11 100 J.11 
Toluene:Isoamyl alcohol 1 ml 1 ml 
Shake for 5 minutes 
Centrifuge of 30 seconds at 2000 x g 
Borate buffer 100 J.11 100 III 
Shake for 5 minutes 
Centrifuge for 30 seconds at 2000 x g 
Transfer 500 J.11 supernatant to a scintillation vial 
Add 3 ml scintillation cocktail 
Shake for 10 minutes and count radioactivity 
* The working solution comprised per sample: 2 J.11 0.05M sodium 
phosphate buffer, pH 6.8, 4 J.11 r3Hlacetyl coenzyme A diluted 
to 0.01 j.1Ci/j.11 with water and 4 III tryptamine HCI (1.377 
mg/ml in sodium phosphate buffer). 
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2.3.5 Discussion 
An attempt to use chloroform as the organic solvent for the 
extraction of N-acetyl-[3H]tryptamine was less successful than the 
toluene isoamyl alcohol alternative. The radioactive counts 
obtained using the former were very much lower than those obtained 
wi th the latter sol vent and there appeared to be inadequate 
extraction of the labelled product with chloroform. Furthermore. 
in the original method. cold acetyl coenzyme A was included in the 
incubation tubes to compete with the radioactive [3H] acetyl 
coenzyme A for the enzyme. When cold acetyl coenzyme A was 
included, radioactive counts were not significantly different from 
the blank values. Omission of the cold coenzyme did not affect the 
blank readings, but increased the other radioactive counts while 
still resulting in a linear increase in the amount of product 
formed with time. It was therefore decided to omit the cold acetyl 
coenzyme A from the incubation mixture. 
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2.4 THE DETERMINATION OF PINEAL HYDROXYINDOLE-O-
METHYLTRANSFERASE ACTIVITY 
2.4.1 Introduction 
Hydroxyindole-O-methyltransferase (HIOMT) is the final enzyme in 
the biosynthetic pathway of melatonin in the pineal gland. It is 
responsible for catalysing the conversion of N-acetylserotonin to 
melatonin with S-adenosyl methionine acting as the methyl donor. 
The enzyme assay used in this study was a modification of the 
method of Axelrod and Weissbach [1961]. The assay is based on the 
transfer of the radioacti ve [14C] -methyl group from 
S-adenosyl-L-[methyl-14C]methionine to N-acetylserotonin by HIOMT 
to form N-acetyl-5- r14C]methoxytryptamine or radioactive melatonin. 
The radiolabelled melatonin can then be extracted into an organic 
solvent and the radioactivity measured by liquid scintillometry. 
The amount of radioactive melatonin formed is an indication of 
HIOMT activity. 
2.4.2 Materials 
2.4.2.1 Animals 
Male Wi star rats of the albino strain weighing 250 - 300 g were 
randomly assembled into test groups of five and maintained as 
described previously (Section 2.1). The-animals were sacrificed 
between 10hOO and 12hOO. 
2.4.2.2 Chemicals and Reagents 
S-Adenosyl-L-[methylJ4Clmethionine was purchased from Amersham 
International (England). The specific activity was 56.0 mei/romol 
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and the radioactive concentration was 25 }1Ci/ml. N-acetylserotonin 
was purchased from Sigma Chemical Co. (St. Louis, USA) and Packardi 
Scintillator 299™ liquid scintillation cocktail from Packard 
Instrument Co Inc. (Netherlands). All other chemicals were obtained 
from local commercial sources. 
2.4.3 Hydroxyinrlole-O-methyltransferase Assay Procedure 
The pineal glands were swiftly removed from the rats after 
sacrifice as previously described (section 2.1). Each pineal gland 
was individually placed in a small glass homogenizer containing 100 
~l of ice cold 50 mM sodium phosphate buffer. pH 7.9. The pineals 
were then homogenized on ice for approximately 30 seconds until a 
homogeneous solution was obtained. A 20 }1l aliquot was transferred 
to an Eppendorf tube. 10 JJ.I of 0.05 mM sodium phosphate buffer 
containing 0.9 mM N-acetylserotonin and 2 nCi S-adenosyl-L- [methyl-
[14C]methionine was placed on the side of the Eppendorf tube. The 
surface tension was sufficient to keep the drops of homogenate and 
working solution separate until the tubes were tapped and quickly 
vortexed to thoroughly mix the two liquids. This ensured a 
constant incubation time. Each assay was performed in triplicate 
and blanks were included in which the pineal homogenate was 
substituted with 20 ~l 50 mM sodium phosphate buffer. pH 7.9. The 
tubes were incubated at 37°C for 45 minutes in a shaking water 
bath. The reaction was terminated by the addition of 100 ul 
chilled 0.2 M borate buffer. pH 10. 1 ml of toluene : isoamyl 
alcohol (97 : 3) was then added to each tube which was subsequently 
sealed and shaken for 5 minutes. The resulting emulsion was 
cent~ifuged at 2000 x g for 30 seconds in a Hettich Universal II 
centrifuge. The supernatant was washed by the addition of a 
further 100 ~l of borate buffer. pH 10. re-shaken for 5 minutes 
and re-centrifuged at 2000 x g for 30 seconds. A 0.5 ml aliquot 
of the supernatant was transferred to a plastic scintillation vial 
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containing 3 ml of scintillation cocktail. The vials were shaken 
for 10 minutes and the radioactivity quantified in a Beckman LS 
2800 scintillation counter. The procedure is the same as that 
summarized in Table 2.3 for NAT activity except that the working 
solution comprised per sample: 5 III 0.05 ll1!\f sodium phosphate 
buffer, pH 7.9. 1 III S-adenosyl-L- [methyl-HC] methionine. 3 III 
N-acetylserotonin (0.6549 mg/ml made up in phosphate buffer) and 
1 III deionized water. 
In experiments involving the evaluation of a test compound 'on HIOMT 
activity in vi~ro. pineal glands removed from the rats following 
sacrifice were incubated with the test compound for 6 hours in 
organ culture as described in section 2.2.3. 
2.4.4 Results 
The actual cpm obtained from the enzyme assay were converted to dpm 
by correcting for the counting efficiency of the scintillation 
counter and the blank values were subtracted from the sample 
values. As in the case of the NAT assay, blank values obtained in 
the absence of enzyme were very low indicating that a negligible 
amount of the S-adenosyl-L-[methyl-14C]methionine, was extracted 
into the solvent. The dpm were converted to Curies (1 Curie = 2.2 
x 1022 dpm) and subsequently to moles of melatonin using the 
specific act! vi ty of the S-adenosyl-L- [methyl-14C]methionine (1 mole 
= 56 Ci). Corrections were also made for using one fifth of the 
pineal homogenate and for incubating the enzyme for 45 minutes. 
The final results were expressed in terms of pmoles N-acetyl-5-
r14C]methoxytryptamine formed per pineal gland per hour. 
Triplicate determinations were found to agree closely and were 
averaged before the data were analyzed statistically by one-way 
analysis of variance. Significant differences between groups were 
determined using the Student's t-test. The results are expressed 
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as the mean of the five separate incubations ± SEM. 
2.4.5 Discussion 
As with the NAT assay, an attempt to use chloroform as the organic 
solvent for the extraction of N-acetyl-5-[14C]methoxytryptamine in 
place of toluene: isoamyl alcohol was unsuccessful. Once again, 
cold S-adenQsylmethionine was omitted for the same reasons the cold 
cofactor was omitted before {section 2.3.5}. When the HIOMT and 
NAT assays are done on the same homogenate. the pineal gland is 
homogenized in 100 ~l sodium phosphate buffer, pH 6.8. A 10 ~l 
sample of this homogenate is removed for the HIOMT assay and its 
pH adjusted to 7.9 with approximately 10 ~l of sodium phosphate 
buffer, pH 11.3. This provides a rapid. highly efficient method 
of quantifying both of these important enzymes in the melatonin 
biosynthetic pathway. 
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2.5 THE MEASUREMENT OF PINEAL CYCLIC ADENOSINE MONOPHOSPHATE 
(cAMP) LEVELS 
2.5.1 Introduction 
Although only discovered in the 1950's, cyclic AMP has made a major 
impact on many areas of biochemical research. It is recognized as 
a ubiquitous, yet vital mediator of numerous intracellular events 
playing a particularly important role as a second messenger in the 
transduction of hormonal responses. Methods to quantify cyclic AMP 
levels are therefore in great demand. Various researchers· have 
employed a variety of techniques to assay for this cyclic 
nucleotide. 
Cyclic AMP is synthesized from ATP by adenylate cyclase, a membrane 
bound enzyme, and degraded to AMP by a specific phosphodiesterase. 
The earliest cyclic AMP assays involved determining the activity 
of adenylate cyclase as an indirect index of cyclic AMP levels. 
The formation of radioactive cyclic AMP from its labelled 
precursor, [14C]ATP. could be quantified radiochemically. Later, 
direct, competitive binding assays were developed which utilized 
purified specific cyclic AMP binding proteins. Brown et a1 {1971] 
used a binding protein, a protein kinase, with a very high 
specificity for cyclic AMP previously identified in adrenal 
glands. to develop a saturation assay for cyclic AMP. More 
recently. radioimmunoassays have been developed which use 
r125 I] antigen and antiserum to measure. cyclic AMP levels. Al though 
these radioimmunoassays are generally quick and simple to use, with 
a high degree of specificity and sensitivity, they are usually very 
expensive. 
The assay used in this study was based on that developed by Brown 
et a1[1971J with modifications by Daya [1985]. It is sensitive, 
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specific and relatively inexpensive. 
2.5.2 Materials 
2.5.2.1 Animals 
Male Wistar rats of the albino strain weighing 250 - 300 g were 
randomly assembled into test groups of five and maintained as 
described previously (Section 2.1). The animals were sacrificed 
between 10hOO and 12hOO. 
2.5.2.2 Chemicals and Reagents 
£8-3H]Adenosine-3' .5' -Cyclic Phosphate, ammonium salt was purchased 
from Amersham International (England). The specific activity was 
28 Curies/mmol and the radioactive concentration was 1 mCi/ml. 
Adenosine -3' ,5'- Cyclic Phosphate was purchased from Boehringer 
Mannheim (Germany), theophylline, isoproterenol and bovine serum 
albumin (whole fraction) from Sigma Chemical Co (St. Louis, USA) 
and activated charcoal from Merck (Germany). All other chemicals 
were obtained from local commercial sources. 
A [8-3H]adenosine-3' ,5'-cyclic phosphate working solution was 
prepared by diluting the commercial stock to a 0.1 mCi/ml solution 
with ethanol: water (1:1). The final solution was obtained by 
adding 10 ~l of this was to 6.24 ml of deionized water. 
The homogenizing buffer, pH 7.4 was 50 roM Tris-HCl containing 0.25 
M sucrose, 25 roM potassium chloride and 5 roM magnesium chloride. 
The protein diluting buffer, pH 7.4 was 50 roM Tris-HCl containing 
8 roM theophylline and 6 roM 2-mercaptoethanol. 
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10% w/v charcoal saturated with 2% BSA was prepared by dissolving 
400 mg of whole crystalline bovine serum albumin in protein 
diluting buffer. To this. 2 g of activated charcoal was added and 
the mixture stirred. It was stored frozen. 
2.5.3 Prepara~ion of cAMP Binding Protein 
Bovine adrenal glands were collected from the Grahamstown abattoir 
as soon as possible after slaughter and transported to the 
laboratory on ice. The adrenal cortices were dissected 'free and 
homogenized in a glass homogenizer in 1.5 volumes of ice, cold 
homogenizing buffer. The homogenate was centrifuged at 2000 x g 
for 10 minutes at 4°C. The resulting supernatant was centrifuged 
at 5000 x g for 15 minutes at 4"C. The supernatant from this 
centrifugation was recovered and stored in 1 ml aliquots at -20·C 
for up to 3 months. 
A protein dilution curve was constructed to determine the optimum 
cyclic AMP binding to give radioactive counts in the region of 1000 
cpm. A series of dilutions of the binding protein was prepared in 
protein diluting buffer and assayed as described below. The 
protein dilution curve is presented in Figure 2.2 and shows that 
a 1:3 dilution of the protein provided optimum binding and 
radioactive counts. This dilution was used for all subsequent 
assays. 
2.5.4 Preparation of Pineal Tissue and Incubation Procedure 
The pineal glands were rapidly removed from the rats after 
sacrifice as described previously (section 2.1). Each pineal gland 
was carefully bisected into the two hemispheres. The one 
hemisphere was placed in 50 p.l pre-warmed BGJb culture medium while 
the other hemisphere was transferred to culture medium containing 
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10 ~M isoprenaline. Each hemisphere was then incubated at 37°C 
for 20 minutes. Following incubation, the pineal hemispheres were 
removed from the media and homogenized in 10 ~l of ice cold buffer. 
A 50 ~l aliquot of the homogenate was used for determination of 
cAMP levels. 
2.5.5 Cyclic AMP Assay Procedure 
The cyclic AMP assay procedure is summarized in Table 2.4. Reaction 
tubes were prepared containing 150 ~l of the protein diluting 
buffer. 8 nei 18-3H]adenosine-3' ,5 ' -cyclic phosphate, 50 ~l of cold 
cyclic standard in the range 0 - 8 pmoles or 50 !!l of pineal 
homogenate and deionized water to give a final volume of 250 ~l. 
The tubes were mixed gently. Where possible. assays were performed 
in duplicate. Blanks containing no cyclic AMP standard or pineal 
homogenate were included. 100 ~l of diluted binding protein were 
added to each of tubes which were gently mixed and incubated at 4°C 
in a refrigerator or on ice for 100 minutes. Following 
incubation, 100 ~l of the activated charcoal suspension were added 
to each tube and vortexed for 10 seconds. The tubes were 
centrifuged at 1200 x g for 15 minutes at 4·C and a 100 ~l aliquot 
of the supernatant was added to scintillation vials containing 3 
ml of scintillation cocktail. The vials were shaken for 5 minutes 
and the radioactivity quantified in a Beckman LS 2800 scintillation 
counter. 
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TABLE 2.4 Scheme of the Cyclic AMP Assay 
-- ---
---_ .. -
-------- ---- ------ ---- --- ----- -- ------------- ------- --- ------ ------ ----------
----
REAGENTS CYCLIC AMP STANDARDS (pmoles) ! 
(111 ) BLANK SAMPLE ! 
0 0.25 0.5 1.0 2.0 4.0 8.0 
I 
Buffer 250 150 150 150 150 150 150 150 150 
Standard: 
- 20 nM --- --- 12.5 25 50 --- --- --- ---
- 200 nM --- --- --- --- --- 10 20 40 ---
Sample I --- --- --- --- --- --- --- --- 50 
Water 50 50 37.5 25 --- 40 30 10 ---
[3H] cAMP 50 50 50 50 50 50 50 50 50 
Mix Gently 
Protein --'- 100 100 100 100 100 100 100 100 
Incubate at 4°C for 100 minutes 
Charcoal 100 100 100 100 100 100 100 100 100 
Vortex for 15 seconds 
Centrifuge at 1200 x g for 15 minutes at 4°C 
Add 100 111 of supernatant to 3 ml scintillation cocktail 
Shake for 10 minutes and count radioactivity . 
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2.5.6 Results 
Blank values were subtracted from all readings. The Co/Cx ratio 
was calculated by dividing the radioactivity (cpm) of the zero 
standard (Co) by the radioactivity of the higher standards and test 
samples. A calibration curve was plotted using the Co/Cx ratio of 
the standards against the concentration of the cyclic AMP standards 
(pmoles). A typical standard curve is presented in Figure 2.3. 
The interference of non-cyclic AMP material in the binding assay 
was estimated by incubating pineal homogenate with approximately 
50 ~g of phosphodiesterase for 1 hour at 37"C before conducting the 
assay to degrade all endogenous cyclic AMP. Cyclic AMP values 
obtained following incubation were not significantly different from 
the zero standard indicating negligible interference by non-cyclic 
AMP material. 
The data from sample assays were statistically analyzed by one-way 
analysis of variance and the significant difference between the 
means determined using the Student's t-test. 
2.5.7 Discussion 
The results of this competition assay indicate a linear 
relationship between the binding of cold and radioactive cyclic AMP 
to a cyclic AMP binding protein. Furthermore, the assay was 
specific and sensitive down to 0.25 pmoles of cyclic AMP. It is 
preferred to the method of Brown et 81 [1971] because it does not 
require any additional preparatory treatment of the crude pineal 
homogenate. 
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FIGURE 2.3 A Typical Cyclic AMP Standard Curve 
Each point is the mean of duplicate determinations. 
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2.6 THE MEASUREMENT OF PINEAL .a-ADRENERGIC :RECEPTOR BINDING 
USING [3H]DIHYDROALPRENOLOL 
2.6.1 Introduction 
The observation that many cells respond in a highly selective way 
to minute concentrations of a particular chemical or drug, led 
different investigators to hypothesize about cell receptors or 
specific sites on cells which were the site of dru~ action 
[cf.Carman-Krzan, 1986], Langley in 1905, studying the effect of 
nicotine and curare on the vOluntary smooth muscle, postulated the 
existence of specific receptors or "receptive sites" on the cell 
which would receive the stimulus from the drug and transmit it to 
the cell, causing the effect. However, it was not until the 1950s 
that the receptor theory became a major area of research interest 
in pharmacology. The synthesis of structurally related analogues 
of drugs and endogenous substances expanded the field to work on 
the detailed structure-function relationship between drugs and 
their receptors. These studies established the structural 
requirements of agonists and antagonists and led to the 
distinguishing of competitive and non-competitive antagonists 
[Titeler, 1981; Carman-Krzan, 1986]. 
The beginning of radioligand receptor binding studies was in 1965 
wi th the partly successful labelling of muscarinic cholinergic 
receptor sites in guinea-pig ileum with [3HJ atropine. Today. 
well-validated radioligand binding assays exist for labelling 
almost all known receptors and a wide variety of high affinity, 
highly specific radioactive ligands are available. 
Previously available electrophysiological or biochemical techniques 
measured receptor activation indirectly by recording an event which 
may be several steps removed from the initial interaction, 
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Radio1igand binding methodology facilitates the direct measurement 
of the ligand-receptor interaction in the absence of cellular 
influences and functionally coupled biological responses. 
Furthermore, the binding of ligand molecules to a receptor 
population is a second order reaction which can be quantified by 
applying kinetic analyses similar to those originally devised for 
the study of enzyme catalysed reactions. Thus the affinity of the 
ligand for the receptor and the total number of binding sites 
present can be readily assessed. The binding of the ra~io1igand 
to receptor and non-receptor sites can be distinguished by 
examining the saturabi1ity and pharmacological specificity of the 
radioligand binding sites. 
reversible and display 
If the binding sites are saturable. 
the same stereospecificity and 
pharmacological characteristics as the receptor mediated biological 
response, it can be concluded that the radio1igand has specifically 
labelled the recognition site of the receptor [Titeler. 1981; 
Foster and Fagg, 1984; Carman-Krzan, 1986]. 
Ligand binding techniques may be used to determine the affinity of 
various agents for the receptor site, the distribution of the 
receptors in different tissues and subcellular fractions as well 
as the plasticity of receptor parameters following drug treatments, 
experimental lesions and pathological states such as disease or 
injury. Additionally. binding studies can be used to monitor the 
isolation of the receptor molecule and determine its biochemical 
characteristics. An extension of these procedures is the recent 
development of autoradiographical techniques for the localisation 
of receptor-bound ligand in tissue sections. This has allowed 
detailed investigations of the regional distributions of a number 
of important receptor binding sites. 
The study of 13-adrenergic receptors necessitates the use of a 
radioligand with a high affinity, specificity and specific activity 
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to identify the small number of B-adrenergic receptors present in 
tissues. Many such competi ti ve B-adrenergic antagonists are 
available including r3H] propranolol, [125 1 ) iodohydroxy-
benzylpindolol, r3HJCGP-12177 and [3 H] dihydroalprenolol (DHA). 
The method used in this study was adapted for the pineal gland by 
Greenberg and Weiss [1978] and employs r3HJDHA as the radioactive 
ligand. 
2.6.2 Materials 
2.6.2.1 Animals 
Male Wistar rats of the albino strain weighing 250 - 300 g were 
randomly assembled into test groups of eight and maintained as 
described previously (Section 2.1). 
between 10hOO and 12hOO. 
2.6.2.2 Chemicals and Reagents 
The animals were sacrificed 
1-[Propyl-2,3-3H]dihydroalprenolol was purchased from Amersham 
International (England). The specific activity was 53.9 Ci/mmol 
and the radioactive concentration was 1.0 mCi/ml. dl-Propranolol 
hydrochloride was purchased from Sigma Chemical Co. (St. Louis. 
USA) and PackardR Scintillator 299D liquid scintillation cocktail 
from Packard Instrument Co Inc. (Netherlands). All other chemicals 
were obtained from local commercial soure-es. 
2.6.3 Preparation of Pineal Homogenate 
The pineal glands were rapidly removed from the rats after 
sacrifice as described previously (section 2.1). Two similarly 
treated pineals were homogenized together in 5 ml of ice cold 50 
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roM Tris-Hel buffer, pH 8.0,containing 3 mM MgCI2.6H20 in a glass 
homogenizer. The homogenate was centrifuged at 49000 x g for 15 
minutes at 4·C in a Beckman L8-80M ultracentrifuge with a 70.1 Ti 
rotor. The pellet was washed once by resuspension in the original 
volume of buffer and re-centrifuged as before. The pellet was 
finally resuspended in 0.9 ml of Tris-HCI buffer. A 300 iiI aliquot 
was frozen to be used for the protein determination while the 
remaining volume was used for the [3H1DHA binding assay. 
For the saturation curve, pineal glands from 8 rats were 
homogenized in 10 ml of ice cold Tris-HCI buffer in a glass 
homogenizer. The homogenate was centrifuged at 49000 x g for 15 
minutes at 4°C. The pellet was washed once as described above and 
resuspended in 3.6 ml of buffer. A 300 iiI aliquot was frozen to 
be used for the protein determination while the remaining fraction 
was used for the [3H]DHA saturation curve. 
2.6.4 r3H1Dihydroalprenolol Binding Assay Procedure 
The binding assay procedure is summarized in Table 2.5. A 100 iiI 
aliquot of the prepared pineal honi~genate was added to 10 mm x 12 
rum Kimble tubes containing 50 iiI of 8 nM [3H]DHA and 50 mM Tris-HCI 
buffer, pH 8.0. For assessment of the total binding. the final 
volume was made up to 450 iiI with buffer and for non-specific 
binding, 10 iiI of buffer were substituted with 10 iiI of 450 liM 
dl-propranolol. Each assay was performed in triplicate and a blank 
containing no pineal homogenate was included in each series of 
assays. The tubes were vortexed gently and incubated at 37'C for 
10 mi~utes. The incubation was terminated by the addition of 5 ml 
of ice cold buffer. The samples were then rapidly filtered through 
pre-wetted Whatman GF/C glass microfilters in a 12 place Millipore 
sampling manifold. Each filter was washed five times with 4 ml of 
cold buffer. The filters were transferred to scintillation vials 
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TABLE 2.5 Scheme of the [3B]DHA Binding Assay 
REAGENTS TOTAL BINDING NON-SPECIFIC BINDING 
(Ill) 
BLANK STANDARD SAMPLE BLANK . STANDARD SAMPLE 
Buffer * 400 300 300 390 290 290 
[ 3H]DHA 50 50 50 50 50 50 
Propranolol --- --- --- 10 10 10 
Homogenate --- 100 100 --- 100 100 
Incubate at 37°C for 45 minutes 
Buffer * 5 ml 5 ml 5 ml 5 ml 5 ml 5 ml 
Filter through Whatman GF/C glass filters 
Wash filters 5 x with 4 ml ice cold buffer* 
Scintillation 
cocktail 3 ml 3 ml 3 m1 3 ml 3 ml 3 ml 
Shake for 30 minutes and count radioactivity 
* 
50 roM Tris-HCl Buffer, pH 8.0. containing 3 roM MgC12.6H20. 
containing 3 ml scintillation cocktail and shaken for 30 minutes. 
Finally the radioacti vi ty was quantified in a Beckman LS 2800 
scintillation counter. 
The saturation curve was prepared by incubating 100 III of binding 
protein with 50 III of varying concentrations of r3H]DHA (0 - 20 nM) 
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made up to a final volume of 450 ~l with 50 mM Tris-HCl buffer '. pH 
8.0. Non-specific binding was again assessed by replacing 10 ~l 
of buffer with 10 ~l of 450 ~M dl-propranolol and blanks were 
included in which the binding protein was omitted. 
were assayed as described above. 
2.6.5 Protein Determination of Pineal Homogenate 
The samples 
The protein concentration of the pineal homogenates was determined 
by a modification of the method of Lowry et a1 [1951]' for small 
samples. The scheme for the protein assay is summarized in Table 
2.6. A 0.1 ml aliquot of protein sample was made up to 0.4 ml 
with 50 mM Tris-HCl buffer, pH 8.0. To this was added 2 ml of an 
alkaline solution prepared by mixing 
0.5% CuS04.5H20 in 1% sodium tartrate 
2% Na2C03 in O. 1 N NaOH with 
in a ratio of 50 : 1. The 
tubes were mixed and left to stand at room temperature for 15 
minutes. Folin-Ciocalteu reagent was diluted 1 : 1 with deionized 
water and 0.2 ml aliquots were added to the assay mixture. The 
tubes were vortexed gently and left to stand at room temperature 
for 30 minutes in the dark. after which the absorbance was 
measured at 750 nm. For the standard curve, protein standards 
containing 0 - 40 ~g of bovine serum albumin were assayed as above. 
A typical standard curve thus obtained is presented in Figure 2.4. 
The assays were always performed in duplicate or triplicate. 
2.6.6 Results 
The actual cpm obtained from the binding study were converted to 
dpm by correcting for the counting efficiency of the scintillation 
counter. Blank values were subtracted from sample values. The 
saturable specific binding was calculated as the total binding 
minus the non-displaceable, non-specific binding determined in the 
presence of 10 ~M propranolol. These dpm were converted to Curies 
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(1 Curie = 2.2 x 1022 dpm) and subsequently to moles of r3H]DHA using 
the specific activity of the radioactive compound (1 mole = 53.9 
x 103 Ci). The specific binding was expressed as fmoles [3H]DHA 
bound/mg protein. The final result is the mean of the duplicate 
or triplicate determinations. The data were statistically analyzed 
by one-way analysis of variance and the significant difference 
between the means was determined using the Student's t-test. 
TABLE 2.6 Scheme of the Protein Assay 
REAGENTS PROTEIN STANDARDS (J.lg) 
(ml) BLANK SAMPLE 
2.5 5.0 10.0 20.0 40.0 
Protein Std: 
-
0.1 mg/ml --- 25 50 100 --- --- ---
- 1.0 mg/ml --- --- --- --- 20 40 ---
Unknown --- --- --- --- --- --- 100 
Buffer' 400 375 350 300 380 360 300 
Alkaline soln t 2000 2000 2000 2000 2000 2000 2000 
Stand at room temperature for 15 minutes 
FC Reagent u 200 200 200 200 200 200 200 
Stand at room temperature for 30 minutes 
Read absorbance at 750 nm 
# 50 roM Tris-HCI buffer, pH 8.0 
* 2% Na2C03 in 0.1 N NaOH : 0.5% CuS04' 5HZO in 1% sodium tartrate (50 : 1) 
** Folin - Ciocalteu Reagent : Water (1 : 1) 
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2.6.7 Discussion 
The specific binding was between 20 - 24% of the total binding. 
The saturation curve in Figure 2.5 shows the binding of [3HJDHA to 
rat pineal membranes is saturable at 15 - 20 nM.- The Scat chard 
plot in Figure 2.6 demonstrates the presence a single class of 
B-adrenergic receptors with an equilibrium dissociation constant 
(KD) of 8.3 riM and an apparent maximum number of binding sites (Bmax) 
equivalent to 417.6 fmole/mg protein. These findings are in close 
agreement with previous reports [Greenberg and Weiss, 1978; Banoo, 
1991J. 
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2. 7 THE MEASUREMENT OF LIVER TRYPTOPHAN PYRROLASE ACTIVITY 
2.7.1 Introduction 
Tryptophan pyrrolase 
which catalyzes 
is 
the 
a haem-dependent 
conversion 
liver cytosolic enzyme 
of L-tryptophan to 
N'-formylkynurenine in the first and rate-determining step in the 
catabolic kynurenine-nicotinic acid pathway [Badawy and Evans. 
1975] . It is the most important peripheral factor regulating 
plasma tryptophan levels in vivo. Tryptophan pyrrolase enzyme 
assays have provided important information about the various 
factors regulating both the activity of the enzyme and endogenous 
tryptophan levels in normal and diseased animals. 
In the livers of some animal species, tryptophan pyrrolase exists 
in at least two forms: the active reduced holoenzyme which does 
not require the presence of a cofactor for the demonstration of its 
activity, and the inactive apoenzyme which requires the addition 
of exogenous haem for the demonstration of its activity [Badawyand 
Evans, 1974]. Activation of the apoenzyme in vitro involves its 
conjugation with haem to form the oxidized (ferrihaem) holoenzyme 
which is then reduced to the active form in the presence of 
tryptophan. When assessing the affect of a particular agent on 
tryptophan pyrrolase activity, it is important to measure both 
apoenzyme and holoenzyme activities in order to draw conclusions 
about the site of action of the agent. Both forms of the enzyme 
are present in the liver of rats, mice, chickens and possibly man, 
but the apoenzyme has not been found in guinea pigs, hamsters, 
rabbits. sheep, frogs. cats and the gerbil. 
The tryptophan pyrrolase enzyme assay employed in this study was 
previously described by Badawy and Evans [1973; 1975]. A few 
modifications were made to increase the number of assay points 
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possible on each liver. The activity of the enzyme is determined 
by measuring the formation of kynurenine from L-tryptophan. The 
holoenzyme is measured in the absence of added haemin and total 
enzyme acti vi ty in the presence of exogenous haemin. The apoenzyme 
is calculated as the difference. 
2.7.2 Materials 
2.7.2.1 Animals 
Male Wistar rats of the albino strain weighing 250 - 300 g were 
randomly assembled into test groups of five and maintained as 
described previously (Section 2.1). The animals were sacrificed 
between 10hOO and 12hOO. 
2.7.2.2 Chemicals and Solutions 
L-Tryptophan, melatonin and haemin hydrochloride were purchased 
from Sigma Chemical Co. (St. Louis, USA). All other chemicals were 
obtained from local commercial sources. 
The haemin solution was prepared by dissolving 7.8 mg haemin 
hydrochloride in a minimal amount of 4 M NaOH. The pH was 
carefully adjusted to 7.0 with 1 M HCI and the final volume made 
up to 10 mI. This solution was always prepared immediately prior 
to use. 
2.7.3 Preparation of Rat Liver Homogenate 
The procedure is summarized in Table 2.7. The liver was rapidly 
removed after sacrifice as described previously (section 2.1) and 
homogenized in 60 ml of 140 mM KCI - 2.5 mM NaOH homogenizing 
buffer, pH 7.0, with a Waring blender for 1 minute {1000 
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rev /minute) . Care was taken not to allow excessive foaming 
associated with protein denaturation. The resulting suspension was 
further homogenized in a Dounce homogenizer with a loose-fitting 
glass pestle until a completely homogeneous solution was obtained. 
To this. 60 ml of 0.2 M sodium phosphate buffer, pH 7.0 was added 
and the mixture gently stirred. These procedures were performed 
on ice and as quickly as possible. 
2.7.4 Determination of Tryptophan Pyrrolase Activity 
To determine apoenzyme activity, a 15 ml aliquot of liver 
homogenate was added to a solution containing 12.5 ml of deionized 
water and 2.5 ml of 0.03 M L-tryptophan. To determine total enzyme 
activity, 0.1 ml of a 1.2 roM haemin solution was included to give 
a final overall concentration of 2 ~M. To assess the conversion 
of endogenous tryptophan to kynurenine, controls were prepared in 
which the tryptophan was replaced with 2.5 ml 0.2 M sodium 
phosphate buffer. When a test compound was used, the water 
fraction or part thereof was replaced with a solution of the test 
compound. In these instances. a control was included which 
received the vehicle. 
The rest of the assay was performed in triplicate. 3 ml aliquots 
of the assay mixture were transferred to boiling tubes and 
stoppered in an atmosphere of 95% 02 : 5% CO2, The tubes were 
incubated at 37·C for 0, 15, 30, 45, 60 and 75 minutes in a shaking 
water bath (120 oscillations/minute). The reaction was terminated 
by the addition of 2 ml of 0.9 M trichloracetic acid. The mixtures 
were shaken for a further 2 minutes and then filtered through 
ml of the fitrates were Whatman No. 1 filter paper. 2.5 
transferred 
absorbance 
to 
was 
tubes containing 1.5 ml of 
measured at 365 nm in 
0.6 M NaOH. 
a Unicam SP 
The 
1001 
spectrophotometer against a blank consisting of 2 ml of 0.9 M 
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trichloracetic acid and 1.5 m1 of 0.6 M NaOH. 
2.7.5 Results 
Absorbance readings from the triplicate determinations were pooled 
and averaged. The concentration of kynurenine was calculated by 
applying Beer-Lamberts Law and measuring the increase in absorbance 
at 365 nm. The molar extinction coefficient of kynurenine is E = 
4540 litre/mole. cm. Results were expressed as mole kynurenine 
formed/mg protein per hour. Holoenzyme activity was that 
determined in the absence of haemin and total activity was that 
determined in the presence of added haemin. The difference was a 
measure of apoenzyme activity. The data were analyzed by one-way 
analysis of variance and statistical differences between the means 
of test groups were determined using the Student's t test. 
The time course for the enzyme activity (Figure 2.7) indicated that 
the formation of product was linear for the first 60 minutes and 
45 minutes was chosen to be the most suitable incubation time for 
all the studies. 
Due to the long duration of the entire assay procedure, it was 
often not possible to perform all the required assays on one day. 
To determine the effect of freezing on tryptophan pyrrolase 
activity, the enzyme was assayed in fresh livers and in livers 
previously frozen in liquid nitrogen and stored at -70·C. The 
frozen livers exhibited a small, but consistent decrease in enzyme 
activity. 
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TABLE 2.7 Scheme of the Tryptophan Pyrrolase Enzyme Assay 
TRYPTOPHAN TRYPTOPHAN + HAEM 
Homogenize liver in KC1-
NaOH buffer 60 ml 
Add Na K monophosphate 
buffer 60 ml 
Add water to 100 ml 
reaction beakers 12.5ml 12.5m1 
Transfer to 100 ml 
reaction beakers 15ml 15ml 
Add haem to give 2J.lM 
solution - 100 J.ll 
Add 0.03 M tryptophan 2.5 ml 2.5 ml 
CONTINUE IN TRIPLICATE 
Transfer to boiling tube 3 ml 3 ml 
Incubate in atmosphere of carbogen for 1 hour at 37·C with 
shaking 
Stop reaction with 0.9M 
TCA 2 ml 2 ml 
Shake for 2 minutes 
Filter through Whatman No. 1 filter paper in Buchner apparatus 
Remove filtrate to test 
tubes containing 1.5 ml 
NaOH 2.5 ml 2.5 ml 
Read Absorbance at 365 nm 
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2.7.6 Discussion 
The tryptophan pyrro1ase enzyme assay was shown to produce a linear 
increase in kynureriine formed with time. Due to the limited 
reduction in tryptophan pyrro1ase activity following freezing, all 
livers were frozen in liquid nitrogen and stored at -70·C prior to 
the enzyme assay. This accommodated practical problems associated 
wi th the assay while still producing consistent, reproducible 
results. 
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2. 8 THE MEASUREMENT OF GLUTAMATE BINDING TO RAT CEREBRAL 
MEMBRANES USING r14CJGLUTAMATE 
2.8.1 Introduction 
A brief. general introduction to radioligand binding studies and 
their uses was presented in section 2.6.1. 
Glutamate, aspartate and a number of related amino acids have the 
common ability to activate the central nervous system. The 
pharmacology of these excitatory amino acids has been extensively 
investigated using electrophysiological techniques. and it has 
become apparent that multiple receptors exist for these substances. 
The advantages to be gained using radioligand binding assays in the 
study of these receptors include the ability to directly quantify 
receptor occupancy in vi~ro, to monitor the isolation and 
purification of the receptor molecules and to kinetically 
characterize the binding sites. 
The first investigations of L-glutamate binding to eNS membranes 
were conducted independently by Roberts [1974] and Michaelis et 
81 I1974]. These studies indicated the binding of glutamate to a 
specific population of receptors was saturable. of reasonably high 
affini ty and could be displaced by other neuroexci tatory amino 
acids. However. further progress was hampered by the low specific 
activity of L-I 14C]glutamate. When L-[3H]glutamate with a higher 
specific activity became available. more detailed studies of 
glutamate binding to CNS membranes was possible. Comparison of the 
data obtained from these studies reveals a very wide range of 
values for the equilibrium dissociation constant (8 - 8300 nM) and 
maximum number of binding sites (0.13 - 381 pmole/mg protein) have 
been reported [cf. Foster and Fagg, 1984]. Some of the variation 
in these parameters can be explained by the different methods of 
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membrane preparation and the use of tissue from different areas of 
the brain from different species. However, these factors alone do 
not account for the wide variation in kinetic values. This 
suggests that wi thin the procedures of tissue preparation and 
binding assay, are variables which determine the characteristics 
of glutamate binding. 
An ideal preparation for use in binding assays is one which has a 
reasonably high density of binding sites and is free of en~ogenous 
contaminants which could interfere with the assay. Subcellular 
fractionation techniques are often designed to isolate synaptic 
membranes based on one or two morphological or biochemical 
criteria, but certainly do not isolate the total synaptic membrane 
fraction. This may result in the loss of potential binding sites 
during the fractionation procedures. However, the use of crude 
preparations leads to relatively high levels of non-specific 
binding which can make the accurate estimation of specific binding 
very difficult. The choice of a subcellular fractionation 
technique therefore should balance the need to prevent the loss of 
membraneous fractions with the need to reduce the levels of 
non-specific binding as far as possible. 
Another important aspect of the membrane preparation is the removal 
of endogenous compounds which interfere with the binding assay. 
Soluble endogenous substances, trapped in membrane vesicles or 
tightly bound to membrane components. may be carried through 
several stages of the subcellular fractionation procedure. Thus 
a crucial step in membrane preparation is the lysis of synaptosomes 
and ~embrane vesicles by osmotic or mechanical shock. and 
subsequent washing by repeated centrifugations to rid the membranes 
of such contaminants. 
The methodology used in this study to prepare cerebral synaptosomal 
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membranes and obtain optimal conditions for the glutamate binding 
assay was experimentally developed using the principles employed 
by Cotman and Taylor [1972], Jones and Matus [1974J, Foster e~ 81 
[1981], Monaghan and Cotman [1986] and Brose e~ 81 [1989; 1990]. 
2.8.2 Materials 
2.8.2.1 Animals 
Male Wistar rats of the albino strain weighing 250 - 300 g were 
randomly assembled into test groups of ten and maintained as 
described previously (Section 2.1). The animals were sacrificed 
between lOhOO and 12hOO. 
2.8.2.2 Chemicals 
L-[G-3H]Glutamate was purchased from Amersham International 
(England). L-Glutamic acid was purchased from Sigma Chemical Co. 
(St. Louis. USA). All other chemicals were purchased from local 
commercial stores. 
2.8.3 Preparation of Cerebral Synaptosomal Membranes 
The brains were rapidly removed from the rats after sacrifice as 
described previously (section 2.1) and the forebrains dissected 
free. The ten forebrains were homogenized together in ice cold 10% 
(w/v) 0.32 M sucrose in a glass homogenizer with a Teflon pestle. 
All procedures were strictly performed on ice and all 
centrifugations performed at 4°C. The homogenate was centrifuged 
at 1500 x g for 5 minutes in a Beckman centrifuge with a JA 21 
rotor. The supernatant was set aside on ice while the pellet was 
washed by resuspending it in a similar volume of ice cold sucrose 
and re-centrifuging as before. The supernatants from the first 
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two steps were combined and centrifuged at 17000 x g for 10 minutes 
in a Beckman L8 - 80M ultracentrifuge with a 70 Ti rotor. The 
supernatant was discarded while the pellet was resuspended in 20 
ml of 200 ~M tris acetate buffer, pH 7.2, and incubated for 15 
minutes at 4·C. After incubation. the suspension was centrifuged 
at 50000 x g for 25 minutes in a Beckman L8 - 80M ultracentrifuge 
with a 70 Ti.1 rotor. The pellet was recovered and washed four 
times by resuspending it in 200 ~M tris acetate buffer, pH 7.2, and 
re-centrifuging as before. The final pellet was resuspended in 10% 
sucrose and layered onto a discontinuous sucrose density gradient 
consisting of 10 ml of each of 0.85M. 1.0 M and 1.3 M. As the 
centrifuge tubes were made non-wettable polyallomer, the gradient 
was layered by adding the lightest sucrose solution first. A 
syringe with a long needle was used to apply successive sucrose 
concentrations of increasing density to the apex of the tube and 
float the lighter concentrations up from the bottom. Loading non-
wettable tubes from the top by allowing solutions to run down the 
side of the tube causes mixing. The gradient was centrifuged in 
a Beckman L8 - 80M ultracentrifuge with a SW 28 rotor. The 
synaptic plasma membrane fraction at the 1.0 1.3 M sucrose 
interface was collected, diluted with 200 ~M tris acetate buffer, 
pH 7.2, and centrifuged at 50000 x g for 20 minutes in a Beckman 
L8 - 80M ultracentrifuge with a 70 Ti. 1 rotor. The resulting 
pellet was resuspended in 50 mM tris acetate buffer, pH 7.2 to give 
a protein concentration of 1 mg/ mI. 
2.8.4 Protein Determination of Pineal Homogenate 
The p,rotein concentration of the cerebral homogenates were 
determined by the method of Lowry er a1 11951]. A 1.2 ml aliquot 
of protein sample was placed in a test tube. To this was added 6 
ml of an alkaline solution prepared by mixing 1 ml of a 1% 
CuS04.5H20 solution, 1 ml of a 2% sodium tartrate solution and 98 
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ml of a 2% Na2C03 in 0.1 N NaOH in order. The tubes were mixed and 
left to stand at room temperature for 10 minutes. 0.3 ml of 
Folin-Ciocalteu reagent was added to each of the tubes which were 
vortexed gently and left to stand at room temperature for 30 
minutes in the dark. 
measured at 750 nm. 
After the incubation, the absorbance was 
For the standard curve, protein standards 
containing 0 - 0.5 mg of bovine serum albumin were assayed as 
above. The assays were always performed in duplicate or 
triplicate. A typical standard curve thus obtained is presented 
in Figure 2.2. 
2.8.5 Saturation Curve for Cerebral Glutamate Receptors 
The binding assay procedure is summarized in Table 2.8. The 
saturation curves were prepared by adding 200 ~l aliquots of the 
prepared cerebral homogenate to 10 x 12 mm Kimble tubes containing 
40 ~l of varying concentrations of [3H]glutamate (0 - 500 nM) made 
up to a final volume of 250 ~l with 50 mM tris acetate buffer, pH 
7.2. Non-specific binding was assessed by replacing 10 ~l of the 
tris acetate buffer with 10 ~l of 2.5 mM cold glutamate solution. 
Blanks were included which omitted the binding protein. The tubes 
were incubated at 30'C for 20 minutes. The incubation was 
terminated by the addition of 4 ml of ice cold buffer. The samples 
were then rapidly filtered through pre-wetted Whatman GF/C glass 
microfil ters in a 12 place Millipore sampling manifold. Each 
filter was washed 3 times with 4 ml of cold buffer. The filters 
were transferred to scintillation vials containing 3 ml of 
scintillation cocktail and shaken :t;or 30 minutes. Finally the 
radio~ctivity was quantified in a Beckman LS 2800 scintillation 
counter. 
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TABLE 2.8 Scheme of the [3H]Glutamate Binding Assay 
REAGENTS TOTAL BINDING NON-SPECIFIC BINDING 
(~l) 
BLANK STANDARD SAMPLE BLANK STANDARD SAMPLE 
Buffer * 210 10 10 200 --- ---
[ 3H]Glutamate 40 40 40 40 40 40 
Glutamate --- --- --- 10 10 10 
Homogenate --- 200 200 --- 200 200 
Incubate at 30·C for 20 minutes 
Buffer * 4 ml 4 ml 4 ml 4 ml 4 ml 4 ml 
Filter through Whatman GF/C glass filters 
Wash filters 3 x with 4 ml ice cold buffer* 
Scintillation 
cocktail 3 ml 3 ml 3 ml 3 ml 3 ml 3 ml 
Shake for 30 minutes and count radioactivity 
* 50 mM Tris-acetate buffer. pH 7.2. 
2.8.6 Results 
The actual cpm obtained from the binding study were converted to 
dpm by correcting for the counting efficiency of the scintillation 
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counter. Blank values were subtracted from samples values. The 
saturable specific binding was calculated as the total binding 
minus the non-displacable. non-specific binding determined in the 
presence of 0.1 mM cold glutamate. These dpm were converted to 
Curies (1 Curie = 2.2 x 1022 dpm) and subsequently to moles of 
[3H]glutamate using the specific activity of the radioactive 
compound (1 mole = 45 x 103 Ci). The specific binding was finally 
expressed in terms of fmoles r3H]glutamate bound/mg protein. The 
final result is the mean of duplicate or triplicate determinations 
for n = 10. 
2.8.7 Discussion 
The receptor purification process took approximately 12 hours. As 
it was not always possible to complete the whole purification 
procedure on the day of sacrifice, it was often necessary to store 
the forebrains or a subcellular fraction overnight. As freezing 
has been reported to not affect NMDA binding sites, intermediate 
steps were stored frozen at -20'C when necessary. This did not 
effect a marked change in total or specific glutamate binding. 
although it did appear to increase the protein concentration of the 
synaptic plasma membrane fraction. Further purification of 
synaptic structures from the synaptic plasma membrane fraction by 
detergent treatment, which results in the removal of non-synaptic 
membranes. has been reported to lead to large enrichments in 
glutamate binding sites [Monaghan and Cotman. 1986]. Detergent 
treatment was not attempted in this study due to the limited amount 
of protein obtained from the sucrose gradient. 
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CHAPTER 3 
THE EFFECT OF CHRONIC HYDROCORTISONE TREATMENT 
ON PINEAL PHYSIOLOGY AND BIOCHEMISTRY 
3 . 1 INTRODUCTION 
Careful and complete elucidation of pineal adrenal gland 
interactions awaits further research. Much of the literature 
proposes that there is an interaction between these two endocrine 
glands and supports an inhibitory or regulatory role for the pineal 
gland on adrenal function [Romijn. 1978; Armstrong et a1, 1982]. 
While much attention has been focused on the possible influence of 
the pineal on the adrenal glands. few researchers have addressed 
the reverse influence of the adrenals on the pineal gland. The 
latter issue is worthy of deeper understanding because if the 
pineal gland were to regulate adrenal function, it would be 
necessary for the pineal to detect and respond to adrenal output. 
The adrenal glands secrete catecholamines and glucocorticoids as 
the final step in a neuroendocrine cascade initiated on perception 
of a stressor by the brain {Haynes and Larner, 1975; Ganong, 1979]. 
In view of the anti-stressogenic role proposed for the pineal 
gland, it was of interest to determine whether either of these 
secretions could induce any physiological response from the 
pineal. Lynch et a1 [1973] demonstrated that factors which 
increase sympathetic activity could rapidly increase pineal 
melatonin levels. As the rise in melatonin levels in rats could 
be prevented by propranolol, a B-adrenergic antagonist, it was 
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concluded that this effect was mediated by catecholamines. As an 
end organ of the sympathetic nervous system with a rich blood 
supply, the pineal gland would be an obvious target for the action 
of catecholamines derived from nervous or peripheral sources. 
Thus. an increase in pineal activity following stress could 
indicate a non-specific response to increased circulating 
catecholamine levels resulting from enhanced stress-induced 
sympathetic activity, or an important regulatory mechanism 
initiated to modulate the neuroendocrine consequences of stress. 
Other researchers have proposed that a high affinity uptake system 
in the pineal gland protects the organ against the action of 
generalized sympathetic activity during the day by ensuring the 
rapid sequestration of catecholamines by presynaptic nerve 
terminals [Armstrong et 81 [1982]. 
The effect of glucocorticoids on the pineal gland has not been 
directly assessed, although sustained elevation of circulating 
glucocorticoid levels are the major neuroendocrine consequence of 
long term stress. The aim of this study was to directly assess the 
effect of glucocorticoids on pineal indoleamine metabolism, and the 
secretion of the putative pineal hormone, melatonin. 
3.2 THE EFFECT OF CHRONIC HYDROCORTISONE TREATMENT ON RAT PINEAL 
AND ADRENAL GLAND WEIGHT AND PINEAL INDOLEAMINE METABOLISM IN 
ORGAN CULTURE 
3.2.1 Introduction 
The change in mass of an organ is often associated with altered 
physiological processes within the organ. Generally, hyperplasia 
or an increase in mass indicates increased activity and metabolism 
within the organ, while hypoplasia or a decrease in mass is 
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associated with a decrease in the metabolic activities within the 
organ. This parameter has been used in many experiments as a crude 
indication of a possible effect of treatment on a particular organ. 
As discussed previously, pineal organ culture provides an ideal 
tool with which to examine pineal indoleamine metabolism. When 
incubated in the presence of a radioactive [14C J serotonin precursor. 
the pineal gland utilizes this substrate to synthesize 
radioactively labelled metabolites. These are secreted into the 
culture medium from where they can be isolated and finally 'measured 
using liquid scintillometry. 
In this experiment, an attempt was made to ascertain whether 
chronic hydrocortisone treatment would induce any marked weight 
changes in the pineal or adrenal glands indicative of enhanced or 
reduced activity. The pineal glands were then cultured in vitro 
to determine the effect of the hydrocortisone treatment on 
indoleamine metabolism. 
3.2.2 Materials and Methods 
Two groups of five male Wistar rats of the albino strain were 
randomly assembled. The test group was treated for seven days with 
hydrocortisone according to the schedule described in section 
2.1.1. The control group received the appropriate vehicle. The 
animals were sacrificed on the eighth morning and their pineal and 
adrenal glands rapidly removed and weighed. The pineal glands were 
then cultured in vitro for 24 hours in the presence of radioactive 
serotonin as described in section 2.2.3. After 24 hours, the 
incubation was terminated and the culture medium was analyzed for 
radioactive metabolites of pineal metabolism using thin layer 
chromatography and liquid scintillometry as outlined in section 
2.2.4. 
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3.2.3 Results 
The mass of the pineal and adrenal glands from the normal and 
hydrocortisone treated animals is tabulated in Tables 3.1 and 3.2. 
respectively. The difference between the means of the control and 
treated groups was statistically analyzed using the Student's t 
test. There was no change in pineal weight after seven days of 
hydrocortisone treatment. but the weight of the adrenal glands from 
the treated animals was significantly reduced (p < 0.05). 
TABLE 3.1 
I 
TABLE 3.2 
Weights of Pineal Glands from Hydrocortisone 
Treated Rats 
TREATMENT 
I 
WEIGHT ± SEM 
I (mg) 
Control 1.8 ± 0.25 
Hydrocortisone 2.1 ± 0.30 
Weights of Adrenal Glands from Hydrocortisone 
Treated Rats 
TREATMENT WEIGHT ± SEM 
(mg) 
Control 67.7 ± 5.28 
Hydrocortisone 49.3 ± 3.74 * 
* p < 0.05 compared with the control. 
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The radioactivity corresponding to each of the indole metabolites 
isolated from the culture medium following the incubation of the 
pineal glands with [14C]serotonin are tabulated in Table 3.3 and 
graphically presented in Figure 3.1. 
TABLE 3.3 Pineal [ 14Cl Indole Metabolism by Pineal Glands in 
Organ Culture following Chronic Hydrocortisone 
Treatment 
INDOLE dpm/lO ~l medium ± SEM P VALUE 
CONTROL HYDROCORTISONE 
Melatonin 2701 ± 464 4660 ± 690 < 0.05 
N-acetylserotonin 1232 ± 306 2513 ± 383 < 0.05 
Hydroxyindole 
acetic acid 56231 ± 2566 40516 ± 4590 < 0.05 
Hydroxytryptophol 14539 ± 809 21893 ± 1264 
Methoxyindole 
acetic acid 345 ± 48 403 ± 78 
Methoxytryptophol 453 ± 38 688 ± 75 < 0.05 
The difference between the means of the control and treated groups 
for each particular indole was statistically analyzed using the 
Student'S t test. The pineal glands from the hydrocortisone 
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treated animals synthesized considerably more N-acetylserotonin~ 
melatonin and 5-methoxytryptophol than the control pineal glands. 
The levels of hydroxyindole acetic acid were lower in the pineals 
from the normal rats than those from the treated animals. while 
metabolism of hydroxytryptophol and methoxyindoleacetic acid was 
unaffected by the steroid treatment. 
3.2.4 Discussion 
As hydrocortisone is absorbed through the gastrointestinal tract, 
it may be assumed that the oral hydrocortisone treatment resulted 
in a significant increase in plasma hydrocortisone levels. 
Marinova er al [1991] reported that the treatment schedule used in 
this study can be expected to produce supraphysiological levels of 
circulating glucocorticoid. The decrease in adrenal mass is 
consistent with decreased stimulation of the adrenal glands by ACTH 
released from the pi tui tary gland. Elevated circulating 
hydrocortisone levels would be expected to interact with 
glucocorticoid receptors in the hypothalamus, reducing the release 
of CRH, and subsequently the release of ACTH from the pituitary 
gland. The reduced stimulation of ACTH on the adrenal glands would 
characteristically result in inactivity and hypoplasia of these 
organs. The observed hypertrophy therefore confirms that 
circulating glucocorticoid levels were significantly elevated by 
the hydrocortisone treatment. 
Although there was no significant increase "in pineal mass. the oral 
hydrocortisone treatment increased the ability of the pineal gland 
to synthesize N-acetylserotonin, melatonin and 5-methoxytryptophol. 
This observation suggests that a positive feedback mechanism is 
operative between the adrenal glands and melatonin metabolism. It 
suggests that glucocorticoids derived from the adrenal glands 
during periods of increased adrenal activity, may exert a 
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stimulatory effect on pineal metabolism to increase melatonin 
synthesis. An increase in melatonin synthesis in response to 
increased circulating glucocorticoid levels such as those 
associated with exposure to stress, supports the involvement of 
melatonin in the adaptational response to stress . 
• 
3.3 THE EFFECT OF CHRONIC HYDROCORTISONE TREATMENT ON RAT PINEAL 
N-ACETYLTRANSFERASE ACTIVITY 
3.3.1 Introduction 
Having repeatedly established that chronic hydrocortisone treatment 
significantly enhances the ability of the pineal gland to 
synthesize N-acetylserotonin and melatonin in vi tro. a possible 
mechanism of action was explored. NAT is responsible for 
catalysing the conversion of serotonin to N-acetylserotonin and has 
been shown to play a vital role in regulating pineal melatonin 
synthesis. NAT in vivo is primarily regulated by rises in 
intracellular cyclic AMP levels elicited by 53-adrenergic 
stimulation. The episodic release of norepinephrine from nerve 
variscosities terminating on the pineal gland, stimulates 
postsynaptic B1-adrenergic receptors which are coupled to adenylate 
cyclase. The subsequent rise in intracellular cyclic AMP levels 
elevates NAT acti vi ty via a process involving protein transcription 
and translation. 
The purpose of this experiment was to determine whether chronic 
hydro.cortisone treatment could affect pineal NAT acti vi ty. In 
addition to monitoring basal NAT activity during the daytime when 
it is generally low. a B-adrenergic agonist, isoprenaline, was 
used to mimic the nighttime rise in enzyme activity. This made 
it possible to determine the effect of the hydrocortisone treatment 
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on B-adrenergic receptor stimulated NAT activity. 
3.3.2 Materials and Methods 
Four groups of five male Wistar rats of the albino strain were 
randomly assembled. Two groups were treated for seven days with 
hydrocortisone according to the scheme described in section 2.1.1 
and two groups received the vehicle. The animals were sacrificed 
at 12hOO on the eighth morning. Three hours prior to sacrifice, 
a set of the hydrocortisone-treated and a set of the control rats 
were injected intraperitoneally with isoprenaline (5mg/kg). while 
the remaining two groups were injected with the vehicle. Following 
sacrifice, the pineal glands were swiftly removed and assayed for 
NAT activity according to the scheme described in section 2.3. 
3.3.3 Results 
The enzyme acti vi ty, expressed in terms of pmoles N-
acetyl tryptamine formed per pineal gland per hour, was calculated 
as described in section 2.3.4. The data were analyzed by one-way 
analysis of variance and statistical differences between groups 
were determined using the Bonferroni multiple range test. Values, 
which represent the mean ± SEM (n = 5), are tabulated in Table 3.4 
and graphically presented in Figure 3.2. 
Hydrocortisone treatment alone did not significantly affect NAT 
acti vi ty during the day. Isoprenaline effected a 7 8 fold 
increase in NAT acti vi ty in both control and hydrocortisone treated 
rats (p < 0.0001). Furthermore, hydrocortisone significantly 
increased isoprenaline stimulated NAT activity (p < 0.0001). 
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TABLE 3.4 N-Acetyltransferase Activity in Normal and 
Hydrocortisone treated rats 
TREATMENT 
Control 
Isoprenaline 
Hydrocortisone 
Hydrocortisone + 
Isoprenaline 
Con. vs Iso. 
HC vs Iso. 
p < 0.0001 
P < 0.0001 
3.3.4 Discussion 
pMoles N-ACETYLTRYPTAMINE 
formed per hour ± SEM 
0.25 ± 0.017 
1. 72 ± 0.171 
0.34 ± 0.032 
2.67 ± 0.208 
He vs HC + Iso. : p < 0.0001 
Iso. vs HC + Iso. : p < 0.0001 
Al though the hydrocortisone treatment did not affect basal NAT 
activity during the day. it significantly enhanced B-adrenergic 
receptor stimulated enzyme activity. From this it appears that 
glucocorticoids sensitize NAT to .I3-adrenergic receptor stimulation. 
This could indicate a mechanism whereby pineal indole metabolism 
may be enhanced under stressful conditions. Glucocorticoids 
released from the adrenal cortex could sensitize pineal NAT 
activity to stimulation by catecholamines derived from sympathetic 
nervous activity or the adrenal medullae during the normal 
physiological response to stress. 
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3.4 THE EFFECT OF CHRONIC HYDROCORTISONE TREATMENT ON RAT PINEAL 
CYCLIC AMP LEVELS 
3.4.1 Introduction 
Having established that the increase in melatonin metabolism in 
pineal organ culture is accompanied by elevation in NAT activity, 
the mechanism responsible for the increase in NAT activity was 
investigated. The hydrocortisone could be acting by binding to 
cytosolic steroid receptors, inducing a classical rise in protein 
synthesis and general enzyme proteins wi thin the pinealocytes. 
This could explain the rise in N-acetylserotonin and melatonin as 
well as the rise in 5-methoxytryptophol. Another possibility is 
that the hydrocortisone could be stimulating NAT acti vi ty by 
increasing the cyclic AMP responsiveness of .a-adrenergic receptors. 
The two mechanisms are not mutually exclusive. 
Cyclic AMP is synthesized from ATP by adenylate cyclase. NAT is 
controlled in vivo by changes in cyclic AMP levels elicited by 
.a-adrenergic receptor-linked adenylate cyclase. Chronic 
stimulation of the B-adrenergic receptors results in decreased 
sensi ti vi ty of 
Joubert [1984] 
the receptors to further stimulation. Daya and 
showed that B-adrenergic receptor subsensitivity 
resulting from- chronic stimulation by isoprenaline was reversed by 
a single dose of hydrocortisone 16 hours before sacrifice. The 
authors concluded that their findings implied that glucocorticoids 
might have a feedback ~elationship on the -pineal gland by altering 
the cyclic AMP responsiveness of pineal .a-adrenergic receptors. 
The ability of chronic hydrocortisone treatment to alter the cyclic 
AMP responsiveness of .a-adrenergic receptors was investigated by 
examining the basal and B-adrenergic agonist stimulated cyclic AMP 
levels in pineal homogenates from rats chronically treated with 
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hydrocortisone. 
3.4.2 Materials and Methods 
Two groups of five male Wistar rats of the albino strain were 
randomly assembled. The test group was treated for seven days with 
hydrocortisone according to the scheme described in section 2.1.1 
and the control group received the vehicle. The animals were 
sacrificed at lOhOO on the eighth morning and their pineal glands 
swiftly removed. The pineals were carefully bisected and cultured 
in vitro as described in section 2.2.3. A set of the 
hydrocortisone treated pineal hemispheres and a set of the control 
pineal hemispheres were incubated in the presence of 100 ~M 
isoprenaline while the remaining two groups of hemispheres were 
incubated in the presence of the vehicle. The incubation was 
terminated after 6 hours by freezing the pineal tissue on dry ice. 
The hemispheres were then homogenized and assayed for cyclic AMP 
according to the schedule described in section 2.5. 
3.4.3 Results 
The pmoles of cyclic AMP in each pineal gland were calculated as 
described in section 2.5.6. The data were analyzed by one-way 
analysis of variance and statistical differences between groups 
were determined using the Bonferroni multiple range test. Results 
are presented as the mean ± SEM (n = 5), and are tabulated in 
Table 3.5 and graphically presented in Figure 3.3. 
Hydrocortisone treatment significantly increased daytime basal 
cyclic AMP levels (p < 0.05). Isoprenaline increased basal cyclic 
AMP levels in both normal (p < 0.01) and hydrocortisone (p < 0.001) 
treated rats. 
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TABLE 3.5 Cyclic AMP levels in Normal and Hydrocortisone 
Treated Rats 
TREATMENT 
Control 
Isoprenaline 
Hydrocortisone 
Hydrocortisone + 
Isoprenaline 
Con. vs HC : p < 0.05 
Con. vs Iso. p < 0.01 
3.4.4 Discussion 
pMoles CYCLIC AMP 
formed per hour ± SEM 
2.155 ± 1.424 
. 
35.055 ± 5.337 
20.093 ± 5.743 
64.775 ± 10.443 
Iso vs HC + Iso. 
HC vs HC + Iso. 
p < 0.01 
P < 0.001 
Cyclic AMP is an important intracellular messenger which, in the 
pineal gland, is intimately associated with regulating NAT 
activity. Hydrocortisone caused an increase in both basal and 
isoprenaline-stimulated cyclic AMP levels in rat pineal glands. 
The increase in basal cyclic AMP evoked by hydrocortisone was 
significantly less than the nighttime rise found in rats not 
treated with the steroid. Viewed together with the inability of 
hydrocortisone to increase basal NAT activity found previously, it 
can be deduced that the rise in basal cyclic AMP levels was not 
sufficient to invoke a significant rise in the activity of this 
enzyme . However, it is likely that limited stimulation of the 
.a-adrenergic receptors will be required to increase cellular cyclic 
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AMP levels above the "threshold" necessary for NAT induction. This 
is a further indication of a mechanism whereby hydrocortisone does 
not directly increase NAT activity and the synthesis of melatonin, 
but rather sensitizes the pineal gland to future stimulation by 
B-adrenergic agonists. 
3.5 THE EFFECT OF CHRONIC HYDROCORTISONE TREATMENT ON RAT PINEAL 
B-ADRENERGIC RECEPTOR BINDING SITES 
3.5.1 Introduction 
The pineal gland is richly supplied with B-adrenergic receptors. 
They have been found to exhibit a circadian rhythm and display the 
phenomena of super- and sub-sensitivity. As such they play an 
important role in regulating dark-induced stimulation of pineal 
indoleamine metabolism. In the dark or at nighttime, 
norepinephrine released from postganglionic sympathetic nerves 
terminating on the pineal gland. interacts with B-adrenergic 
receptors on pinealocytes to initiate a classical rise in 
intracellular cyclic AMP. The cyclic AMP in turn stimulates the 
synthesis of NAT and subsequently leads to an increase in the 
conversion of serotonin to N-acetylserotonin and melatonin. 
Having established that the hydrocortisone-induced rise in 
melatonin synthesis was accompanied by both a rise in NAT activity 
and cyclic AMP levels. it was necessary to'investigate whether the 
effect was proximal or distal to the a-adrenergic receptors, i.e. 
whether hydrocortisone enhances cyclic AMP levels by influencing 
the interaction of a-adrenergic agonists with adenylate 
cyclase-linked B-adrenergic receptors, 
independent of the a-receptors. 
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or by a mechanism 
In this experiment, the specific binding of r3H]DHA to pineal 
B-adrenergic receptors was determined in both normal and 
hydrocortisone treated rats. 
3.5.2 Materials and Methods 
Two groups of eight male Wi star rats of the albino strain were 
randomly assembled. The test group was treated for seven days with 
hydrocortisone according to the scheme described in section 2.1.1. 
The control group received the appropriate vehicle. The animals 
were sacrificed on the eighth morning and their pineal glands 
rapidly removed. Two 
homogenized together and 
similarly treated pineal 
the specific binding of 
glands were 
r3H]DHA to 
B-adrenergic receptors was measured according to the method 
described in section 2.4 using 8 nM [3H ]DHA. 
3.5.3 Results 
The specific binding' of r3H]DHA to the pineal B-adrenergic 
receptors, expressed as fmole/mg protein, was calculated as 
described in section 2.6.6. The statistical difference between the 
means from the two groups was determined using the Student I s 
t-test. Values represent the mean of quadruplicate determinations 
± SEM (n = 4). The effect of chronic hydrocortisone treatment on 
B-adrenergic receptor binding is tabulated in Table 3.6 and 
graphically presented in Figure 3.4. 
The hydrocortisone treatment resulted in a small, but significant, 
increase in the specific binding of [3B]DHA to pineal .a-adrenergic 
receptors (p < 0.05). 
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TABLE 3.6 Binding of r3H]DBA to B-Adrenergic receptors in the 
Pineal Glands of Normal and Hydrocortisone treated 
TREATMENT SPECIFIC BINDING 
(fmoles/mg pro~ein) 
Con~rol 0.104 ± 0.0064 
Hydrocor~isone 0.134 ± 0.0085 
Control vs He p < 0.05 
3.5.4 Discussion 
The present results indicate that hydrocortisone increases pineal 
melatonin synthesis by a mechanism involving the B-adrenergic 
receptors. Hydrocortisone increases the specific binding of 
B-adrenergic agonists to pineal B-adrenergic receptors. Whether 
this is due to an increase in affin"i ty or number of binding sites. 
remains to be established. The number of B-adrenergic receptors 
may be increased by processes involving the externalization of the 
receptors on the cell membrane or an increase in the synthesis of 
receptors. 
- 145 -
0'> 
c: 
u 
c: 
co 
Figure 3.4 
0'> 
E 
(J) 
(]) 
o 
E 
,20r-------------------------------~ 
* 
,15 
,10 
,os 
o~--~--------~-----=========~--~ 
Control Hydrocortisone 
Effect of Chronic Hydrocortisone Treatment on 
Specific Binding of [3H1DHA to Rat Pineal Membranes 
Values represent the mean + SEM of triplicate 
determinations for n = 5. 
* p < 0.05 compared with the control 
- 146 -
3.6 DISCUSSION 
It is apparent from the preceding series of experiments that the 
glucocorticoid. hydrocortisone, is able to endow pinealocytes with 
the ability to increase melatonin and 5-methoxytryptophol 
synthesis. 
least two 
The rise in indole synthesis could be the result of at 
possible mechanisms: hydrocortisone could bind to 
steroid receptors in the pinealocyte cytosol [Haynes and Larner. 
1975; Ganong, 1979] and increase the synthesis of enzymes ,involved 
in the biosynthesis of melatonin, or hydrocortisone could act by 
altering the responsiveness of B-adrenergic receptors to their 
natural ligands and thereby enhance the B-receptor stimulated rise 
in intracellular cyclic AMP, NAT and finally melatonin synthesis 
[Daya and Joubert, 1984]. Although it does not explain the rise 
in 5-methoxytryptophol. it appears as if at least the latter 
mechanism is true. Hydrocortisone increased the specific binding 
of a radiolabelled 13-adrenergic agonist to pineal membranes in 
vitro. Increases in cyclic AMP levels and NAT activity were also 
observed following chronic hydrocortisone treatment. 
The hydrocortisone treatment resulted in insignificant or small 
increases in the basal NAT activity and cyclic AMP levels, but 
dramatically increased these parameters under B-adrenergic receptor 
stimulation. This suggests that rather than directly increasing 
melatonin synthesis, glucocorticoids, like hydrocortisone, increase 
the sensitivity of the pineal gland to stimulation by B-adrenergic 
agonists. This would explain the ability of B-adrenergic 
antagonists to block the increase in pineal melatonin following 
stres,s responses. Such observations have lead previous researchers 
to attribute the increase in melatonin synthesis following stress, 
to catecholamines [Lynch et a1. 1973]. 
In this study, circulating glucocorticoid levels were increased by 
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the oral administration of hydrocortisone. No particular stress 
was employed to elevate serum corticosteroid levels as has been the 
pattern in previous research [Johnson, 1982; Touitou e~ a1, 1983]. 
This excluded the variable parameters associated with individual 
responses to different stresses. 
Although it has been clearly shown that the glucocorticoid, 
hydrocortisone, can endow the biochemical machinery of pinealocytes 
with the ability to increase melatonin production, it remains to 
be established whether this is purely a pharmacological' effect or 
whether physiological levels of the glucocorticoid can elicit the 
same effect. This would clarify the possibility of stress-elevated 
glucocorticoid levels inducing an increase in pineal melatonin 
synthesis. Furthermore, it remains to be established that it is 
the high concentration of systemic glucocorticoids that is 
producing the effect and not the ratio of corticosterone to 
hydrocortisone as has been proposed for other steroid effects. 
Corticosterone is the predominant glucocorticoid in rats, while 
hydrocortisone is the predominant glucocorticoid in humans. 
Therefore, it is possible that either the hydrocortisone alone, or 
the increased hydrocortisone corticosterone ratio presumably 
induced by the steroid treatment which increased the ability of the 
pineal gland to synthesize melatonin and other indoles. In view 
of this, it is essential that in future research. serum levels of 
the glucocorticoids should be measured. 
An attempt was also made to ascertain whether the increase in 
melatonin production observed in vi"tro also occurred in vivo during 
the hydrocortisone treatment. As melatonin is not stored in the 
pineal gland, increases in melatonin synthesis are rapidly 
reflected in the blood. A radioimmunoassay was employed to measure 
plasma melatonin levels. Unfortunately, the method of Fraser e"t 
a1 £19831 which was used, had a number of drawbacks. Primarily 
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used for measuring melatonin levels in humans, it required a 
relatively large amount of plasma to be extracted from each test 
individual. This was often difficult to achieve when working with 
rats. The second major problem was that of haemolysis. Haem 
released on lysis of the red blood cells inconsistently interfered 
with the assay by causing quenching problems during radioactive 
counting. It was, therefore, not possible within the duration of 
this study to overcome all the problems and get the procedure to 
produce consistent and valid results. However, preliminary, 
individual, trial experiments appear to indicate that basal plasma 
melatonin levels in hydrocortisone treated animals are unaffected 
during the daytime, but may rise above normal nighttime levels at 
night. If this effect could be conclusively demonstrated, it would 
further support the theory that glucocorticoids sensitize the 
pineal gland to B-adrenergic stimulation, rather than leading 
directly to increased indoleamine metabolism. The particular 
radioimmunoassay used was appealing because of its reputed 
sensi ti vi ty and simplicity. It only required isolation of the 
blood plasma fraction from the test animals without any additional 
extraction or purification procedures. However, the possibility 
of using urinary 6-sulphatoxymelatonin as an index of plasma 
melatonin should be investigated. This method would have the 
advantage of eliminating the sacrifice of the animals and hence it 
would be possible to assay more time points over a longer 
experimental duration. The use of such a method is proposed in 
view of the fact that a more dynamic picture of endogenous events 
could be obtained without the costly use of large numbers of 
animals. One of the major criticisms of research in this field is 
the use of time-point studies which provide limited information 
with 'intervals of undefined activity. Furthermore, comparisons 
are difficult when different researchers choose different time 
intervals or time points within the photoperiod. 
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CHAPTER 4 
THE INFLUENCE OF MELATONIN ON PERIPHERAL EFFECTS 
OF CHRONIC HYDROCORTISONE TREATMENT 
4.1 INTRODUCTION 
Elevated circulating levels of glucocorticoids have been associated 
with numerous undesirable conditions, the most serious of which is 
damage to the brain and disruption of brain function. Elevated 
circulatory glucocorticoid levels occur endogenously in times of 
stress [Haynes and Larner, 1975; Ganong, 1979]. In response to a 
variety of stressors, the hypothalamus releases CRH, which 
stimulates the release of ACTH from the anterior pituitary. The 
latter subsequently stimulates the adrenal glands to release 
gl ucocorticosteroids. In a heal thy individual. the glucocorticoids 
interact with receptors in the hypothalamus and pituitary gland to 
suppress further CRH and ACTH release and thereby regulate further 
stimulation of the adrenal cortex [Haynes and Larner. 1975]. 
However, following chronic, or continual long-term activation of 
this feedback system such as that experienced by chronically 
stressed or by aged animals. 
feedback mechanism is reduced 
the sensitivity of the negative 
and eventually results in the 
inability to terminate the adrenocorticoid response to subsequent 
stimulation r Sapolsky e1: 81. 1986]. The continuously elevated 
glucocorticoid levels have a number of physiological side effects 
which include myopathy, steroid diabetes, hypertension, 
immunosuppression, infertility, inhibition of growth, depression 
and other mental disorders. 
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Al~hough an in~erac~ion be~ween ~he pine~l gland and ~he adrenal 
glands has no~ been conclusively es~ablished, a large body of 
evidence sugges~s ~ha~ ~he pineal gland exer~s an inhibi~ory 
influence on ~he adrenal glands. Enhanced pineal activi~y. pineal 
ex~racts and trea~men~s wi ~h exogenous melatonin may inhibit 
adrenocorticos~eroid syn~hesis and release. The initial 
inves~iga~ions in the present study suggest that ~he pineal gland 
responds to increased circulating glucocorticoid levels by 
increasing its potential ~o synthesize melatonin and 
5-methoxy~ryptophol. This indicates a possible physiological role 
for melatonin in conditions of elevated circulating glucocor~icoid 
levels. 
The aim of the following series of experiments was to investigate 
~he possible physiological significance of the 
glucocorticoid-mediated increase in pineal melatonin synthesis, by 
determining whether melatonin could protec~ against two of ~he 
deleterious consequences of sustained elevated hydrocortisone 
concentrations. 
4.2 EFFECT OF CHRONIC HYDROCORTISONE TREATMENT AND MELATONIN ON 
RAT LIVER TRYPTOPHAN PYRROLASE ACTIVITY 
4.2.1 Introduction 
Liver tryptophan pyrrolase is responsible for ca~alysing the 
rate-de~ermining step in the catabolic pathway of tryptophan 
degra~ation [Badawy and Evans. 1975]. I~ is thus the major 
peripheral determinant of free serum and brain tryptophan. Factors 
which enhance the catabolism of this essential amino acid, reduce 
the circulating levels of tryptophan. and concomitantly. its 
availability to the brain. In the brain, tryptophan is utilized 
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in the synthesis of serotonin, an important neurotransmitter 
involved in various behavioural activities. Reduced availability 
of tryptophan to the brain, leads to behavioural and mental 
disorders associated with deficiencies of the cerebral 
serotoninergic system {Van Praag. 1982]. 
Glucocorticoids are one of several factors which increase 
tryptophan pyrrolase activity. These steroids cause a hormonal 
induction of the enzyme by mediating the synthesis of new apoenzyme 
[Knox and Auerbach. 1955; Young. 1981J. Young [1981] demonstrated 
that high tryptophan pyrrolase activity induced by hydrocortisone 
diminishes brain tryptophan and serotonin. Patients with 
depressi ve disorders have frequently been reported to exhibit 
abnormally high plasma corticosteroid concentrations. Badawy and 
Evans [1981] reported that a large number of antidepressant drugs 
act by inhibiting tryptophan pyrrolase activity. Inhibition of 
this catabolic pathway, increases brain tryptophan and serotonin 
levels. alleviating the depression. 
The pineal gland has been implicated in both depressive mental 
disorders {Wurtman and Wurtman, 1989] and in the physiological 
response to stress [Romijn, 1978; Johnson, 1982; Armstrong et 81, 
1982]. An inverse relationship exists between tryptophan pyrrolase 
activity and pineal melatonin synthesis ICurzon, 1979] . 
Furthermore, it has been shown that activation of tryptophan 
pyrrolase by the haem precursor, 5-ALA [Daya et 81, 1989], and by 
the barbiturate, pentobarbitone [Van Wyk 'et 81, 1991]. decreases 
rat forebrain serotonin without affecting pineal serotonin levels. 
Al though derived from the same' precursor. pineal serotonin is 
highly conserved. The resultant stability of melatonin levels in 
adverse conditions is supportive of the homeostatic, regulatory 
role proposed for the pineal gland. 
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The aim of this experiment was to determine the effect of melatonin 
and chronic hydrocortisone treatment on rat liver tryptophan 
pyrrolase activity. 
4.2.2 Materials and Methods 
Two groups of five male albino Wistar rats were randomly assembled. 
The test group was treated for seven days with hydrocortisone 
according to the schedule described in section 2.1.1. The control 
group received the appropriate vehicle. The animals were 
sacrificed on the eighth morning and their livers rapidly removed 
as described in section 2.1 and frozen at 70 DC in liquid 
ni trogen. The livers were assayed for tryptophan pyrrolase 
activity using the schedule described in section 2.7. The effect 
of melatonin (100 nM - 1 mM) on tryptophan pyrrolase activity in 
normal and hydrocortisone treated animals was also assessed. 
4.2.3 Results 
Enzyme activity, expressed as ~moles kynurenine formed/mg protein 
per hour, was calculated as described in section 2.7.5. Holoenzyme 
activity was determined in the absence of haemin and total activity 
in the presence of added haemin. The difference was a measure of 
apoenzyme activity. The data were analyzed by one-way analysis 
of variance. Statistical differences between the means were 
determined using the Students t-test. Values represent the mean 
± SEM (n = 5). The results of the enzyme assay are tabulated in 
Table 4.1 and graphically presented in Figure 4.1. The effect of 
melatonin on tryptophan pyrrolase activity in normal and 
hydrocortisone treated rats is tabulated in Table 4.2 and 
graphically presented in Figures 4.2 and 4.3. 
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TABLE 4.1 
ENZYME 
ACTIVITY 
Effect of Chronic Hydrocortisone Treatment on Rat 
Liver Tryptophan Pyrrolase Activity 
~Moles KYNURENINE formed per 
mg protein per hour ± SEM P VALUE 
CONTROL HYDROCORTISONE 
Total enzyme 5.656 ± 1.0 10.392 ± 1.2 < 0.'001 
I 
Holoenzyme 4.500 ± 1.2 7.080 ± 0.8 
Apoenzyme 1.156 ± 0.4 3.478 ± 0.8 < 0.05 
Tryptophan pyrrolase acti vi ty was enhanced in the presence of 
haemin. There was nearly a 50% increase in total tryptophan 
pyrrolase activity in the livers from the hydrocortisone treated 
rats relative to the untreated controls (p < 0.001). This was 
mainly due to a significant increase in apoenzyme activity in the 
treated animals (p < 0.05) as the activity of the holoenzyme 
fractions were not significantly different. 
Haemin increased the acti vi ty of tryptophan pyrrolase in both 
normal and hydrocortisone treated animals. Melatonin caused a 
dose-dependent inhibition of haemin-induced tryptophan pyrrolase 
acti vi ty in both groups of rats to levels approximating those 
observed in the absence of haemin. Tryptophan pyrrolase was 
significantly inhibited by melatonin concentrations above 200 ~M 
in both normal (p < 0.05) and hydrocortisone treated rats (p < 
0.001) . The percentage inhibition in both groups of rats was 
approximately the same. 
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TABLE 4.2 Effect of Melatonin on Tryptophan Pyrrolase Activity in Normal and Hydrocortisone Treated Rats 
---
~~--~---------- - -~-----.--------------
MELATONIN CONCENTRATION 
TREATMENT HOLOENZYME TOTAL 
ENZYME 
1 mM 200 J!M 50 J!M 1 J!M 100 nM 
J!Moles KYNURENINE formed per mg protein per hour 
Control 4.9 ± 0.8 6.2 ± 1.0 3.2 ± 0.6 4.7 ± 1.0'" 5.4 ± 1.1 5.8 ± 1.0 5.8 ± 0.9 
Hydrocortisone 7.6 ± 0.7 11.1 ± 0.6 5.6 ± 0.6 8.5 ± 1.0 9.4 ± 0.8 10.5 ± 1.1 11.1 ± 1.1 
Percentage of Total Activity 
, 
Control 79.5 100.0 51.1 73.2 83.5 92.0 94.0 
Hydrocortisone 68.1 100.0 50.5 75.9 84.8 94.6 99.9 
Control: Total enzyme vs 1 mM P < 0.01 
Total enzyme vs 200 J!M P < 0.05 
Hydrocortisone : Total enzyme vs 1 mM P < 0.001 
Total enzyme vs 200 J!M P < 0.001 
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was suspended in 
(1:9) and diluted 
absolute 
in 0.5% 
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4.2.4 Discussion 
Tryptophan pyrrolase is a haem-dependent liver cytosolic enzyme and 
the addition of the haemin cofactor produced the expected rise in 
tryptophan pyrrolase acti vi ty. Typically, hydrocortisone increases 
tryptophan pyrrolase apoenzyme activity {Young, 1981]. This was 
confirmed in the present study. Apoenzyme and total activity were 
significantly increased while holoenzyme activity was unaffected 
by the hydrocortisone treatment. 
Melatonin. the principal pineal hormone. caused a dose-dependent 
inhibition of haemin-activated tryptophan pyrrolase activity, with 
indole concentrations in excess of 200 ~M completely reversing the 
This observation is haemin-induced activation of the apoenzyme. 
confirmed by the findings of Walsh e~ al According to 
inhibits tryptophan 
indole concentrations above 50 ~M. The 
{1991]. 
these authors, melatonin 
pyrrolase acti vi ty at 
ability of melatonin to 
significantly 
inhibit activation of the apoenzyme 
suggests that the indole is interfering with the availability of 
haem to the enzyme. The mechanism of this inhibition requires 
further investigation. 
The fact that hydrocortisone increases apoenzyme activity, and that 
melatonin inhibits activation of the apoenzyme, suggests that 
melatonin may play a protective role in preventing excessive 
tryptophan catabolism resulting from the glucocorticoid-induced 
increase in tryptophan pyrrolase activity. Young {1981] 
demonstrated that although glucocorticoids also have an action on 
prote~n metabolism that is primarily catabolic. and causes the 
release of tryptophan from protein to augment the free tryptophan 
stores, the glucocorticoid-mediated increase in tryptophan 
pyrrolase activity causes a major decline of total free tryptophan 
stores in the whole animal. Thus melatonin may play an important 
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role in preventing excessive loss of this essential amino acid from 
the body. 
4.3 EFFECT OF CHRONIC HYDROCORTISONE TREATMENT AND MELATONIN ON 
GLUTAMATE BINDING IN RAT BRAIN 
4.3.1 Introduction 
Another deleterious effect of glucocorticoids, is inhibition of the 
re-uptake of excitatory amino acid neurotransmitters from the 
synaptic clefts in the eNS. The resultant accumulation of 
especially glutamate in the synapse. causes continuous stimulation 
of postsynaptic glutamate receptors. This effects excessive 
mobilization of calcium and the influx of ions and water into the 
neurons which ultimately leads to lysis of the cells. The 
excitotoxic effects of glutamate are predominantly attributed to 
stimulation of the NMDA receptor. NMDA- mediated neuronal 
degeneration is associated with the pathology of cerebral ischaemia 
and trauma, hypoglycaemia, anoxia, epilepsy, Huntington's disease, 
senile dementia of the Alzheimer type. Parkinsonism and amyotrophic 
lateral sclerosis [Schramm et aI, 1990; Meldrum and Garthwaite, 
1990]. 
The aim of this experiment was to determine the effect of chronic 
hydrocortisone treatment on cerebral NMDA receptors. 
4.3.2 Materials and Methods 
Two groups of ten male albino Wistar rats were randomly assembled. 
The test group was treated for seven days with hydrocortisone 
according to the schedule described in section 2.1.1. The control 
group received the appropriate vehicle. The animals were 
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sacrificed on the eighth morning and their brains rapidly removed. 
The forebrains were dissected free and measured for glutamate 
binding sites according to the method described in section 2.8. 
Saturation curves were prepared by measuring the specific binding 
of 0 - 500 nM r3H]glutamate to cerebral membranes derived from 
both normal and treated rats. 
4.3.3 Results 
The specific binding, expressed as fmoles [3H]glutamate bound/mg 
protein, was calculated as described in section 2.8.6. Saturation 
curves and Scat chard plots were derived for the data obtained from 
both normal and treated rats. The data is tabulated in Table 4.3 
and graphically presented in Figures 4.4 - 4.7. 
As is shown in Figure 4.4, the binding of r3H]glutamate to cerebral 
membranes from untreated rats was not completely saturating in the 
range tested. Scat chard analysis of the data (Figure 4.5) 
demonstrated the presence of glutamate receptors with an apparent 
equilibrium dissociation constant (KD) of 327.3 nM and a maximal 
number of binding sites (Bmax) equivalent to 1.127 pmoles/mg 
protein. The hydrocortisone treatment caused a 30-fold increase 
in the specific binding of glutamate to rat cerebral membranes. 
The binding of [3H]glutamate was not saturating in the range tested 
(Figure 4.6). From the Scat chard analysis (Figure 4.7), the 
apparent equilibrium dissociation constant was approximately 825.3 
nM and the maximum number of binding sites was equivalent to 35.834 
pmoles/mg protein. 
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TABLE 4.3 
FREE 
Specific Binding of t3H1Glutamate to Cerebral 
Membranes from Normal and Treated Rats 
GLUTAMATE SPECIFIC BINDING 
(nM) (fmoles/mg protein) 
CONTROL HYDROCORTISONE 
25 80.8 650.4' 
50 146.3 1266.0 
100 263.1 4111.9 
200 463.2 6177.1 
300 499.6 10496.0 
400 636.7 11715.0 
500 671.4 12903.0 
4.3.4 Discussion 
The equilibrium dissociation constant (0.327 ~M) and maximum number 
of binding sites (1.127 pmoles/mg protein) obtained for the binding 
of r3H]glutamate to cerebral membranes from untreated rats are in 
agreement wi th previous reports of glutamate binding to 
NMDA-sensitive binding sites [Monaghan and Cotman, 1986]. The 
receptor purification procedure employed was theoretically fairly 
specific for NMDA receptors. Firstly, ions such as calcium, sodium 
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and chloride. known to enhance the binding of glutamate to non-NMDA 
binding sites, were omitted from all buffers and solutions [Foster 
and Fagg, 1984; Monaghan and Cotman, 1986]. Secondly, the brains 
and receptor homogenates were frozen at various stages. Freezing 
is also known to diminish non-NMDA binding sites without affecting 
NMDA-sensitive binding [Foster and Fagg, 1984]. Numerous attempts 
to characterize the glutamate receptors by performing competition 
studies with 10-11 - 10-3 M NMDA were unsuccessful. as were attempts 
to determine the effect of 10-11 - 10-3 M melatonin on r3H] glutamate 
binding to rat cerebral membranes. Both of these failures may be 
due to the filtration method used to separate the bound from the 
free radioactive ligand. Due to the relatively low affinity of 
glutamate for the glutamate receptors. centrifugation should be the 
preferred and recommended method for the separation of bound and 
free radioactive ligand. 
The hydrocortisone treatment decreased the affinity of glutamate 
binding sites for its ligand and caused a 30-fold increase in the 
maximum number of glutamate receptors in rat cerebral membranes. 
As saturation of the receptors with r3H]glutamate was not fully 
achieved. no conclusions can be drawn about the number of classes 
of glutamate receptor isolated. although it is likely that they are 
NMDA receptors because of the purification procedures employed. 
Glucocorticoids, like other steroid hormones are known to control 
the rate of synthesis of proteins and receptors. They react with 
proteins in the cytoplasm of sensitive cells to form a 
steroid-receptor complex. This complex undergoes a conformational 
change and moves into the nucleus where it binds to the chromatin 
material and stimulates the transcription and translation of 
specific proteins [Haynes and Larner, 1975]. It is thus likely 
that hydrocortisone increased the number of glutamate binding sites 
by inducing an increase in the rate of synthesis of the receptors. 
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From this study, it can be seen that although hydrocortisone 
apparently causes a dramatic decrease in affinity of glutamate 
receptors for its ligand in rat forebrain, it causes a massive 
increase in the number of glutamate binding sites. Glucocorticoids 
are also known to cause increases in synaptic glutamate. by 
inhibiting the uptake of the amino acid by glial cells. Whether 
the rise in synaptic glutamate concentration would be sufficient 
to cause excessive stimulation of the glutamate receptors, in view 
of the decrease in affinity of the receptors for glutamate, remains 
to be established. Excessi ve stimulation of especially NMDA 
receptors 
potential 
in 
of 
the brain results in neuronal degeneration. The 
this mechanism to produce excessive neural damage 
warrants further attention. 
4.4 DISCUSSION 
The findings of these experiments, confirm that elevated 
circulating glucocorticoid levels can adversely affect normal 
physiology to the detriment of cerebral function. Hydrocortisone 
depletes free tryptophan stores by enhancing the catabolism of this 
essential amino acid by liver tryptophan pyrrolase. This has been 
shown previously to decrease brain serotonin which causes 
behavioural and mental disorders associated with deficiencies of 
the cerebral serotoninergic system {Young, 1981]. The ability of 
melatonin to inhibit tryptophan pyrrolase indicates a mechanism 
whereby the pineal gland may protect against excessive loss of free 
tryptophan and the reduction in brain serotonin. 
It was also shown that chronic hydrocortisone treatment causes a 
large increase in the number of glutamate receptors in the brain. 
Taken together with the finding that glucocorticoids inhibit the 
uptake of glutamate from synaptic clefts and thereby increase 
synaptic glutamate concentrations, it is possible that increased 
circulating glucocorticoid levels may result in increased 
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stimulation of cerebral glutamate receptors. Glutamate receptors 
in the central nervous system have been implicated in numerous 
neurodegenerative diseases, and protection against excessive 
stimulation of these receptors would be vital in preventing, or at 
least delaying, the degenerative loss of brain cells. 
Unfortunately, wi thin the duration of this· study, it was, for 
technical reasons, not possible to show that melatonin either 
interferes with the binding of glutamate to cerebral glutamate 
receptors, or affects the hydrocortisone-mediated increase in 
glutamate receptor numbers. However, in view of the cumulative 
evidence favouring an anti-stressogenic role for the pineal gland, 
and the ability of melatonin to alter the affinity of other 
cerebral receptors for their natural ligands (eg GABA {Niles, 1989] 
and corticosterone [Marinova er al, 1991]), the ability of 
melatonin and other pineal indoles to affect the binding of 
glutamate to cerebral glutamate receptors, warrants further 
research. 
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CHAPTER 5 
EFFECT OF GLUTAMATE AND GABA ON PINEAL GLAND 
BIOCHEMISTRY 
5 • 1 INTRODUCTION 
Glutamate is present in significant concentrations in the pineal 
gland [Collin and Oksche. 1981 J, and the proportion of this 
neurotoxic excitatory amino acid increases in the pineal gland with 
pineal maturation and aging. It has tentatively been suggested 
that glutamate exhibits a mild circadian rhythm in rats with 
nighttime levels being marginally lower than daytime levels. {Quay, 
1981] . 
Previously, the presence of glutamate in the pineal gland was 
attributed to the fact that it is the precursor of gamma-amino 
butyric acid (GABA). GABA, known to be present in the pineal, is 
synthesized from glutamate by a pyridoxal phosphate-dependent 
gl utamate decarboxylase. High a.nd low aff ini ty GABA receptors 
have been identified in the pineal gland. Chan and Ebadi [1980] 
showed that GABA exerts a chloride-dependent inhibition of the 
norepinephrine-induced stimulation of NAT activity in a 
dose-dependent manner. Foldes et a1 [1984] also reported that 
preincubation with GABA inhibits the norepinephrine-induced 
increase in NAT activity in pineal slices. However, the precise 
functional significance of GABA in the pineal gland, is unknown. 
Recen'tly. glutamate receptors have also been described in rat IKus 
et a1, 1990] and bovine [Ebadi et a1, 1986] pineal glands. The 
functional significance of these receptors remains to be 
established. Investigation into the role and function 'of glutamate 
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receptors in the pineal gland is warranted, not only to gain 
greater insight into the functioning and regulation of the pineal 
itself, but especially in view of the damaging toxic effects 
attributed to glutamate in the central nervous system. 
The aim of this series of experiments was to investigate the effect 
of glutamate and GABA on pineal biochemistry. 
5.2 THE EFFECT OF GLUTAMATE ON RAT PINEAL INDOLEAMINE METABOLISM 
IN ORGAN CULTURE 
5.2.1 Introduction 
Kus er al [1990], monitoring melatonin synthesis by pineal glands 
in an in virro perfusion system, recently reported that the rise 
in melatonin production stimulated by the addition of the a- and 
.a-adrenergic agonists. isoprenaline and phenylephrine respectively, 
was prevented when the pineal glands were preincubated with 
glutamate. The authors showed that the effect was not prevented 
by glutamate agonists to any of the known glutamate receptor 
populations. It was further shown, that the inhibition of 
melatonin production was not manifest when glutamate was 
administered together with isoprenaline and phenylephrine or when 
the pineals were stimulated with isoprenaline alone. The authors 
concluded that the inhibition of melatonin production was possibly 
mediated via a glutamate metabolite. such as GABA. 
In the first experiment, the effect of glutamate on 
isoprenaline-stimulated pineal glands was investigated in organ 
culture. 
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5.2.2 Materials and Methods 
Four groups of 5 male Wistar rats of the albino strain were 
randomly assembled. The animals were sacrificed between 10hOO and 
12hOO and their pineal glands were cultured in vitro for 24 hours 
in the presence of radioactive serotonin as described in section 
2.2.3. The first group of pineals was incubated in the presence 
of 100 ~M isoprenaline, and the second group, in the presence of 
100 ~M isoprenaline and 100 ~M L-glutamate. The third g~oup was 
incubated with 100 ~M glutamate for 4 hours before 100 ~M 
isoprenaline was added. The control pineals were incubated in the 
presence of the vehicle. After 24 hours, the incubation was 
terminated and the culture medium was analyzed for radioactive 
metabolites of pineal metabolism using thin layer chromatography 
and liquid scintillometry as outlined in section 2.2.4. 
5.2.3 Results 
The radioactivity corresponding to each of the indole metabolites 
isolated from the culture medium following the incubation of the 
pineal glands with [14 C]serotonin are tabulated in Table 5.1. The 
data were analyzed by one-way analysis of variance and statistical 
difference between groups were determined using the Bonferroni 
multiple range test. Values represent the mean ± SEM for n = 5. 
The indole metabolites, where significant differences were 
recorded. are graphically presented in Figures 5.1 - 5.6. 
Isoprenaline induced a significant increase in pineal 
N-ace~ylserotonin and melatonin synthesis from rHe] serotonin in 
pineal organ cultures. Preincubation of pineal glands with 
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TABLE 5.1 : Effect of Glutamate on Pineal Indoleamine Metabolism in Organ Culture 
dpm / 10 ~l medium / pineal gland ± SEM 
INDOLE 
CONTROL ISOPRENALINE GLUTAMATE GLUTAMATE 
+ + 4 HOUR I ISOPRENALINE ISOPRENALINE 
N-acetylserotonin 2439 ± 504 4611 ± 574 1231 ± 393 1391 ± 197 
Melatonin 2047 ± 250 5187 ± 305 1805 ± 406 2444 ± 227 
Hydroxyindole 
acetic acid 37112 ± 5188 17739 ± 2039 21566 ± 2900 20365 ± 4270 
Hydroxytryptophol 15984 ± 4727 4179 ± 620 5363 ± 478 9701 ± 2359 
Methoxyindole 
acetic acid 293 ± 41 75 ± 14 102 ± 12 107 ± 7 
Methoxytryptophol 290 ± 48 195 ± 37 161 ± 34 269 ± 56 
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glutamate for four hours, as well as simultaneous administration 
of glutamate and isoprenaline, significantly inhibited the 
isoprenaline-induced increase in N-acetylserotonin and melatonin 
production (p < 0.001). Nei ther of the glutamate treatments 
affected the isoprenaline-induced decrease in 5-hydroxyindole 
acetic acid (p < 0.05), 5-hydroxytryptophol (p < 0.05) or 
5-methoxyindole acetic acid production (p < 0.01) . 
5-Methoxytryptophol synthesis was unaffected by any of isoprenaline 
or glutamate treatments. 
5.2.4 Discussion 
The results from this study indicate that glutamate inhibits the 
isoprenaline-stimulated rise in pineal melatonin production. This 
is in agreement with the findings of Kus et a1 [1990]. 
Additionally. the inhibition of melatonin synthesis was 
demonstrated in the absence of a-adrenergic receptor stimulation, 
and also when glutamate and isoprenaline were administered 
simultaneously. The latter observation suggests that glutamate 
itself could. at least partly. be responsible for the inhibition 
of melatonin production. However, in contrast with the perfusion 
system employed by Kus et a1 f1990] which enabled the continual 
measurement of pineal melatonin synthesis over short time periods, 
the organ culture method employed in this study, measures the 
quanti ty of melatonin which accumulates over the 6 hour incubation 
period. Therefore, it is possible that, even when glutamate and 
isoprenaline were administered simultaneously, the glutamate was 
converted to a metabolite with inhibitory effects on melatonin 
synthesis. 
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5.3 THE EFFECT OF GABA ON RAT PINEAL INDOLEAMINE METABOLISM IN 
ORGAN CULTURE 
5.3.1 Introduction 
It had previously been suggested that the principal effects of 
glutamate in the pineal gland were mediated by a glutamate 
metabolite, since preincubation of the pineal gland with glutamate 
was essential for the demonstration of its inhibitory influence on 
melatonin synthesis [Kus e-c a1, 1990). The incubation time was 
deemed necessary for the conversion of glutamate to its 
physiologically active metabolite. With the knowledge that GAB A 
receptors have been demonstrated in the pineal gland [Chan and 
Ebadi, 1980], GABA was considered the most likely candidate. 
In the initial experiment in this study, it was demonstrated that 
simultaneous administration of glutamate and isoprenaline could 
inhibi t the isoprenaline-induced rise in N-acetylserotonin and 
melatonin production in organ culture. Due to the fact that in 
an organ culture system, there would be time for glutamate to be 
converted to a physiologically active metabolite, which could, 
after the required lag period, decrease the accumulation of 
melatonin, it is possible that glutamate itself could be exerting 
the inhibitory influences on pineal melatonin synthesis. 
The aim of this experiment was to determine whether GABA, an 
important metabolite of glutamate. could mimic the effects of 
glutamate observed in the previous experiment. 
5.3.2 Materials and Methods 
Three groups of 6 male Wistar rats of the albino strain were 
randomly assembled. The animals were sacrificed between lOhOO and 
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12hOO and their pineal glands were cultured in vi~ro for 24 hours 
in the presence of radioactive serotonin as described in section 
2.2.3. The first group of pineals was incubated in the presence 
of 100 ~M isoprenaline, and the second group, in the presence of 
100 ~M isoprenaline and 100 ~M GABA. The control pineals were 
incubated in the presence of the vehicle. After 24 hours, the 
incubation was terminated and the culture medium was analyzed for 
radioactive metabolites of pineal metabolism using thin layer 
chromatography and liquid scintillometry as outlined in section 
2.2.4. 
5.3.3 Results 
The radioactivity corresponding to each of the indole metabolites 
isolated from the culture medium following the incubation of the 
pineal glands with [14C] serotonin are tabulated in Table 5.2. The 
data were analyzed by one-way analysis of variance and statistical 
difference between groups were determined using the Bonferroni 
multiple range test. Values represent the mean ± SEM for n = 5. 
The indole metabolites. where significant differences were 
recorded, are graphically presented in Figures 5.7 - 5.9. 
Isoprenaline induced a significant increase in pineal 
N-acetylserotonin and melatonin synthesis from [HC] serotonin in 
pineal organ cultures. GABA significantly inhibited the 
isoprenaline-induced increase in N-acetylserotonin synthesis (p < 
0.05), but effected only a marginal, insignificant decrease in the 
isoprenaline-stimulated rise in melatonin production, so that it 
was no longer significantly different from control values. 
Furthermore. GABA enhanced the isoprenaline-induced decrease in 
5-hydroxytryptophol production by pineal organ cultures (p < 0.05) . 
5-Hydroxy- and 5-methoxy-indole acetic acid and 5-methoxytryptophol 
were unaffected by either isoprenaline or GABA. 
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TABLE 5.2 Effect of GABA on Pineal Indoleamine Metabolism in 
Organ Culture 
dpm I 10 ~l medium I pineal gland ± SEM 
INDOLE 
CONTROL ISOPRENALINE GABA + 
ISOPRENALINE 
N-acetylserotonin 2299 ± 542 4558 ± 1031 2787 ± 712 
Melatonin 2607 ± 347 4639 ± 751 4417 ± 582 
Hydroxyindole 
acetic acid 21985 ± 2270 27483 ± 4109 30864 ± 4562 
Hydroxytryptophol 16638 ± 5077 11684 ± 2499 4226 ± 582 
Methoxyindole 
acetic acid 224 ± 47 131 ± 35 169 ± 46 
Methoxytryptophol 196 ± 14 201 ± 43 148 ± 17 
5.3.4 Discussion 
Although GABA could mimic the inhibitory effect of glutamate on the 
isoprenaline-stimulated accumulation in N-acetylserotonin, it did 
not significantly inhibit melatonin production. A possible 
explanation is that GABA, rather than exert inhibitory effects, 
actually enhances the conversion of N-acetylserotonin to melatonin. 
This would also explain why there was less serotonin precursor 
available for conversion to 5-hydroxytryptophol. Balemans and 
co-workers [cf. Ebadi et a1, 1986] demonstrated that the addition 
of GABA together with an acetyl donor, resulted in a significant 
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increase in the synthesis of the N-acetylated products. Hence there 
are indications that GABA may stimulate rather than inhibit pineal 
indoleamine synthesis. Typically the amounts of the methoxyindoles 
are very small and the amount of hydroxyindole acetic acid, very 
large. Hence. the failure of the treatments to induce significant 
differences in these indoles is not unusual. 
5.4 THE EFFECT OF GLUTAMATE ON RAT PINEAL N-ACETYLTRANSFERASE 
ACTIVITY 
5.4.1 Introduction 
It has thus far been demonstrated that the influence of glutamate 
on pineal N-acetylserotonin and melatonin synthesis in pineal organ 
cuI tures is primarily inhibitory. GABA was able to mimic the 
inhibitory effect of glutamate on N-acetylserotonin, but not on 
melatonin accumulation. A possible explanation is that GABA 
enhances the conversion of N-acetylserotonin to melatonin, while 
glutamate inhibits the melatonin biosynthetic pathway at a point 
prior to the synthesis of N-acetylserotonin. To investigate this 
possibility, the effect of glutamate on NAT, the principal 
regulatory enzyme in the melatonin biosynthetic pathway. was 
examined. NAT is responsible for converting serotonin to 
N-acetylserotonin. In addition to monitoring basal NAT activity 
during the day when it is generally low, 'a a-adrenergic agonist, 
isoprenaline. was used to mimic the nighttime rise in enzyme 
activity. This made it possible to determine the effect of 
glutamate on .a-adrenergic stimulated NAT activity. 
- 187 -
5.4.2 Materials and Methods 
Four groups of five male Wistar rats of the albino strain were 
randomly assembled. The animals were sacrificed between 10hOO and 
12hOO and their pineal glands were cultured in vitro for 6 hours. 
The first group of pineals was incubated in the presence of 100 ~M 
isoprenaline; the second group, in the presence of 100 ~M glutamate 
and the third group, in the presence of 100 ~M isoprenaline and 
100 ~M L-glutamate. The control pineals were incubated in the 
presence of the vehicle. After 6 hours, the incubation was 
terminated by freezing the pineal glands on dry ice. The pineals 
were then assayed for NAT activity according to the scheme 
described in section 2.3. This freezing procedure is known not to 
alter NAT activity. 
5.4.3 Results 
The enzyme activity. expressed as pmoles N-acetyltryptamine formed 
per pineal gland per hour. was calculated as described in section 
2.3.4. The data were analyzed by one-way analysis of variance and 
statistical differences between groups were determined using the 
Bonferroni multiple range test. Values which represent the mean 
± SEM (n = 5). are tabulated in Table 5.3 and graphically presented 
in Figure 5.10. 
Glutamate significantly increased basal NAT activity (p < 0.05). 
Isoprenaline also effected a significant increase in basal NAT 
activity of similar magnitude in both control and glutamate treated 
pineal glands (p < 0.01). 
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TABLE 5.3 Effect of Glutamate on N-Acetyltransferase Activity 
in Rat Pineal Glands 
TREATMENT pMoles N-ACETYLTRYPTAMINE 
formed I pineal gland I hour 
Control 0.172 ± 0.0063 
Isoprenaline 0.268 ± 0.0148 
Glutamate 0.251 ± 0.0143 
Glutamate + 
Isoprenaline 0.345 ± 0.0333 
5.4.4 Discussion 
The ability of glutamate to increase basal pineal NAT activity, is 
in conflict with the finding that the amino acid inhibits the 
accumulation of N-acetylserotonin.~ and melatonin in pineal organ 
cultures. No explanation is immediately obvious. 
It is possible to propose that glutamate may be converted to GABA 
during the organ culture incubation and the stimulation of NAT 
activity observed is actually due to GABA. This theory would be 
in keeping with the findings of Balemans and co-workers Icf. Ebadi 
et 81, 1986] that GABA enhances the B-adrenergic stimulated 
synthesis of N-acetylated products in the pineal gland. However, 
this would not explain the ability of glutamate to inhibit 
melatonin synthesis in organ culture. It would probably have been 
advisable to include a glutamate decarboxylase inhibitor in the 
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culture medium to prevent any possible conversion of glutamate to 
GABA. 
Another possibility is that glutamate only inhibits melatonin 
synthesis in intact tissue and that the effect is lost when the 
cell membranes are disrupted. Rather than acting directly on the 
biosynthesis of melatonin, glutamate may be acting via receptors 
to initiate an intracellular series of events which leads to the 
inhibition of melatonin synthesis. For example, glutamate is an 
agonist at NMDA receptors. NMDA receptors are ion-channel linked 
and have been associated with extensive intracellular mobilization 
of calcium [Meldrum and Garthwaite, 1990]. Recently, Olivieri and 
Daya [1992] proposed that intracellular calcium concentrations are 
important for the regulation of pineal NAT activity. These authors 
implied that high levels of intracellular calcium exert inhibitory 
effects on NAT activity. This would subsequently lead to decreased 
melatonin synthesis. Development of this idea awaits greater 
understanding of the pineal glutamate receptor population involved. 
5.5 THE EFFECT OF GLUTAMATE ON RAT PINEAL HYDROXYINDDLE-O-
METHYLTRANSFERASE 
5.5.1 Introduction 
Having demonstrated that glutamate stimulates NAT acti vi ty although 
it causes a decrease in N-acetylserotonin and melatonin synthesis 
from serotonin by pineal glands in organ culture, the effect of 
glutamate on HIOMT activity was investigated. HIOMT is responsible 
for the conversion of N-acetylserotonin to melatonin, and it is 
possible that the glutamate-induced decrease in melatonin synthesis 
could result from a possible inhibition of HIOMT by glutamate. 
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5.5.2 Materials and Methods 
Two groups of five male Wi star rats of the albino strain were· 
randomly assembled. The rats were sacrificed at lOhOO and their 
pineal glands were rapidly removed. The pineals were assayed for 
HIOMT activity according to the scheme described in section 2.4. 
5.5.3 Results 
The enzyme activity, expressed as pmoles [14C]melatonin formed per 
pineal gland per hour. was calculated as described in section 
2.4.4. The data were analyzed by one-way analysis of variance and 
statistical difference between groups were determined using the 
Students t-test. Values which represent the mean ± SEM (n = 5), 
are tabulated in Table 5.4 and graphically presented in Figure 
5.11. 
TABLE 5.4 Effect of Glutamate on Hydroxyindole-O-
Methyltransferase Activity in Rat Pineal Glands 
TREATMENT pMoles MELATONIN 
formed / pineal gland / hour 
Control 13.055 ± 12.088 
Glutamate 13.363 ± 11.041 
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Glutamate did not significantly affect HIOMT activity in vitro. 
5.5.4 Discussion 
The finding that glutamate did not influence pineal HIOMT activity 
is not unexpected. The enzyme appears to be very stable and does 
not exhibit rapid or extreme changes in acti vi ty. It is not 
believed to be involved in the pineal melatonin circadian rhythm 
and does not respond rapidly to changes in the photoperiod as NAT 
is known to do. Most evidence suggests that HIOMT activity is only 
affected by long term treatments. 
5.6 DISCUSSION 
The presence of large concentrations of glutamate in the pineal 
gland, has been appreciated for many years. Its function in the 
pineal was primarily considered to be that of precursor to GABA. 
an amino acid with high and low affinity binding sites previously 
described in the pineal gland [Chan and Ebadi, 1980]. However, 
recently glutamate receptors have been described in the pineal 
gland and although their functional significance remains to be 
defined, a more direct influence of glutamate on the pineal is 
implied. In view of the important regulatory role ascribed to the 
pineal gland. and the toxic effects of glutamate in the central 
nervous system. the identity, function and operation of pineal 
glutamate receptors requires attention. 
Previously, preincubation of pineal glands with glutamate was found 
to inhibit the increase in melatonin synthesis following the 
administration of isoprenaline and phenylephrine [Kus et a1, 1990]. 
In this study. glutamate was found to inhibit the increase in 
melatonin synthesis in organ culture when the pineal glands were 
stimulated with isoprenaline alone, and when the pineals were not 
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preincubated with glutamate. It is, however, difficult to 
distinguish between the effects of glutamate and the possible 
action of its metabol i te, GABA, in organ culture. Presumably, 
glutamate is converted to GABA by glutamate decarboxylase in the 
pineal glands during the incubation period. In an attempt to 
ascertain whether the effects of glutamate on melatonin synthesis 
in pineal organ culture could be simulated by GABA, it was found 
that the inhibition of isoprenaline-stimulated melatonin 
accumulation by GABA was insignificant. Although the 
isoprenaline stimulated N-acetylserotonin levels were significantly 
lower in the presence of GABA, this could possibly indicate 
enhanced conversion of N-acetylserotonin to melatonin. It thus 
appeared that the inhibition of melatonin synthesis was directly 
due to the action of glutamate rather than GABA. 
An attempt was then made to determine the point at which glutamate 
inhibi ts the conversion of serotonin to N-acetylserotonin and 
melatonin. In conflict with the findings from the organ culture 
experiment, glutamate increased both basal and isoprenaline 
stimulated NAT activity, although it did not affect HIOMT activity. 
It can only be proposed that the ability of glutamate to inhibit 
melatonin biosynthesis is lost when the intact organ is disrupted 
by homogenization. 
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CHAPTER 6 
SUMMARY 
A general review of pineal gland anatomy, biochemistry and function 
reveals that this once disregarded, diminutive structure on top of 
the brain has evolved into a sophisticated. neuroendocrine gland 
capable of eliciting a multi tude of effects. These multiple 
influences have been collectively interpreted as reflecting a 
general regulatory role for the pineal gland maintaining 
homeostasis in close association with changing environmental 
conditions. The long-standing role played by the adrenal glands 
in modulating homeostatic equilibrium in vivo is undisputed and an 
interaction between the pineal gland and the adrenal glands has 
been inferred, but not conclusively established. Manipulation of 
pineal output has produced results consistent with an inhibitory 
influence of the pineal gland on adrenal function. However, there 
is a scarcity of information available on the influence of modified 
adrenal output on pineal function and much of this literature is 
inconclusive and controversial. This matter is worthy of deeper 
understanding because if the pineal gland were to regulate adrenal 
function, it would be necessary for the pineal to detect and 
respond to altered adrenal output. 
The secretion of glucocorticoids is a major neuroendocrine 
consequence of adrenal gland stimulation, especially in response 
to stressful stimuli which challenge homeostatic equilibrium. The 
primary objective of this study was therefore to examine the 
possible influence of increased circulating glucocorticoid levels 
on pineal indole metabolism. The animals were treated orally with 
the glucocorticoid, hydrocortisone, to overcome the variable 
influences arising from subjecting the animals to any of a variety 
of stressors, as has been the pattern in previous research. The 
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resul ts show that seven days of oral hydrocortisone treatment 
endows the pineal gland with the ability to increase the synthesis 
of r14C]melatonin from r14C] serotonin in pineal organ cultures. This 
increase in melatonin synthesis was accompanied by a rise in NAT 
activity, cyclic AMP levels and enhanced binding of B-adrenergic 
agonists to the pineal B-adrenergic receptors. The hydrocortisone 
treatment resulted in small increases in basal NAT and cyclic AMP 
levels, but dramatically increased these parameters under B-
adrenergic stimulation. In view of this. it was proposed that 
hydrocortisone. rather than directly increasing melatonin 
production via a mechanism involving cytosolic steroid receptors, 
acted by sensitizing the pineal gland to 13-adrenergic agonists 
rendering the pineal more responsive to B-adrenergic stimulation. 
Under conditions of chronic or prolonged stress, the ability of the 
HPA axis to terminate the release of glucocorticoids from the 
adrenal glands, is severely impaired. The result is elevated 
circulating glucocorticoid levels which produce numerous 
deleterious physiological side effects, the most serious of which 
is damage to the brain and disruption of cerebral function. The 
second objective of this study was to investigate whether the 
principal pineal indole, melatonin, could protect against the 
deleterious effects of elevated circulating hydrocortisone levels. 
The results show that chronic oral hydrocortisone treatment 
significantly increases liver tryptophan pyrrolase apoenzyme 
activity; The catabolism of tryptophan by tryptophan pyrrolase is 
an important peripheral determinant of tryptophan availability to 
the ,brain. and subsequently of brain serotonin levels. The results 
further show that melatonin inhibits both basal and hydrocortisone-
stimulated liver tryptophan pyrrolase activity in a dose-dependent 
manner. This inhibition suggests that melatonin may protect 
against excessive loss of tryptophan from circulation and against 
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deficiencies in the cerebral serotoninergic system which have been 
associated with mood and behavioural disorders. 
Another deleterious effect of sustained elevated glucocorticoid 
levels is inhibition of the re-uptake of excitatory amino acid 
neurotransmitters from the synaptic clefts in the CNS. Glutamate 
is a neurotoxic, excitatory amino acid which accumulates in the 
synaptic clefts and excessive stimulation by this neurotransmitter 
at especially NMDA receptors, has been associated with potent 
neural damage. The results show that chronic hydrocortisone 
treatment decreased the affinity of glutamate binding sites in the 
rat brain for glutamate, but caused a 30-fold increase in the 
number of glutamate receptors in rat cerebral membranes. The 
abili ty of melatonin to protect against either the binding of 
glutamate to cerebral glutamate receptors, or to interfere with the 
hydrocortisone-mediated increase in glutamate receptor numbers 
could not be demonstrated due to practical problems with the 
radioligand binding assay. However, the possible influence of the 
pineal gland in protecting against glutamate-induced neural 
degeneration should not be overlooked by future research. 
In view of the neurotoxic effects of glutamate on the CNS, the 
functional significance of recently described glutamate receptors 
in the pineal gland was investigated. The results show that 10·4M 
glutamate significantly inhibits isoprenaline-stimulated N-
acetyl serotonin and melatonin synthesis in organ cultures. This 
effect was demonstrated when the pineal glands were pre-incubated 
wi th glutamate prior to the addition of isoprenaline, and when 
glutamate was administered together with isoprenaline in vitro. 
GABA,' a glutamate metabolite could not mimic the glutamate-induced 
decrease in isoprenaline-stimulated melatonin synthesis by pineal 
organ cultures, and it is likely that the observed effect was 
directly due to glutamate. Incubation of the pineal glands with 
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10-4M glutamate did not affect HIOMT activity in pineal homogenates, 
but significantly elevated both basal and isoprenaline-stimulated 
NAT activity in pineal homogenates in vitro. It was proposed that 
glutamate only inhibits melatonin synthesis in intact tissue. 
possibly by a receptor-mediated series of events and that the 
effect is lost when the pinealocytes are disrupted by 
homogenization. 
The present study has provided further support for an interaction 
between the pineal and the adrenal glands, by showing that pineal 
biochemistry is altered by enhanced adrenocorticoid activity. It 
has also shown that the principal pineal indole, melatonin, may 
protect against at least one of the adverse effects arising from 
elevated circulating hydrocortisone levels. such as those 
associated with chronic or long-term stress. There is an ever 
increasing likelihood that melatonin is an anti-stressogenic 
hormone and that the pineal gland may have a protective role to 
play in the pathology of stress-related diseases. In view of the 
severi ty of such diseases in modern day societies. the anti-
stressogenic effects of the pineal gland are deserving of further 
investigation. 
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